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Enzymes and cofactors. Enzymes are polypeptides consisting of a combination of twenty 
different and common L-α-amino acids, just like all proteins. They form a heterogeneous 
group of complex macromolecules, and catalyze many types of chemical reactions. The 
conformation and properties of a subset of these twenty L-α-amino acid side chains are crucial 
for function. In general only catalysis of general acid/base and nucleophilic/electrophilic 
reactions are allowed and therefore enzymes bind cofactors, organic or inorganic molecules 
such as metal-ions, biotin, heme, and nicotinamide adenine dinucleotide, which provide 
functional groups or particular properties that are not provided by the side chains of 
the enzyme’s L-α-amino acids (Broderick, 2000). More specific examples, relevant to the 
work described in this thesis, are the cofactor bound by the intra-molecular isomerase 
phenylalanine-2,3-aminomutase (PAM) (Chapter 5), the 4-methylidene-imidazole-5-one 
(MIO) prosthetic group, generated from internal condensation reactions of a three-amino-
acid sequence motif, and the cofactor bound by the inter-molecular β-aminotransferase 
from Mesorhizobium sp. LUK (MesAT) (Chapter 3) and β-aminotransferase from Variovorax 
paradoxus (VpAT) (Chapter 4), the pyridoxal-5’-phosphate (PLP) cofactor.
The PLP cofactor. The PLP cofactor is synthesized by PLP synthase, which is a glutamine-
dependent amidotransferase (Massiere & Badet-Denisot, 1998) with two domains, a Pdx1 
and a Pdx2 domain. The Pdx2 domain hydrolyses glutamine to glutamate and ammonia. 
The Pdx1 domain condenses the ammonia molecule generated by the Pdx2 domain with 
glyceraldehyde-3-phosphate and D-ribose-5-phosphate (Fig. 1) (Mukherjee et al., 2011). 
The enzymes that bind PLP (PLP-dependent enzymes) catalyze more than 160 distinct 
reactions (Percudani & Peracchi, 2009) and are found in enzyme groups 1 (oxidoreductases), 
2  (transferases), 3 (hydrolases), 4 (lyases) and 5 (isomerases), but not in enzyme group 
6 (ligases). These latter enzymes depend on nucleoside triphosphate hydrolysis for catalysis 
(Webb, 1992). Most PLP-dependent enzymes catalyze a transferase reaction (Enzyme 
Commission (EC) nr. 2); they represent 59 % of the total number (418) of structurally 
characterized PLP-dependent enzymes. The second most common reaction that PLP-
dependent enzymes catalyze is the lyase reaction (EC nr. 4). These enzymes represent 31 % 
of the total number of structurally characterized PLP-dependent enzymes. The remaining 
10  % structurally characterized PLP-dependent enzymes catalyze an oxidoreductase 
reaction (0.2 %), a hydrolase reaction (1.8 %) or an isomerase reaction (8 %), respectively. It 
Figure 1. Synthesis of pyridoxal-5’-phosphate (PLP). The amino group originates from glutamine. Pdx1 
binds D-ribose-5-phosphate (R5P) via the ε-amine group of K81 (G3P = glyceraldehyde-3-phosphate). 
Figure adapted from Mukherjee et al. (2011).
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Introduction
1is thus evident that the distribution of PLP-dependent enzymes among the enzyme groups 
is rather asymmetric. An example of a PLP-dependent enzyme that catalyzes an isomerase 
reaction is alanine racemase (PDB entry 1SFT (Shaw et al., 1997)). This enzyme catalyzes 
an isomerization reaction in which L-α-alanine is converted into D-α-alanine (Fig. 2A), 
an essential reaction for the synthesis of the peptidoglycan layer of the cell wall of Gram-
negative and Gram-positive bacteria (Wasserman et al., 1984; Wood & Gunsalus, 1951). An 
example of a PLP-dependent hydrolase is kynureninase (PDB entry 1QZ9 (Momany et al., 
2004)). The enzyme catalyzes the hydrolytic cleavage of L-α-kynurenine into anthranilate 
and L-α-alanine (Fig. 2B), a key step in tryptophan catabolism (Phillips, 2011). An example 
of a PLP-dependent enzyme that catalyzes an oxidoreductase reaction is P-protein (PDB 
entry 1WYU (Nakai et al., 2005)). P-protein is a component of the glycine cleavage system 
composed of the P-, H-, T- and L-protein. P-protein decarboxylates glycine and reduces 
the lipoyl-lysine arm of the H-protein with the amino-methyl group generated from the 
decarboxylated glycine (Fig. 2C) (Douce et al., 2001). PLP-dependent enzymes that catalyze 
a lyase reaction cleave C-C/C-N/C-S or other types of bonds or, in the reverse reaction, add 
Figure 2. Examples of reactions catalyzed by PLP-dependent enzymes. A) The reaction catalyzed by 
alanine racemase. B) The reaction catalyzed by kynureninase. C) The reaction catalyzed by P-protein. 




functional groups to double bonds. An example of a PLP-dependent lyase is aspartate-β-
decarboxylase (PDB entry 3FDD (Lima et al., 2009) that converts L-α-aspartate into L-α-
alanine and CO2 (Fig. 2D) and functions in a pathway that, in anaerobic bacteria, generates 
adenosine triphosphate via decarboxylation phosphorylation (Dimroth & Schink, 1998). Last, 
PLP-dependent enzymes that catalyze transferase reactions (EC nr. 2) transfer a functional 
group, a one-carbon group, acyl-group, glycosyl-group, aryl- or alkyl-group or nitrogen-
containing group (EC nr. 2.6) from compound A (the donor) to compound B (the acceptor) 
(246 known structures in total). PLP-dependent enzymes that transfer an amino group from 
molecule A to molecule B (EC nr. 2.6.1) are named aminotransferases or transaminases. 
These enzymes represent 65 % of the total number of structurally characterized transferases. 
An example of an aminotransferase is aspartate aminotransferase (PDB entry 2AAT (Smith 
et al., 1989)) that converts L-α-aspartate and α-ketoglutarate into oxaloacetate and L-α-
glutamate (Fig. 2E).
Amino group transfer: historical background. The phenomenon of amino group transfer 
between two molecules was established in 1930 by Moyle-Needham who found that the 
addition of glutamate and aspartate to minced muscle led to an increase in the levels 
of succinate, fumarate and malate without forming ammonia, urea, uric-acid or amide 
nitrogen (Moyle-Needham, 1930). For this reason it was hypothesized that the amino 
group of glutamate/aspartate combines with a reactive carbon chain, and that splitting 
and oxidation of the aminated carbon chain generates a new α-amino acid. The hypothesis 
was confirmed when it was found in subsequent research that glutamate, in muscle tissue, 
is converted into α-ketoglutarate and that the amino group of glutamate is transferred 
to pyruvate, which generated alanine, a new amino acid (L-α-glutamate + pyruvate D 
α-ketoglutarate + L-α-alanine), a reaction referred to as Um-aminierung (Braunstein & 
Kritzmann, 1937). Hereafter it was demonstrated that the reaction also occurred in the 
absence of muscle tissue, when in solution, after autoclaving, an α-amino acid and pyridoxal 
(PL) (Fig. 3) were converted into an α-keto acid and pyridoxamine (PM) (Fig. 3) (Snell, 
1945). This non-enzyme PL catalyzed reaction was therefore proposed to be a model of 
enzyme-catalyzed aminotransferase reactions (Snell, 1953). It was furthermore shown that 
most enzyme-catalyzed reactions could be duplicated by non-enzyme, PL (+ metal-salt) 
catalyzed reactions with the exception of the lyase reaction (Fig. 9D) (Metzler et al., 1954). 
Therefore non-enzyme PL(P) (+ metal-salt) catalyzed transferase/lyase/isomerase reactions 




1were proposed to represent models of reactions catalyzed by PLP-dependent enzymes (Snell, 
1953) and it was proposed that non-enzyme, and enzyme-catalyzed reactions proceed via 
similar mechanisms (Metzler et al., 1954).
Insight into this mechanism was reached via experiments with non-enzyme catalyzed 
reactions. For example, experiments with analogues of PL revealed that the 3’-OH group, and 
a strong electron-withdrawing group in the 4- or 6-position of the PL ring, were required for 
catalysis (Fig. 4) (Ikawa & Snell, 1954; Metzler et al., 1954). It was further established: a) that 
since glutamate and PL generated α-ketoglutarate and PM (Snell, 1945), the formyl-group of 
PL was reactive and likely formed an imine with an amino acid substrate (Fig. 5), b) that the 
formation of an imine with PL(P) increased the reactivity of the enzyme because, as shown 
via non-enzyme catalyzed reactions, a PL(P) imine was more reactive (> 30 fold) than its 
free aldehyde (Cordes & Jencks, 1962), and c) that the phosphate-group of PLP prevented 
formation of a cyclic hemi-acetal (Fig. 6) as concluded after comparison of non-enzyme PL 
versus a non-enzyme PLP catalyzed reactions (Metzler & Snell, 1952). These experiments 
Figure 4. Three derivatives of PL. A) 2-formyl-3-hydroxypyridine. B) 4-nitro-salicylaldehyde. 
C) 6-nitro-salicylaldehyde.
Figure 5. A) An imine. B) A secondary aldimine. R1 is the C4-atom of PLP. C) A secondary ketimine. 
R3 is the C4A-atom of PLP.
Figure 6. The formation of the cyclic hemi-acetal of PL (right) in solution, diminishes the concentration 
of reactive PL.
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1subsequently led to the formulation of a general mechanism for non-enzyme PL(P) catalyzed 
reactions. It was proposed that the formation of an imine (external aldimine) resulted in a 
planar system of conjugated double bonds in which electrons from bonds attached to the 
Cα-atom of the bound amino acid substrate migrate toward the electrophilic, heterocyclic 
nitrogen atom of PL(P) (Fig. 7). It was hypothesized that this leads to a decrease in the 
electron density around the Cα-atom of the bound amino acid substrate and to the release 
of a proton, a carboxyl-group or another R-group from an amino acid substrate, which 
results in catalysis of a transferase/isomerase, lyase or another (R)-type reaction (Fig. 8) 
(Metzler et al., 1954).
In 1957 it was finally proven that enzymes bind PLP (Baranowski et al., 1957) and that 
the cofactor was bound by the enzyme via a covalent bond between the formyl-group of 
the cofactor, and the ε-amino group of a lysine residue (internal aldimine, Fig. 10) (Fischer 
et al., 1958). In addition, the general mechanism of enzyme-catalyzed PLP-dependent 
reactions was further developed by Perault et al. (1961), who pointed out that the Cα-atom 
of the external aldimine is not part of a planar system of conjugated double bonds (Fig. 10). 
Figure 7. The electrophilic pyridine N-atom of the PLP cofactor functions as an electron sink. Figure 
adapted from Metzler et al. (1954).
Figure 8. How PLP-dependent enzymes attain reaction specificity. The wedged σ-bond is perpendicular 
to π-system of the pyridine ring of the PLP cofactor. A) The conformation that results in catalysis of an 
isomerase or transferase reaction. B) The conformation that results in catalysis of an R-type reaction. 
C) The conformation that results in catalysis of a lyase reaction (decarboxylation). D) The metal ion 
(M) forms a chelate and prevents decarboxylation.
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1Their quantum mechanical calculations suggested that the driving force of labilization of 
any of the bonds attached to the Cα-atom (Fig. 7) was the gain in resonance energy upon 
formation of a transitional Schiff’s base (quinonoid, Fig. 10) that joins the isolated conjugated 
fragments of the external aldimine. Hereafter it was also revealed that the enzyme-catalyzed 
aminotransferase reaction was mediated by general acid-base catalysis, which was based 
upon experiments that showed that PL catalyzed an aminotransferase reaction at neutral 
pH, at room temperature, in the absence of metal-salt catalysts, but in the presence of 
imidazole (Bruice & Topping, 1962). It was therefore hypothesized that imidazole mediates 
a prototropic shift that facilitates the tautomeric re-arrangement between the external 
aldimine and the ketimine intermediates (Fig. 10). For enzyme-catalyzed aminotransferase 
reactions it was subsequently proposed that the prototropic shift was facilitated by general 
acid-base catalysis of the lysine residue that binds the PLP cofactor because the lysine residue 
is liberated once PLP forms the external aldimine (Fig. 9A, 10) (Snell, 1962).
A hypothesis on the reaction specificity of PLP-dependent enzymes was developed in 
1966 (Dunathan, 1966). The hypothesis was based on: a) experiments suggesting that the 
stereochemical preference of bromination of 3β-acetoxycholestan-7-one (a steroidal ketone) 
via its enol, was dictated by the degree of electron delocalization due to overlap of the 
Cα-atom σ-orbital and the π-orbital of the adjacent carbonyl C-atom (Corey & Sneen, 1956), 
b) the observation that the non-enzyme PLP catalyzed lyase reaction (decarboxylation) was 
inhibited by the addition of metal-salts (Fig. 8D) (Kalyankar & Snell, 1962), and c) the idea 
that if the gain in delocalization (resonance) energy (Perault et al., 1961) was to aid the bond 
breaking process, in the transition state, the bond to be broken must assume a geometry 
perpendicular to the plane of PL imine system (Fig. 8). It was therefore hypothesized that the 
architecture of the active site of a PLP-dependent enzyme controls the reaction specificity 
of the enzyme by controlling which bond, the Cα-H (for catalysis of a transferase/isomerase 
Figure 9. A) The 1,3-prototropic shift is catalyzed by a lysine (K) general acid-base. This residue is 
located at the si-face of the C4-atom of the PLP cofactor. B) The 1,1-prototropic shift is catalyzed by 
two bases: a tyrosine residue at the si-face of the C4-atom of the PLP cofactor and a lysine residue at 
the re-face of C4-atom of the PLP cofactor. The pyridine N-atom of the PLP cofactor is not protonated 
since the N-atom is near the side chain of an arginine residue, which contrasts with A) in which an 
aspartate residue protonates the pyridine N-atom.
16
1reaction) or Cα-COOH (for catalysis of a lyase reaction (decarboxylation)), is allowed to 
bind in a conformation perpendicular to the plane of the pyridine ring of the PLP cofactor 
(Fig.  8A-C). In addition, the reaction between DL-alanine and 3-hydroxypyridine-4-
aldehyde illustrated that the fate of the proton abstracted from the Cα-atom of the external 
aldimine also influenced the reaction specificity of a PLP-dependent enzyme (Fig. 9) (Auld 
& Bruice, 1967). If the abstracted proton was used to protonate the C4A-atom of the PLP 
cofactor (Fig. 3), a ketimine intermediate was generated and a (amino)transferase reaction 
was catalyzed (Fig. 9A), but if the proton was re-added to the Cα-atom of the external 
aldimine, before the ketimine intermediate was generated, the enzyme-catalyzed an 
isomerase (racemase) reaction (Fig. 9B).
Aspartate aminotransferase. The full primary structure of pig heart cytoplasmic aspartate 
aminotransferase (AspAT; L-α-aspartate + α-ketoglutarate D oxaloacetate + L-α-glutamate) 
was published in 1972 (Ovchinnikov et al., 1972) . A first low resolution (5 Å) 3D structure 
of cytosolic chicken heart AspAT was elucidated in 1978 (Borisov et al., 1978) and a 2.8 Å 
Figure 10. The reaction catalyzed by an aminotransferase. 1) An amino compound enters the active 
site of the enzyme and replaces the existing (internal) aldimine between the cofactor and the lysine 
general acid-base with an (external) aldimine between the amino group of the amino compound 
and the PLP cofactor. This process is named trans-aldimination. 2) The active site lysine residue (K) 
abstracts a proton. 3) Tautomeric re-arrangements and re-protonation at the C4A-atom of the PLP 
cofactor. 4) Hydrolysis and formation of a keto-compound.
17
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1resolution 3D structure of mitochondrial AspAT followed in 1980 (Ford et al., 1980). These 
data revealed that two monomers assembled into a homo-dimer and that each monomer 
was composed of a small domain (NC-domain, Chapter 3) and a large PLP-binding domain 
that contains a seven stranded α/β-motif, whereby chains pass alternately through helices 
and sheet strands. In addition, it was revealed that residues from both domains formed 
each of the two active sites of the enzyme, that the PLP-binding domain bound the cofactor 
through the ε-amine group of a lysine residue (K258), and that the pyridine N-atom of the 
PLP cofactor interacted with an aspartate residue (D222). Analogue bound structures of 
AspAT further revealed that R386, located at the 3’-O side of the PLP cofactor (analogous to 
AroAT, Chapter 3, Fig. 3)), bound the α-carboxylate group of L-α-aspartate while R292, on 
Figure 11. The 3D structures of PLP-dependent enzymes that represent fold-types I through V 
(A-E). A) The 3D structure of aspartate aminotransferase monomer; the enzyme’s quarternary 
structure is a dimer, which is the same for the enzymes mentioned in B-E. B) The 3D structure of 
the monomer of tryptophan synthase, which consists of an α-subunit and a β-subunit. C) The 3D 
structure of the monomer of alanine racemase. D). The 3D structure of the monomer of D-α-amino 
acid aminotransferase. E) The 3D structure of the monomer of glycogen phosphorylase. The right half 
of the figure is a domain with a Rossmann-fold that binds adenosine monophosphate.
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1the phosphate side of the cofactor bound the β-carboxylate group of L-α-aspartate (Kirsch 
et al., 1984). This study also presented a detailed mechanism for the forward half reaction 
catalyzed by AspAT that started from the internal aldimine and an α-amino acid substrate 
and ended with pyridoxamine phosphate (Fig. 3D) and an α-keto acid (Fig. 10). Further 
studies subsequently revealed: a) that D222 stabilized the protonation of the pyridine 
N-atom of the PLP cofactor that served to enhance the electron-withdrawing ability of 
the cofactor, which is critical to the elimination of the Cα-proton of an α-amino substrate 
(Yano et al., 1993; Yano et al., 1992) (Fig. 8A), b) that K258 was the general acid-base catalyst 
that mediated the 1,3-prototropic shift (Fig. 9A) and thus mediated the external aldimine/
ketime transition (Toney & Kirsch, 1993), c) that proton abstraction from the Cα-atom of 
an amino acid substrate was the rate limiting step in the forward half reaction while in the 
reverse half reaction, proton abstraction from the C4A-atom of PLP cofactor was the rate 
limiting step (Sterk & Gehring, 1991; Malashkevich et al., 1995), d) that the aminotransferase 
reaction had multiple partially rate determining steps (Cα-proton abstraction, ketimine 
hydrolysis and keto acid dissociation) (Goldberg & Kirsch, 1996), and e) that the torsional 
strain of the protonated internal aldimine (Fig. 10) enhanced the catalytic ability of aspartate 
aminotransferase by increasing the energy level of the free enzyme plus substrate, relative 
to the transition state (Hayashi et al., 1998).
Structural classification of PLP-dependent enzymes. The determination of the 3D structure 
of AspAT was followed by the elucidation of structures of many other PLP-dependent 
enzymes. The structures of these enzymes have currently been classified into seven fold-
types (http://bioinformatics.unipr.it/B6db (Percudani & Peracchi, 2009)). The 3D structure 
of AspAT represents the archetype of fold-type I PLP-dependent enzymes (Fig.  11A), 
which catalyze oxidoreductase/transferase/hydrolase/lyase and isomerase reactions (EC 
nr. 1-5). The 3D structure of tryptophan synthase with PDB entry 1BKS (Rhee et al., 1996), 
a multi-enzyme complex of four (α2β2) subunits, represents the archetype of fold-type II 
PLP-dependent enzymes (Fig. 11B). The α-subunit has an 8-fold α/β-barrel structure (TIM-
Figure 12. A) The amino acid side chains bind at the phosphate side of the PLP cofactor and the enzyme 
catalyzes a si-face 1,3-prototropic shift. B) The amino acid side chains bind at the 3’-O side of the PLP 
cofactor and the enzyme catalyzes a re-face 1,3-prototropic shift. C) The amino acid side chains bind 




barrel (Banner et al., 1976)) while the β-subunit that binds the PLP cofactor has an N- and 
C-terminal domain that both contain an α-β-α sandwich motif (Hyde et al., 1988). Fold-type 
II PLP-dependent enzymes catalyze transferase/lyase and isomerase reactions. The archetype 
of fold-type III PLP-dependent enzymes (Fig. 11C) is represented by the 3D structure of 
alanine racemase (PDB entry 1SFT (Shaw et al., 1997)). The N-terminal domain has a TIM-
barrel structure in which the PLP cofactor is bound, while the C-terminal domain is mainly 
composed of β-strands but does not contain a recognizable motif (Shaw et al., 1997). The 
enzymes with an alanine racemase-like 3D structure catalyze lyase and isomerase reactions. 
The archetype of fold-type IV PLP-dependent enzymes (Fig. 11D) is represented by the 3D 
structure of D-α-amino acid aminotransferase (D-AAT, PDB entry (Sugio et al., 1995)). The 
enzyme consists of two domains, an N-terminal ‘small’ domain that contains a Greek key 
motif and a C-terminal ‘large’ domain that binds the PLP cofactor and that contains two 
mixed β-sheets that form an β-α-β-motif and a four-stranded anti-parallel β-sheet (Sugio 
et al., 1995). Fold-type IV PLP-dependent enzymes catalyze transferase and lyase reactions. 
The archetype of fold-type V PLP-dependent enzymes is represented by the 3D structure 
of glycogen phosphorylase (PDB entry 1PYG), currently the sole representative of this 
particular fold-type (Fig. 11E). The enzyme has two domains, a domain that binds the PLP 
cofactor and a domain with a Rossmann-fold that binds adenosine monophosphate (Sprang 
et al., 1991). The enzyme catalyzes a reaction that utilizes the phosphate-group of the PLP 
cofactor rather than the Schiff base (Fischer et al., 1958). The archetype of fold-type VI and 
VII PLP-dependent enzymes are D-lysine-5,6-aminomutase and lysine-2,3-aminomutase, 
respectively, and their properties are presented below (pages 12-14). 
Specificity and enantioselectivity of aminotransferases. The 3D structures provide detailed 
insight into the structural basis of the substrate specificity of PLP-dependent enzymes. 
For enzymes that catalyze the aminotransferase reaction the induced-fit and lock-and-key 
mechanisms allow aromatic amino acid aminotransferase (AroAT, fold-type I, aromatic 
amino acid + oxaloacetate D aromatic keto acid + L-α-aspartate (Hayashi et al., 1993)) and 
branched chain amino acid aminotransferase (BCAT, fold-type IV; aliphatic branched chain 
L-α-amino acid + α-ketoglutarate D aliphatic branched chain α-keto acid + L-α-glutamate 
(Ichihara & Koyama, 1966; Taylor & Jenkins, 1966)) to bind amino-donor/acceptor pairs 
with side chains that have very different properties and shapes. These basic concepts are used 
by all aminotransferases that bind amino-donor/acceptor pairs with different properties 
(Soda et al., 2001).
The structural data further reveal that the reaction catalyzed by a PLP-dependent enzyme 
does not necessarily correlate with the fold of the PLP-dependent enzyme as illustrated 
by the observation that lyase reactions are catalyzed by fold-type I, II, III and IV PLP-
dependent enzymes, while the aminotransferase reaction is catalyzed by fold-type I and IV 
PLP-dependent enzymes. However, the stereospecificity of proton transfer catalyzed by the 
general acid/base lysine residue does correlate with the fold of the PLP-dependent enzyme 
(Jhee et al., 1999). For example in AspAT (fold-type I) the lysine residue that mediates 
the 1,3-prototropic shift, is positioned at the si-face of the C4-atom of the PLP cofactor 
(12A), while in D-AAT (PDB entry 3DAA, D-α-amino acid + α-keto acid D α-keto acid + 
20
1D-α-amino acid (Yonaha et al., 1975)), the lysine residue is located at the opposite face, the 
re-face, of the C4-atom of the PLP cofactor (Fig. 12C) (Peisach et al., 1998).
The structural data also provide insight into the enantioselective properties of PLP-
dependent enzymes that, apart from the position of the lysine residue with respect to the 
face of the C4-atom of the PLP cofactor, is also dependent on the orientation of the substrate 
within the active site of the enzyme. For example although D-AAT (fold-type IV) and BCAT 
(fold-type IV) catalyze re-face proton transfer (Fig. 12 B,C), BCAT binds the α-amino acid 
substrate in an orientation in which the α-carboxylate group of the α-amino acid substrate 
binds at the phosphate group side of the PLP cofactor (Fig. 12B) (PDB entry 1IYE (Goto et 
al., 2003)) rather than at the at the 3’-OH side of the cofactor as in D-AAT (Fig. 12C). This 
means that although the structures of BCAT and D-AAT are similar, the enzymes have 
opposite enantioselective properties. The enantioselectivity of a PLP-dependent enzyme 
thus depends on the position of the lysine residue with respect to the face of the C4-atom 
of the PLP cofactor and on the orientation of the substrate in the active site of the enzyme. 
New properties of aminotransferases. Recent investigations into PLP-dependent enzymes 
revealed various new properties. For example, it was revealed that all PLP-dependent enzymes 
bind the phosphate group of the PLP cofactor through a common two-layer recognition pattern 
Figure 13. A) The degradation of Fumonisin B1 (FB1), a primary chiral amine and carcinogenic 
mycotoxin. The first step (1) in the degradation/detoxification of FB1 involves de-esterification of FB1 to 
HFB1 by FumD. This enzyme cleaves off the C14 and C15 tricarballylic acid (TCA) side chains. HFB1 is the 
substrate of FumI, an aminotransferase that in a second step (2) de-aminates HFB1 to form 2-keto-HFB1, 
a non-toxic compound (HFB1 + pyruvate D 2-oxo-12,16-dimethyl-3,5,10,14,15-pentahydroxy-eicosane + 
alanine) (Heinl et al., 2010,Hartinger et al., 2011). B) 7-methoxy-2-aminotetraline (left), a primary chiral 
amine that is a pre-cursor of the β3-adrenergic receptor agonist SR 58611A (right) (Cecchi et al., 1994).
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1(Denesyuk et al., 2002) and that AspAT, an aminotransferase, catalyzes a β-substitution reaction 
(L-chloroalanine + β-mercapto-ethanol D S-(β-amino-ethyl)-L-cysteine), which is typically 
catalyzed by PLP-dependent lyases (Adams et al., 2005). In addition, the substrate scope of 
enzymes that catalyze aminotransferase reactions is even wider than earlier established. 
Apart from all L-α-amino acids, several D-α-amino acids as well as amino acids in which the 
amino group is attached to the Cβ-, Cγ-, Cδ-, Cε- or another C-atom (Cω), and amino sugars 
(Braunstein, 1973), aminotransferases have recently been discovered to accept primary chiral 
amines (Fig. 13) and aromatic β-amino acids (Kim et al., 2006; Yun et al., 2004) . 
β-amino acids. β-amino acids may occur as open chain or cyclic (carbocyclic/hetero-cyclic) 
structures (Fig. 14) and may be substituted at Cα and/or Cβ and thus can be mono-substituted, 
di-substituted, tri-substituted or even tetra-substituted (Juaristi & Soloshonok, 2005). An 
example of a β3-substituted β-amino acid is emeriamine (Fig. 15A) produced by the bacterium 
Emericella quadrilineata IFO 5859 that has anti-diabetic properties (Shinagawa et al., 1987; 
Kanamaru et al., 1985). Another example is cis-pentacin (Fig. 15B), a carbocyclic β-amino 
acid and anti-fungal antibiotic (Konishi et al., 1989). β-amino acids are further incorporated 
into peptides, to create peptide mimics that have improved metabolic stability and greater 
biological activity than their α-amino acid analogues (Drey, 1977). For example, already 
in 1964 it was reported that the incorporation of β-alanine, β-phenylalanine or β-proline 
into angiotensins (peptide hormones that increase blood-pressure) leads to amino-peptidase 
resistant angiotensin analogues that have greater activity over a longer period of time in 
comparison to fully α-amino acid based angiotensins (Riniker & Schwyzer, 1964). Furthermore 
peptides based solely on β-amino acids may fold into α-helices that are resistant to proteolytic 
degradation or may fold into novel secondary structures altogether (Seebach et al., 1996; 
Seebach & Matthews, 1997). However, under natural circumstances, β-amino acids are most 
often found incorporated into secondary metabolites produced by bacteria, cyanobacteria, 
Figure 14. A) A β- versus an α-amino acid. B) Linear α-substituted, linear β-substituted and linear 
α/β-substituted β-amino acids. C) A carbocyclic β-amino acid (left) and two types of heterocyclic 
β-amino acids.
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1fungi and plants. These metabolites often have potent pharmacological activities that are 
potentially useful to medicine. For example: a) β-alanine, among others, a building block of 
vitamin B5 (Fig. 16A), b) β-lysine, a building block of streptothricin F (Fig. 16B), tallysomycin, 
viomycin and several other antibiotics, and c) β-phenylalanine, an aromatic β-amino acid, 
a building block of, among others, the andrimids, astins, and taxines (Chapter 5, Fig. 1B), 
which have anti-bacterial or anti-tumor activity (Juaristi & Soloshonok, 2005).
Synthesis of β-amino acids. Because β-amino acid based metabolites have potent 
pharmacological activities, methods have been developed to synthesize β-amino acids. A 
method is kinetic resolution of β-amino acid racemates with enzymes. This is feasible only 
if the racemate is easily and cheaply made, if the enzyme used is highly enantioselective 
and if the resolved racemate is easily purified. For an overview of enzymes that have been 
used for the kinetic resolution of β-amino acid racemates, see Liljeblad and Kanerva 
(2006). More recent examples are a Baeyer-Villiger mono-oxygenase (Rehdorf et al., 2010) 
and an aminotransferase (Yun et al., 2004; Bea et al., 2011)). However kinetic resolution 
methods suffer from the drawback that the yield is maximally 50 %, although dynamic 
kinetic resolution (Ward, 1995) has the potential to push product yields above 50 % if a 
suitable racemization catalyst is applied. Another method to synthesize β-amino acids is 
catalytic asymmetric organic synthesis. This method is successful (Weiner et al., 2010), 
Figure 15. A) Emeriamine. B) Cis-pentacin.
Figure 16. A) Vitamin B5 (panthothenic acid). B) Streptothricin F.
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1but may suffer from drawbacks such as a need for high catalysts load and the synthesis 
of undesired by-products. Alternatively, biocatalysts such as aminotransferases may be 
used. These enzymes have desirable properties such as a rapid reaction rate, a lack of the 
requirement to regenerate the cofactor and broad substrate specificity (Taylor et al., 1998) 
and therefore are extensively used to synthesize α-amino acids (Crump & Rozzell, 1992). 
However even though several aminotransferases have been identified that accept β-amino 
acids (a β-alanine aminotransferase from Pseudomonas fluorescens (Braunstein, 1973), 
a β-aminobutyrate aminotransferase from Alcaligenes denitrificans (Yun et al., 2004), a 
β-phenylalanine aminotransferase from Variovorax paradoxus and Alcaligenes eutrophus, 
respectively (Banerjee et al., 2005), an acyl-CoA β-aminobutyrate aminotransferase (Perret et 
al., 2011), a β-phenylalanine aminotransferase from Variovorax paradoxus (VpAT, Chapter 4) 
(Crismaru et al., 2013) and Mesorhizhobium sp. LUK (MesAT, Chapter 3) (Wybenga et al., 
2012) thus far, only one aminotransferase method, using MesAT as biocatalyst, has been 
developed for the synthesis of β-amino acids (Kim et al., 2007) (Fig. 17).
The difference between MesAT and a glutamate-1-semialdehyde-2,1-aminomutase. 
MesAT is a PLP-dependent, (S)-selective β-phenylalanine aminotransferase that apart from 
β-amino acids, also accepts α-amino acids (Kim et al., 2007). The structural properties 
that allow this enzyme to bind both β- and α-amino acids are presented in Chapter 3. In 
Chapter 4, the biochemical properties and 3D structure of VpAT, a β-aminotransferase 
from Variovorax paradoxus are presented. This Chapter also contains a proposal for an 
amino acid sequence motif that may be used to distinguish a fold-type I aromatic β-amino 
acid aminotransferase from a fold-type I PLP-dependent glutamate-1-semialdehyde-2,1-
Figure 17. Synthesis of L-β-phenylalanine. The 3-oxo-3-phenylpropanoic acid amino-acceptor (2) 
is unstable in aqueous environment and is therefore added to the reaction mixture as an ethyl-ester 
derivative (1). It is converted to 3-oxo-3-phenylpropanoic acid by a lipase from Candida rugosa. The 
amino-donor D-β-aminobutyric acid is supplied as a racemic mixture (3). The aminotransferase 
reaction is catalyzed by MesAT, which yields L-β-phenylalanine (4), and L-β-aminobutyric acid (5, by 
kinetic resolution). In addition, 3-oxo-butanoic acid (6), the keto-acid of β-aminobutyric acid (3), is 
unstable and is decarboxylated to acetone and CO2 (7). Figure adapted from Kim et al. (2007).
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1aminomutase (GSAM; glutamate-1-semialdehyde D 5-aminolevulinate (Fig. 18) a building 
block of heme, chlorophyll, cobalamine (Fig. 22) and other tetrapyrroles (Beale, 1990)). A 
GSAM catalyzes a reaction (amino-acceptora D amino-donorb D amino-acceptorc) (Fig. 18) 
(Pugh et al., 1992; Hennig et al., 1997) that appears similar to the reaction catalyzed by an 
aminotransferase (amino-donora + amino-acceptorb D amino-acceptora + amino-donorb) 
(Fig. 10). However, the molecule that is synthesized after step 3 (4,5-diaminovaleric acid 
(DAVA)), in which steps 1-3 resemble the reverse reaction catalyzed by an aminotransferase, 
is retained in the active site of the enzyme and subsequently functions as an amino-donor 
(Fig. 18, step 4). DAVA then trans aldiminates with the internal aldimine, formed after 
step 3, which subsequently leads to the formation of a ketimine, after step 5, and to PMP 
and 5-aminolevulinic acid after step 6. These steps (4-6) resemble the forward reaction 
catalyzed by an aminotransferase. DAVA thus functions as both an amino-donor and an 
amino-acceptor and although GSAMs and aminotransferases share a need for substrates 
with an oxo- and amino-functional group and although both bind the PLP cofactor, a GSAM 
catalyzes an isomerase reaction, not a transferase reaction.
Figure 18. The reaction catalyzed by glutamate-1-semialdehyde-2,1-aminomutase (R = CH2CH2COOH). 
After step 3, an internal aldimine is formed (not shown) and 4,5-diaminovaleric acid (DAVA) is 
produced. DAVA is retained in the enzyme’s active site and in step 4 functions as an amino-donor. 
Figure adapted from Stetefeld et al. (2006).
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1Lysine-2,3-aminomutase. GSAM is not the only PLP-dependent enzyme that catalyzes 
an isomerization reaction. For example, lysine-2,3-aminomutase (2,3-LAM) catalyzes 
an isomerization reaction that converts L-α-lysine into L-β-lysine (Fig. 19, enzyme 1). 
This is the first step in the lysine fermentation pathway of Clostridiae (obligate anaerobic 
bacteria) whereby L-β-lysine is broken down to one equivalent of butyrate, one equivalent 
of acetate, two equivalents of ammonia and one molecule of adenosine triphosphate 
(Fig. 19) (Stadtman & White, 1954). Initial investigations into the fermentation pathway 
of Clostridiae demonstrated that the decomposition of L-α-lysine is influenced by several 
cofactors (Stadtman, 1963) and that the absence of these cofactors leads to the accumulation 
of L-β-lysine in Clostridium SB4 extracts. L-β-lysine was therefore proposed to be an early 
intermediate in the lysine fermentation pathway (Costilow et al., 1966). Further investigations 
revealed that the conversion of L-α-lysine into L-β-lysine does not involve exchange with 
free ammonia nitrogen (Bray & Stadtman, 1968) and that the enzyme that catalyzes the 
isomerization reaction (2,3-LAM) requires the absence of molecular oxygen, but the presence 
of PLP, S-adenosylmethionine (SAM) (Fig. 20A), ferrous iron (Fe2+) and dithionite (Chirpich 
et al., 1970). Investigations into the enzymatic mechanism of 2,3-LAM subsequently showed: 
a) that the Cβ pro-R proton of L-α-lysine is transferred, in an intra-molecular manner, to 
the Cα pro-R position of L-β-lysine (Aberhart et al., 1983), b) that the synthesis of L-β-lysine 
from L-α-lysine involved formation of methionine and an adenosyl-C5’ radical from SAM 
(Fig. 20A) (Baraniak et al., 1989; Moss & Frey, 1990), and c) that the interaction of SAM with 
Figure 19. The lysine fermentation pathway in Clostridiae sp., obligate anaerobic bacteria. 1) 2,3-LAM. 
2) 5,6-LAM. 3) NAD(P)-dependent dehydrogenase. 4) 3-keto-5-aminohexanoate cleavage enzyme. 
5) Ammonia lyase. 6) Butyryl-CoA dehydrogenase. 7) Acetoacetate/butyrate CoA transferase. 
8) Acetoacetyl-CoA thiolase. 9) Phosphate acetyltransferase. 10) Acetate kinase. Figure adapted from 
Perret et al. (2011).
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1an iron-sulfur cluster (Petrovich et al., 1992) (Fig. 20B) initiated the aminomutase reaction 
catalyzed by 2,3-LAM (Fig. 21) (Cosper et al., 2000).
Lysine-5,6-aminomutase. The lysine fermentation pathway of Clostridiae also contains a 
cobalamine-dependent lysine-5,6-aminomutase (Fig. 19, enzyme 2) that also catalyzes a 
radical-based isomerization reaction in which L-β-lysine (2,6-diaminohexanoate) produced 
by 2,3-LAM, is converted into 3,5-diaminohexanoate (Tsai & Stadtman, 1968). 5,6-LAM 
has two cofactors, a PLP cofactor and a cyclic tetrapyrrole/corrinoid that binds a cobalt 
ion (Co3+) (Fig. 22). The reaction is initiated when L-β-lysine binds PLP, which leads to 
cleavage of the bond between the Co3+-ion and the adenosyl C5’-atom. The Co3+-ion is 
reduced to a Co2+-ion and the C5’-radical abstracts a C5-proton from the bound β-lysine 
substrate. This leads to radical re-arrangements similar to those shown in figure 21 and to 
a re-protonation event at C6 of the PLP bound intermediate, which leads to the synthesis 
of 3,5-diaminohexanoate (Banerjee & Ragsdale, 2003). Apart from 5,6-LAM, four other 
PLP and cobalamine-dependent aminomutases have been discovered. These are leucine-
2,3-aminomutase (Poston, 1976), ornithine-4,5-aminomutase (OAM) (Dyer & Costilow, 
1968; Somack & Costilow, 1973), glutamate-2,3-aminomutase (GAM) (Marsh & Holloway, 
1992) and a 5,6-LAM with specificity towards D-α-lysine (D-5,6-LAM) (Stadtman & Tsai, 
1967). These enzymes, just as 2,3-LAM and 5,6-LAM, function in fermentation pathways 
of Clostridiae. Thus far 3D structures have been elucidated of GAM (Reitzer et al., 1999), 
Figure 20. 2,3-LAM catalyzes a radical based isomerization reaction. The enzyme binds PLP, in 
addition to A) S-adenosylmethionine (SAM) and B) an iron-sulfur cluster. On the left, the iron-
sulfur cluster in the reduced state [Fe4-S4]1+. On the right, the iron-sulfur cluster in the oxidized state 
([Fe4-S4]2+) after homolytic cleavage of the SAM S-C5’ bond (Fig. 21A). Figure 21B has been adapted 
from Lepore et al. (2005).
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1OAM (Wolthers et al., 2010) and D-5,6-LAM. The structure of the α-subunit of D-5,6-LAM 
(PDB entry 1XRS (Berkovitch et al., 2004)) (Fig. 23) represents the archetype of fold-type 
VI PLP-dependent enzymes. D-5,6-LAM contains an α-domain, with a (β/α)8 TIM barrel, 
and a β-domain, with a Rossmann-fold that provides the lysine residue that binds the PLP 
cofactor. The 3D structure of 2,3-LAM (PDB entry 2A5H (Lepore et al., 2005)) (Fig. 23) has 
three domains, an N-terminal domain that contains 7 short helices, a C-terminal domain 
that contains a three-stranded β-sheet, and a central domain with a structure reminiscent 
of a (β/α)8 TIM barrel that lacks two β-strands and therefore resembles a (β/α)6 crescent. The 
2,3-LAM 3D structure represents the archetype of fold-type VII PLP-dependent enzymes 
that also includes glutamate-2,3-aminomutase (Ruzicka & Frey, 2007).
Figure 21. The reaction catalyzed by 2,3-LAM. 1) L-α-lysine enters the active site of 2,3-LAM and 
trans-aldiminates with the internal aldimine. 2) The adenosyl-C5’ radical forms when the iron-sulfur 
cluster is reduced by an external reducing agent, and abstracts the Cβ pro-R proton (indicated). Radical 
rearrangements lead to 3) the azacyclopropylcarbinyl radical intermediate and upon another radical 
rearrangement 4) in 5) to the re-protonation at Cα of the substrate-PLP intermediate whereby the 
proton is deposited into the pro-R position (dashed bond). During 6) L-β-lysine is synthesized. Figure 
adapted from Frey & Reed (2011).
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1MIO-dependent aminomutases and ammonia lyases. The enzymatic mechanism by which 
the fold-type VI and VII PLP-dependent aminomutases catalyze isomerization reactions 
is fairly complex and requires measures to prevent radical side reactions (Berkovitch et 
al., 2004). However, apart from these PLP/SAM/iron-sulfur cluster and PLP/cobalamine-
dependent aminomutases, another type of aminomutase exists that catalyzes the same 
reaction, but requires a cofactor generated from internal condensation reactions of a 
three-amino-acid sequence motif present within the enzyme’s polypeptide sequence. After 
various erroneous proposals, this cofactor/prosthetic group turned out to be 4-methylidene-
imidazole-5-one (MIO). The properties of various aminomutases, including MIO-dependent 
enzymes, and their possible use in biocatalysis were recently reviewed by Wu et al. (2011). 
Investigations into enzymes with a MIO group started with histidine ammonia lyase 
(HAL), an enzyme that catalyzes a lyase reaction in which L-α-histidine is de-aminated to 
trans-urocanic acid and ammonia (Fig. 26A, 28A). This reaction was first demonstrated to 
occur in 1939 in horse liver extracts (Tabor, 1954) and investigations into the enzymatic 
mechanism of HAL suggested: a) that the de-amination reaction involved formation of a 
complex between HAL and the amino group of the L-α-histidine substrate, b) that HAL 
reached its maximum enzymatic activity at pH 9.2, which indicated that the elimination 
reaction is base catalyzed, c) that elimination likely occurred in a concerted fashion, and 
d) that effective elimination requires a strong electron-withdrawing group provided by the 
enzyme (Peterkofsky, 1960). Hereafter studies into HAL were mainly concerned with attempts 
Figure 22. The cobalamine cofactor bound by 5,6-LAM. A covalent bond is formed between the 
C5’-atom of adenosyl (Ado) and the bound Co3+-ion. This ion also has a hydrogen bond interaction 
(dotted line) with a histidine residue. The 5,6-isomerization reaction catalyzed by 5,6-LAM proceeds 




1to identify the electron-withdrawing group. For example, it was demonstrated that NaBH4 and 
KCN inactivate the enzyme and that HAL is not a PLP-dependent enzyme. It was therefore 
proposed that the enzyme bound electron-withdrawing group is a carbonyl group (Smith et 
al., 1967). Later it was proposed that the electron-withdrawing group was a dehydroalanine 
residue (Givot et al., 1969; Wickner, 1969), a component of nisin, a peptide antibiotic (Sahl et al., 
1995). Further investigations demonstrated: a) that HAL abstracted the Cβ pro-S proton from 
L-α-histidine and that it catalyzed a trans-elimination reaction (Givot et al., 1969), b) that the 
treatment of HAL with sodium borotritide followed by acid hydrolysis allowed the isolation 
of a labeled alanine residue, c) that labeling was prevented when histidine was added to the 
purified HAL sample, and d) that the addition of L-α-histidine prevented the enzyme from 
Figure 23. The 3D structures of the PLP-dependent enzymes that represent fold-types VI (A) and VII 
(B). A) The 3D structure of the monomer of D-5,6-LAM, which consists of an α- and β-subunit; the 
enzyme’s quarternary structure is an α2β2-tetramer. B) The 3D structure of the monomer of 2,3-LAM; 
the enzyme’s quarternary structure is a homotetramer.
Figure 24. The β-addition reaction mechanism. Figure adapted from Hanson & Havir (1970).
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1being inactivated (Wickner, 1969). Investigations into phenylalanine ammonia lyase (PAL), 
an enzyme related to HAL that de-aminates L-α-phenylalanine into trans-cinnamic acid and 
ammonia (Fig. 26B, 28A) (Koukol & Conn, 1961) revealed that the enzymatic properties of PAL 
closely resembled the enzymatic properties of HAL. For example, investigations suggested: a) 
that the amino group of L-α-phenylalanine bound an electrophilic center in the PAL active site 
(Havir & Hanson, 1968b; Havir & Hanson, 1968a), b) that the amino group of the substrate had 
to be unprotonated to react (Hermes et al., 1985), c) that the Cβ pro-S proton was eliminated 
from L-α-phenylalanine (Hermes et al., 1985), and d) that the electrophilic center contained 
a Schiff’s base of a dehydroalanine residue, which was proposed to bind the amino group of 
L-α-phenylalanine via the β-position of the dehydroalanine double bond (β-addition reaction 
mechanism, Fig. 24) (Hanson & Havir, 1970). 
In 1993, an octa-peptide was isolated from HAL that contained a species that absorbed 
at 340 nm and that contained an unidentified modification of mass 184 Da (Hernandez et 
al., 1993). This mass was thought to be attached to S143 and was therefore proposed to bind 
Figure 25. The Friedel-Crafts reaction mechanism. A) (S)-α-phenylalanine and the MIO group. 
E) trans-cinnamic acid. F) (R)-β-phenylalanine. Figure adapted from Langer et al. (1995). 
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1the electrophilic cofactor that was required for HAL activity. However, it was subsequently 
revealed that S143A HAL and S143T HAL were devoid of enzymatic activity, while S143C 
HAL had enzymatic activity comparable to wild-type HAL. It was therefore proposed 
that S143 did not serve as an anchor of an electrophilic cofactor, but was the precursor 
of the active site dehydroalanine residue (Langer et al., 1994a; Langer et al., 1994b). To 
establish the role of the proposed dehydroalanine residue in the reaction mechanism of 
HAL, a HAL derivative reduced with NaBH4, and HAL S143 mutants, with reduced lyase 
activity, were tested for their ability to de-aminate L-α-5-nitrohistidine (Langer et al., 1995). 
The experiment appeared to show that the rate of L-α-5-nitrohistidine de-amination was 
independent of the HAL derivative/mutant used. It was therefore proposed that the nitro-
group of L-α-5-nitrohistidine had the same function as the HAL electrophile; to acidify the 
Cβ-protons of L-α-histidine. Since a previous investigation into the reaction mechanism 
of HAL had suggested that the C5-proton in the aromatic-ring of L-α-histidine readily 
exchanged with the environment during the HAL-catalyzed lyase reaction (Furuta et al., 
1990), the results of the two investigations combined led Langer et al. (1995) to propose that 
HAL used a Friedel-Crafts reaction mechanism to de-aminate L-α-histidine (Fig. 25). For 
PAL this reaction mechanism was also proposed, since the rate of L-α-4-nitrophenylalanine 
de-amination by electrophile-less PAL mutants appeared to be higher than the rate of L-α-
Figure 26. The monomer structures of A) Pseudomonas putida HAL (PDB entry 1B8F), 
B)  Rhodosporidium toruloides PAL (PDB entry 1T6J), C) Streptomyces globisporus TAM (PDB 
entry 2OHY), and D) Taxus canadensis PAM (PDB entry 3NZ4). The monomer structure of Taxus 
canadensis PAM is near identical to the structure of Taxus chinensis PAM (PDB entry 2YII) (Chapter 5, 
supplementary figure S1). The quarternary structure of PAL/HAL/TAM and PAM is a homo-tetramer 
in which the monomers are related by 222-symmetry.
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1phenylalanine de-amination by the same mutants (Schuster & Retey, 1995). Upon elucidation 
of the 3D structure of HAL (Fig. 26A) in 1999 (Schwede & Schulz, 1999), the identity of 
the HAL electrophile was revealed. The electrophile was 4-methylidene-imidazole-5-one 
(MIO), a prosthetic group generated from a three-amino-acid sequence motif via internal 
condensation reactions (Fig. 25, 28). The MIO group was also present in PAL, which was 
initially revealed via spectroscopy (Rother et al., 2000) and later confirmed after elucidation 
of the PAL 3D structure (Fig. 26B) (Calabrese et al., 2004). 
Investigations into a Bacillus brevis Vm4 TAM had started in 1972. The enzyme formed 
β-tyrosine from α-tyrosine (Fig. 27A) and was isolated in an attempt to obtain insight into 
the biosynthesis of β-tyrosine, a building block of edeine antibiotics (Fig. 27B). The results 
revealed that the enzymatic activity of TAM was independent of PLP, and that the enzymatic 
activity of TAM was strongly reduced by carbonyl-group binding agents, especially in the 
presence of NaBH4 (Kurylo-Borowska & Abramsky, 1972). Further investigations into the 
stereochemistry of the reaction catalyzed by this enzyme revealed that TAM catalyzed a 
reaction in which a Cβ pro-S proton was lost and replaced with the Cα-amino group (Parry 
& Kurylo-Borowska, 1980). Later, investigations into a TAM from Streptomyces globisporus 
further revealed that the enzyme: a) reached optimal enzymatic activity at pH 8.8, b) 
contained a MIO group, c) converted α-tyrosine into β-tyrosine via trans p-hydroxycinnamic 
acid (Fig. 27A), d) had lyase activity whereby the enzyme formed trans p-hydroxycinnamic 
acid from α- or β-tyrosine, though predominantly catalyzed an isomerase reaction, e) was 
able to synthesize β-tyrosine from trans p-hydroxycinnamic acid in the presence of high 
concentrations of ammonia, albeit inefficiently, f) is a β-racemase; the enzyme synthesized 
Figure 27. A) The reaction catalyzed by Streptomyces globisporus TAM. The synthesis of (R/S)-β-
tyrosine (3) from (S)-α-tyrosine (1) proceeds via trans p-hydroxycinnamic acid (2) and requires the 
interchange of the Cα-amino group and a Cβ-proton. B) The chemical structure of an edeine that 
contains β-tyrosine as a building block.
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1both L- and D-β-tyrosine from L-α-tyrosine (Fig. 27A), g) utilized Y63 as the enzymatic base, 
h) did not accept/synthesize D-α-tyrosine nor L-α-phenylalanine ((S)-α-phenylalanine), and 
i) had a 3D structure very similar to the 3D structure of MIO-dependent ammonia lyases 
(Fig. 26C) (Christenson et al., 2003a; Christenson et al., 2003b; Christianson et al., 2007a; 
Christianson et al., 2007b; Montavon et al., 2008). 
The studies on tyrosine aminomutase also provided important mechanistic insight, 
especially the role of the MIO electrophile in the reaction mechanism of MIO-dependent 
enzymes. The 3D structure of tyrosine-2,3-aminomutase (TAM) (Fig. 26C) from 
Streptomyces globisporus bound with a (S)-β-tyrosine analogue inhibitor ((R)-3-amino-
Figure 28. A) The PAL-catalyzed lyase reaction. (S)-α-phenylalanine (left) is de-aminated to 
trans-cinnamic acid and ammonia (right). Y (tyrosine base). The PAL-catalyzed lyase reaction is 
representative of the HAL-catalyzed lyase reaction. B) The Taxus canadensis and Taxus chinensis 
PAM-catalyzed isomerase reaction. (S)-α-phenylalanine (left) is de-aminated to trans-cinnamic acid 
(middle), which is subsequently re-aminated and reprotonated to form (R)-β-phenylalanine (right). 
After the reaction, the amino group and the pro-S proton have interchanged their positions.
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1
2,2-difluoro-(4-methoxyphenyl)-propanoic acid) (Christianson et al., 2007a) supported the 
β-addition reaction mechanism originally proposed by Hanson & Havir (1970) (Fig. 25), 
since the analogue was covalently bound to the MIO group via the Cβ-amino group of the 
inhibitor. The covalent bond between the MIO and the β-NH2 group of the covalent inhibitor 
indeed suggested that MIO-dependent enzymes catalyzed deamination reactions not via a 
Friedel-Crafts mechanism involving an electrophilic attack of MIO on the aromatic ring, 
but by a reaction in which the substrate’s NH2 group carries out a nucleophilic attack on 
the MIO methylidene function. This is followed by transfer of the NH2 group to the MIO 
group, after which NH2 is either released as ammonia or, in case of a mutase, re-added onto 
the carbon atom flanking the carbon atom from which the NH2 group was abstracted. A key 
residue in the catalytic site of lyases and aminomutases is the base that abstracts a proton 
from the carbon flanking the NH2-substituted carbon. This base invariably is a tyrosine 
residue (corresponding to Y63 in Streptomyces globisporus TAM), positioned in a loop that 
protrudes into the enzyme’s active site. All known MIO-dependent lyases and mutases act 
on (aromatic) amino acids, indicating the presence of a conserved carboxylate binding site 
as well.
Apart from TAM, investigations were also conducted into the enzymatic properties 
of a phenylalanine-2,3-aminomutase (PAM) from Taxus canadensis and Taxus chinensis. 
This enzyme formed (R)-β-phenylalanine from (S)-α-phenylalanine. The isomerase reaction 
catalyzed by Taxus canadensis PAM was characterized via isotope labeling studies, which 
showed that during the PAM-catalyzed reaction, the Cα-amino group of (S)-α-phenylalanine 
was interchanged with the Cβ pro-S proton, to produce (R)-β-phenylalanine (Walker & Floss, 
1998; Mutatu et al., 2007). Further investigations into Taxus canadensis and Taxus chinensis 
PAM revealed: a) that the enzyme accepted (S)-α-phenylalanine, but did not accept (R)-α-
phenylalanine, (S)-β-phenylalanine (S)-α-tyrosine or (S)-α-amino-cyclohexanepropanoic 
acid (Walker et al., 2004; Wu et al., 2009), b) that PAM, when supplied with (S)-α-
phenylalanine, produced trans-cinnamic acid at a rate equal to 10 % of the rate of synthesis 
of (R)-β-phenylalanine; the enzyme thus also catalyzed a lyase reaction (Walker et al., 2004), 
c) that S176A PAM could not de-aminate (R)-β-phenylalanine/L-α-4-nitrophenylalanine nor 
aminate trans-cinnamic acid/trans 4-nitro-cinnamic acid, which confirmed that the PAM-
catalyzed reaction was not Friedel-Crafts mechanism based (Wu et al., 2009), d) that PAM 
could be used for the asymmetric amination of trans-cinnamic acid and trans-cinnamic 
acid derivatives to synthesize enantiopure preparations of (R)-β-phenylalanine and (R)-β-
phenylalanine derivatives (Wu et al., 2009; Szymanski et al., 2009), e) that PAM via a single 
substitution could be converted into an enantioselective tyrosine-2,3-aminomutase (Wu 
et al., 2010), and f) that the enzyme’s 3D structure was very similar to the 3D structure of 
PAL (Fig. 26D) (Feng et al., 2011; Wu et al., 2012). Nonetheless, although many details of 
the PAM-catalyzed reaction have been elucidated or can be adopted from studies on related 
MIO-dependent enzymes, the structural basis of the stereochemistry of the PAM-catalyzed 
reaction remained difficult to explain. PAM interchanges the amino group with a proton 
in a stereospecific manner (Fig. 28B), but after abstraction of the amino group and the 




stereochemistry of the product formed by re-addition, suggesting that a (partial) rotation of 
cinnamic acid is required. Also the structural basis of regioselectivity can benefit from high-
resolution 3D structures. To gain insight into the stereochemistry of the PAM-catalyzed 
reaction and important substrate-protein interactions, as well as in MIO group formation, 
structural studies into a PAM from Taxus chinensis were performed, the results of which 
are presented in Chapter 5.
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Aim and Outline of this Thesis

2In this thesis the 3D structures are described of two pyridoxal-5’-phosphate-dependent 
(PLP) enzymes and one 4-methylidene-imidazole-5-one-dependent (MIO) enzyme that 
are potential biocatalysts for β-amino acid synthesis. β-amino acids have been identified as 
building blocks of compounds that have potentially useful biological activities (Juaristi & 
Soloshonok, 2005). For this reason, the preparation of enantiopure chiral β-amino acids is of 
great importance. Although several β-amino acids can be synthesized by means of organic 
chemistry (Weiner et al., 2010), the synthesis of β-amino acids using enzymes holds promise 
for green chemistry since such synthesis methods often are highly efficient and produce 
little waste. However, for use in practical biocatalysis, enzymes usually require a degree of 
tailoring through protein engineering, for example with the aim to enhance the selectivity 
and activity of the enzyme towards a target substrate or to diminish the enzyme’s sensitivity 
to product inhibition (Farinas et al., 2001; Schmidt-Dannert & Arnold, 1999; Bornscheuer 
et al., 2012). To facilitate and increase the efficiency of the protein engineering process 
structural information is of importance, since the enzyme’s 3D structure provides insight 
into the size and shape of the active site and the reaction mechanism (Davids et al., 2013). 
Furthermore, knowledge of the 3D structure of an enzyme may facilitate genome mining, 
since it can facilitate efforts to define an amino acid sequence motif that aids the discovery 
of enzymes that catalyze the same reaction, but have different enzymatic properties such as 
specific activity, enantioselectivity, and substrate scope (Davids et al., 2013; Hohne et al., 
2010; Seo et al., 2012).
In this thesis, we have used X-ray crystallography to reveal the 3D structures of three 
potential biocatalysts for β-amino acid synthesis. The work described in this thesis was part 
of a B-Basic project, which was aimed at developing new bio-based production concepts 
for the chemical industry, and more specifically, relevant to this thesis, at developing 
new enzymatic routes toward β-amino acid synthesis. The project was supported by the 
Dutch government and industries and integrates synthetic organic chemistry, enzymology 
& biocatalysis, and protein crystallography (this thesis). The research was carried out in 
collaboration with DSM Pharmaceutical Products. The enzymes targeted in this thesis are i) 
MesAT, a PLP-dependent β-phenylalanine aminotransferase from Mesorhizobium sp. LUK, 
ii) VpAT, a PLP-dependent β-phenylalanine aminotransferase from Variovorax paradoxus, 
and iii) PAM, a MIO-dependent phenylalanine-2,3-aminomutase from Taxus chinensis. 
The Introduction (Chapter 1) provides an overview on the plethora of research into 
the biochemical and structural properties of PLP-dependent enzymes, among which 
aminotransferases, which catalyze the inter-molecular migration of an amino group. It also 
provides an overview of enzymes that catalyze the intra-molecular migration of an amino 
group, among which MIO-dependent 2,3-aminomutases. These enzymes can potentially be 
used for asymmetric transformations and kinetic resolutions to prepare enantiopure, chiral 
β-amino acids (Szymanski et al., 2009; Kim et al., 2007; Turner, 2010).
In Chapter 3, the results of our structural studies into MesAT are presented. MesAT 
accepts β-amino acids ((S)-β-phenylalanine, (R)-3-amino-5-methylhexanoic acid, (R)-3-
aminobutyric acid) and α-amino acids (L-α-glutamate, L-α-alanine), which is unusual 
since most aminotransferases solely accept α-amino acids. For this reason we elucidated 
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2MesAT structures bound with (S)-β-phenylalanine, (R)-3-amino-5-methylhexanoic acid, 
2-oxoglutarate (an amino acceptor) and 2-aminooxyacetic acid (an inhibitor), which, in 
combination with mutagenesis studies, has allowed us to unveil the structural determinants 
of the substrate specificity and enantioselectivity of MesAT. The structures can serve as a 
basis for the design of mutations that modify the activity towards specific target substrates.
In Chapter 4, we present biochemical and structural studies into VpAT, a homologue 
of MesAT (51 % sequence identity). VpAT, just as MesAT, accepts both β-amino acids 
((S)-β-phenylalanine, (R)-3-amino-5-methylhexanoic acid, (R)-3-aminobutyric acid) and 
α-amino acids (L-α-glutamate, L-α-alanine). As expected, the 3D structure of VpAT is 
very similar to the 3D structure of MesAT. The 3D structures of VpAT and MesAT are 
similar to the 3D structure of PLP-dependent glutamate-1-semialdehyde-2,1-aminomutases 
(GSAMs), enzymes that catalyze a 2,1-isomerization reaction. Because an investigation into a 
Polaromonas sp. GSAM established that the enzyme had β-phenylalanine aminotransferase 
activity rather than aminomutase activity, we developed an amino acid sequence motif that, 
based on an enzyme’s primary structure, may be used to distinguish between an aromatic 
β-amino acid aminotransferase and a glutamate-1-semialdehyde-2,1-aminomutase. This 
motif can guide the discovery of further variants of β-amino acid specific aminotransferases 
(Crismaru et al., 2013).
In Chapter 5, the structure of a MIO-dependent phenylalanine-2,3-aminomutase from 
Taxus chinensis is presented. The enzyme catalyzes a reversible 2,3-isomerization, in which 
the amino group and a stereospecific proton are interchanged to convert (S)-α-phenylalanine 
via trans-cinnamic acid into (R)-β-phenylalanine. To obtain insight into the stereochemistry 
of the PAM-catalyzed reaction, we have elucidated PAM 3D structures bound with an (R)-
β-phenylalanine analogue inhibitor and bound with trans-cinnamic acid. In addition, we 
elucidated MIO-less PAM 3D structures to gain insight into how the MIO group is formed 
from its A-S-G amino acid sequence motif, encoded within the enzyme’s polypeptide chain. 
Our investigations reveal that the stereochemistry of the PAM-catalyzed reaction originates 
from the enzyme’s ability to bind trans-cinnamic acid in two different orientations within 
the enzyme’s active site, and that charge repulsion between N231, and S176 in the MIO-
forming loop, initiates MIO group formation. The results have supported the design of 
focused libraries of MIO variants that have altered α/β selectivity, and modified flexibility 
of the loop that closes the active site from the solvent. Employing structural information 
provided in this thesis, mutants with improved β-selectivity and enhanced catalytic rates 
have been discovered (Wu et al., 2012; Bartsch et al., 2013).
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3Background: β-Transaminases are promising biocatalysts for the synthesis of β-amino acids.
Results: First 3D structures were obtained of a native β-transaminase, and complexes with 
a keto-acid and two covalently bound β-amino acids. 
Conclusion: Dual functionality of the carboxylate and side-chain binding pockets allows 
binding of β- and α-amino acids.
Significance: These structures may facilitate the development of improved β-amino acid 
biocatalysts.
Summary
Chiral β-amino acids occur as constituents of various natural and synthetic com pounds 
with potentially useful bioactivities. The pyridoxal-5’-phosphate depen dent (S)-selective 
transaminase from Mesorhi zobium sp. LUK (MesAT) is a fold type I amino transferase that 
can be used for the preparation of enantiopure β-phenylalanine and derivatives thereof. Using 
X-ray crys tallography, we solved structures of MesAT in complex with (S)-β-phenylalanine, 
(R)-3-amino-5-methylhexanoic acid, 2-oxoglutarate, and the inhibitor 2-aminooxyacetic 
acid, which allowed us to unveil the molecular basis of the amino acid specificity and 
enantioselectivity of this enzyme. The binding pocket of the side chain of a β-amino acid is 
located on the 3’-O side of the PLP cofactor. The same binding pocket is utilized by MesAT 
to bind the α-carboxylate group of an α-amino acid. A β-amino acid thus binds in a reverse 
orientation in the active site of MesAT as compared to an α-amino acid. Such a binding mode 
has not been reported before for any PLP-dependent aminotransferase and shows that the 
active site of MesAT has specifically evolved to accommodate both β- and α-amino acids.
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3Introduction
β-Amino acids occur as precursors of many natural and synthetic compounds that display 
a wide range of pharmacological activities. Altering and improving the pharmacological 
properties of these compounds critically depends on the availability of β-amino acids 
and their derivatives as building blocks. Therefore, several strategies for the synthesis 
of β-amino acids have been explored over the years, involving either synthetic (1,2) 
or combined chemo-enzymatic (3) methods. However, fully enzyme-based synthesis 
methods have clear advantages over synthetic or chemo-enzymatic methods (4) and have 
the potential to increase the feasibility of biocatalytic or fermentative routes towards 
β-amino compounds. 
Pyridoxal-5’-phosphate (PLP)1 dependent amino transferases (also called transami-
nases) are attractive for the production of amino acids since they have a broad substrate 
range, can be highly enantioselective, show a high catalytic activity, and are relatively stable 
(5). Aminotransferases catalyze the transfer of an amino group from an amino compound 
to a keto-acid. In the first half reaction, the amino group of the amino compound substitutes 
the covalent Schiff base linkage, or imine bond, between the ε-amino group of a lysine and 
the C4A-atom of the PLP cofactor, generating an external aldimine (Fig. 1). Lysine-assisted 
transfer of a proton from the external aldimine to the C4A-atom of the cofactor results in 
a ketimine intermediate, which is hydrolyzed to yield pyridoxamine (PMP). Subsequently, 
in the second half reaction, the amino group of PMP is transferred to a keto-acid which 
generates a new amino compound (Fig. 1) (6).
The production of β-amino acids using PLP-dependent aminotransferases has been 
demon strated for an ω-transaminase from Polaromonas sp. JS666 (7) and a β-transaminase 
from Mesorhizhobium sp. LUK (MesAT)(8). The genes of these two enzymes were successfully 
cloned and expressed in E. coli BL21(DE3) using pET-based expression systems (7,8) and 
MesAT has been crystallized (9). MesAT is an enzyme of 445 amino acids with an Mr of 
45 kDa, which forms dimers in solution and which accepts β- as well as α-amino acids 
(8,10). The enzyme can convert the aliphatic β-amino acids (R)-3-amino-5-methylhexanoic 
acid and (R)-3-aminobutyric acid as well as the aromatic β-amino acid (S)-β-phenylalanine 
((S)-β-Phe) to the corres ponding β-keto acids using pyruvate or 2-oxo glutarate as the amino-
acceptor. In the reverse reaction, MesAT can be used to produce (S)-β-Phe from its β-keto 
acid ethylester in a coupled enzyme reaction containing a lipase to generate the keto-acid 
in situ and rac-3-aminobutyric acid as amino-donor (8). Unfortunately, the more stable 
keto-ester is a very poor substrate for aminotransferase-mediated conversion to (S)-β-Phe.
Information on 3D structures of β-amino transferases is currently lacking. To enable 
rational protein engineering approaches for improving the activity of the enzyme for 
1 Abbreviations: PLP, pyridoxal-5’-phosphate; PMP, pyridoxamine; MesAT, aminotransferase 
from Mesorhizobium sp. strain LUK; (S)-β-Phe, (S)-β-phenylalanine; AroAT, aromatic amino 
acid aminotransferase from Paracoccus denitrificans; AOA, 2-aminooxyacetic acid; L-PPG, 
2-amino-4-pentynoic acid.
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3application in the biosynthesis of β-amino acids, we have elucidated the crystal structure 
of MesAT in the native state, as well as in complex with β-amino acids, a keto-acid, and an 
inhibitor. The structure of the enzyme conforms to a fold type I aminotransferase structure, 
but the hydrophobic binding pocket is located on the 3’-O side of the PLP cofactor rather 
than on its phosphate side as found in other amino transferases. On the other hand, an 
α-amino acid binds in a normal orientation, with the α-carboxylate on the 3’-O side and 
the side chain of the amino acid on the phosphate side of the PLP cofactor. The architecture 
of the active site explains how MesAT can accept β- as well as α-amino acids (8), while the 
aromatic α-amino acid aminotransferase AroAT (11) and most other aminotransferases 
only accept α-amino acids. The structure also explains the stereo preference of the enzyme 
for α- and β-amino acids.
Experimental procedures
Protein expression and purification. The MesAT gene was codon optimized for E. coli, 
synthesized by DNA2.0 Inc., and cloned into the expression plasmid pET28b+ with an 
N-terminal His6-tag using NdeI/HindIII restriction sites. After transformation into E. coli 
strain BL21(DE3) cells were grown at 37 °C in 1.4 l TBS medium (Terrific Broth Sorbitol 
(12)) containing 50 µg/ml of kanamycin. Protein expression was induced with 0.4 mM 
IPTG (isopropyl-β-D-1-thiogalactopyranoside) when the optical density of the culture at 
600 nm reached 0.6-0.8, and the temperature was adjusted to 17 °C. The cells were grown for 
another 48 h, then harvested and resuspended in a buffer containing 20 mM Tris-HCl, pH 
8.0, 500 mM NaCl, 20 mM imidazole, 1 mg of DNaseI (Roche) and a cOmplete EDTA-free 
protease inhibitor tablet (Roche). The cells were disrupted at 4 °C by sonication followed by 
centrifugation for 1 h at 31,000 × g at 4 °C. 
Figure 1. Half reactions catalyzed by MesAT, a β-specific PLP-dependent transaminase. An amino 
acid ((S)-β-Phe) enters the active site of the enzyme (1) and an external aldimine is generated. K280, a 
base, abstracts the Cβ-proton (2) and transfers the proton to the C4A-atom (1,3-prototropic shift, not 
shown), which results in the ketimine intermediate. Hydrolysis of the ketimine intermediate results in 
the formation of pyridoxamine phosphate (PMP) and a keto-acid (3-oxo-3-phenylpropanoic acid) (3). 
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3The supernatant was applied to a HisTrap HP affinity chromatography column 
(GE Healthcare) and, after washing, MesAT was eluted with 15 column volumes of a linear 
gradient of 20 – 500 mM imidazole in elution buffer (20 mM Tris-HCl, pH 8.0, 500 mM 
NaCl). The fractions corresponding to the peak were pooled and the imidazole was removed 
by a buffer exchange using a HiPrep 26/10 desalting column (GE Healthcare) equilibrated 
with 25 mM Tris-HCl, pH 8.0, 0.01% v/v β-mercaptoethanol. The resulting protein fractions 
were applied to a Q-Sepharose HP anion exchange column (GE Healthcare) and eluted 
with 15 column volumes of a linear gradient of 0 – 1 M NaCl in 25 mM Tris-HCl, pH 8.0. 
The fractions containing active enzyme were pooled, concentrated (Ultracel 30K MWCO, 
Amicon) and applied to a Superdex 200 10/300 GL size exclusion chromatography column 
(GE Healthcare), equilibrated in 20 mM Tris-HCl, pH 8.0, containing 200 mM NaCl. 
After elution the fractions corresponding to the protein peak were pooled, concentrated 
(Amicon) and dialyzed overnight against a buffer containing 20 mM Tris-HCl, pH 7.5. The 
sample was subsequently concentrated to 10 mg/ml as judged from a protein assay and the 
purity of the sample was checked with silver-stained SDS-PAGE gels using a Phast system 
(GE Healthcare).
Mutagenesis. The R412A mutant gene of MesAT (Supplementary Table S2) was constructed 
by site-directed mutagenesis (QuikChange, Stratagene) and transformed into E. coli DH5a 
ElectroMAX electrocompetent cells (Invitrogen). For overexpression E. coli BL21(DE3) was 
used. The mutant construct was confirmed by sequence analysis (GATC Biotech).
Protein crystallization. A Mosquito crystallization robot (TTP LabTech) was used to 
search for suitable crystallization conditions. Crystallization experiments were set up at 
20 °C. Crystals were found in a JCSG+ Suite (QIAGEN) condition containing 0.1 M HEPES 
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), pH 7.5, 8% v/v ethylene glycol and 
10% w/v PEG 8K. After optimization, it was found that this was also the optimal condition 
for crystal growth, with crystals reaching sizes of 80x50x30 μm. Crystals were transferred 
to a cryoprotection solution consisting of mother liquor with 20% v/v ethylene glycol. This 
was done in 4 steps of 5 min each, starting with a solution containing 2% (v/v) ethylene 
glycol, followed by solutions of 5, 10 and finally 20% (v/v) ethylene glycol. Crystals from 
this last solution were cryo-cooled in liquid nitrogen. For amino acid binding studies, the 
same steps were followed, but with the cryoprotection solutions supplemented with 2, 5, 10 
and 20 mM (S)-β-Phe (Peptech Corp.), (R)-3-amino-5-methylhexanoic acid (Fluorochem), 
2-oxoglutarate disodium salt (Fluka), or 2-aminooxyacetic acid (AOA) (Aldrich). 
Diffraction data collection and processing. Diffraction data were collected at beam lines 
ID14-1 and ID14-2 of the European Synchrotron Radiation Facility (ESRF, Grenoble) 
and at beam line X13 of the EMBL outstation at the Deutsches Elektronen-Synchrotron 
(DESY, Hamburg). Reflections were indexed and integrated using XDS (13), and scaling and 
merging of the data was done with the program SCALA (14) from the CCP4 software suite 
(15). Phaser (16) was used for molecular replacement with a mixed input model generated 
by the FFAS03 server (17) on the basis of the structures of glutamate-1-semialdehyde-
2,1-aminomutase from Thermus thermophilus HB8 (PDB entry 2E7U; Mizutani, H., 
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3Kunishima,  N., RIKEN Structural Genomics/Proteomics Initiative, to be published), 
D-phenylglycine aminotransferase from Pseudomonas stutzeri ST-201 (PDB entry 2CY8; 
Kongsaeree, P., Shirouzu, M., Yokoyama, S., RIKEN Structural Genomics/Proteomics 
Initiative, to be published) and 4-aminobutyrate aminotransferase from pig (PDB entry 
1OHV (18)). The resulting model was subjected to successive rounds of automatic model 
building with ARP/wARP (19) followed by manual model building in Coot (20). Refmac5 
was used for refinement of the atomic coordinates and atomic B-factors (21). Data collection 
and refinement statistics are given in Supplementary Table S3. After refinement the model 
was validated with MolProbity (22). Stereochemical restraints for the amino acid analogues 
were generated using the PRODRG2 server (23). RMSD values were calculated with the 
RMSDcalc tool of the CaspR server (24) and structural homologues of MesAT were obtained 
from the Dali server (25). PISA from the CCP4 software suite was used for protein interface 
analysis (26). Simulated annealing composite omit maps where generated with PHENIX (27). 
Chemical structure drawings were made using the ChemDraw program (CambridgeSoft) 
and PyMOL (28) was used for making images of the protein structure.
Atomic coordinates and structure factors have been deposited in the Protein Data Bank, 
www.pdb.org, with PDB codes 2YKU, 2YKY, 4AO4, 2YKX and 2YKV (Supplementary 
Table S3).
Enzyme assay and analytical methods. Aminotransferase assays were performed with 
10 mM amino donor ((S)-β-phenylalanine), 10 mM amino acceptor (pyruvate) and enzyme at 
37 °C in 50 mM MOPS buffer, pH 7.6, containing 50 µM PLP (Acros Organics). Samples were 
taken at different times and treated according to the following procedure: to 50 µl of sample, 
50 µl of a 2M HCl was added to quench the reaction. The sample was left on ice for 5 min and 
neutralized by adding 45 µl of 2M NaOH followed by adding 50 µl of demineralized water. 
In an HPLC autosampler (Jasco), 1 µl sample was mixed with 2 µl of an ortho-phthalaldehyde 
(Sigma) (OPA)-solution [15 mg of OPA was dissolved in 50 μl absolute ethanol, which was then 
mixed with 4.42 ml 0.4 M sodium borate (pH 10.4), 15 μl 30% w/v Brij 35 (Fluka) and 11 μl 
β-mercaptoethanol] and 5 µl 0.4 M sodium borate (pH 10.4). The OPA-derivatized samples 
were analysed by HPLC using a C18 Alltech Adsorbosphere 5u column (5 µm, 4.6 mm x 
100 mm) using a Jasco HPLC system. Separation of OPA-derivatized imines was achieved at 
room temperature at a flow rate of 1 ml/min using a gradient of eluent A (5% THF in 20 mM 
sodium acetate, pH 5.5) and eluent B (99% pure CH3CN) as follows: start with 100:0 A:B for 
5 min; in 7 min from 100:0 to 80:20 A:B; continue with 80:20 for 4 min, 8 min from 80:20 to 
40:60; continue with 40:60 for 6 min; then change from 40:60 to 100:0 in 2 min and finally 
continue for 5 min at 100:0 for re-equilibration of the column. The eluate was analysed by UV 
(338 nm) using a Jasco UV-2075 Plus detector and with a Jasco FP-920 fluorescence detector 
(350 nm excitation and 450 nm emission). Retention times for derivatized L-a-alanine and 
(S)-β-phenylalanine were 7.7 min and 23.2 min, respectively. One unit of enzyme activity is 
defined as the amount of enzyme that produces 1 μmol/min of alanine from 10 mM pyruvate 
(sodium salt; Fluka) and 10 mM (S)-β-phenylalanine (Acros Organics).
To determine the Vmax and Km values of the R412A mutant of MesAT, initial rate assays 
were done with varying concentrations of (S)-β-Phe or pyruvate, fixing the non-variant 
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3substrate at 10 mM. The reactions were started by adding 680 μg of purified protein, and 
incubated at 37 °C.
Inhibition studies were performed by pre-incubating the reaction mixture, lacking 
(S)-β-Phe but containing 40 μg of wild-type enzyme, with 5 mM 2-aminooxyacetic acid 
(AOA) (Aldrich) or 5 mM DL-propargylglycine (2-amino-4-pentynoic acid, PPG) (Sigma-
Aldrich) for 5 min, after which (S)-β-Phe (PepTech. Corp.) was added.
Results
Overexpression, purification and enzyme activity measurements of wild-type and R412A 
MesAT. Previously, an overexpression system of MesAT was reported that gave a yield of 1.4 mg 
pure protein per liter of culture (8). To obtain enhanced expression, we used a codon-optimized 
synthetic gene that was equipped with an N-terminal His tag, cloned it under control of the 
T7 promoter in a pET vector, and cultivated the transformed E. coli BL21(DE3) cells in TBS 
medium at 17 °C. This resulted in an expression level that allowed the isolation of about 
10 mg of pure enzyme per liter of culture (Supplementary Table S1). The specific activity of the 
purified wild-type enzyme was 1.6 U • mg-1, which is similar to what was reported earlier (8).
Structure determination of MesAT. The holo-enzyme crystallizes in space group C2 with 
three molecules (chains A, B and C) per asymmetric unit. The 3D structure of MesAT was 
elucidated at 2.5 Å resolution by molecular replacement and refined at 1.65 Å resolution. 
No density is defined for the first 30 N-terminal residues and the C-terminal residue M445. 
The three molecules are very similar to each other with RMSD values of Cα atom positions 
of ~0.2-0.25 Å. They form 1½ dimer in the asymmetric unit; one dimer consists of chains A 
and B (Supplementary Figure S1), the other dimer is made up of chain C and a chain C from 
a neighboring asymmetric unit related by crystallographic two-fold symmetry. Both dimers 
are very similar, with RMSD values in the order of 0.2 Å (Cα atoms). The two chains in the 
dimer interact tightly, burying a surface area of about 4400 Å2, which is a quarter of their 
total surface area. The presence of dimers in the crystal is in agreement with the occurrence 
of MesAT dimers in solution (10). 
The structure of the MesAT monomer. The MesAT monomer has a curved shape and consists 
of a PLP-binding domain (residues 112-334) and a domain formed by the N- and C-termini of 
the polypeptide chain (NC-domain; residues 1-111 and 335-445) (Supplementary Figure S1). 
These two domains line a cleft into which the PLP cofactor protrudes. The monomer contains 
11 α-helices (of at least 2 or more turns) and 12 β-strands that form a mixed central 7-stranded 
β-sheet in the large domain and a 3-stranded as well as a 2-stranded anti-parallel β-sheet 
in the NC-domain (Supplementary Figure S1). The overall structure is similar to that of 
aspartate aminotransferase, the archetypical representative of fold type I aminotransferases 
(Z-score 21, RMSD of 4.2 Å for 309 Cα atoms, 16 % sequence identity, PDB entry 1BGK) 
(29,30) and the aromatic α-amino acid aminotransferase from Paracoccus denitrificans 
(AroAT) (Z-score 21, RMSD of 4.8 Å for 326 Cα atoms, 15 % sequence identity, PDB entry 
1AY4) (11,31), which is specific for L-α-phenylalanine. 
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3The PLP cofactor. Each MesAT monomer contains a pyridoxal-5’-phosphate (PLP) cofactor, 
covalently anchored via an imine bond (Schiff base) to the ε-amino group of residue K280. 
The amide protons of residues G145, T146 and T314 (from monomer B in case of the AB 
dimer) anchor the phosphate group of the PLP cofactor to the protein backbone. The pyridine 
ring of the PLP cofactor is stacked between residues V255 (at the si-face of the pyridine ring 
(32)) and Y172 (at the re-face of the pyridine ring). The nitrogen atom of the pyridine ring 
is at hydrogen bonding distance to residue D253. These interactions keep the PLP cofactor 
secured in the active site.
The binding of (S)-β-phenylalanine. To analyze how (S)-β-Phe binds in the active site, a 
crystal structure of MesAT with bound (S)-β-Phe was solved at 1.7 Å resolution. (S)-β-Phe 
Figure 2. Stereo figures of simulated annealing composite 2mFo-DFc omit maps contoured at 1σ. A) 
(S)-β-Phe (magenta) bound to the PLP cofactor. For clarity residue Y172 has been omitted from this 
figure as well as from figures 2B, 2C and 2D. B) (R)-3-amino-5-methylhexanoic acid (magenta). For 
clarity residue A312 has been omitted from this figure as well as from figures 2C and 2D (see page 68). 
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3binds covalently to the PLP cofactor via its β-amino group, substituting the imine bond 
between the ε-amine of residue K280 and the C4A atom of the PLP cofactor (Fig. 2A). It binds 
with an estimated occupancy of about 80% in the three subunits. The carboxylate group of 
(S)-β-Phe has a salt bridge interaction with the Nε- and Nη2-atoms of R54. The aromatic ring 
of (S)-β-Phe is bound between the side chains of Y89 and Y172 with edge-to-face interactions 
(Fig. 2A) and has also van der Waals interactions with residues I56, A225, M256 and M414 
from monomer A as well as with residue A312 from monomer B; these residues line a 
hydrophobic binding pocket that is capped by residue R412 (monomer A). Thus, residues 
from both monomer A and monomer B contribute to the binding of the aromatic side chain 
of (S)-β-Phe. The side chain amino group of K280 is close to the Cβ (R)-proton of (S)-β-Phe 
Figure 2. (Continued.) Stereo figures of simulated annealing composite 2mFo-DFc omit maps contoured 
at 1σ. C) 2-oxoglutarate (magenta) bound in the active site of MesAT [LLP = (2-lysine(3-hydroxy-2-
methyl-5-phosphonooxymethyl-pyridin-4-ylmethane)], the internal aldimine. D) 2-aminooxyacetic 
acid (magenta), a β-alanine mimic, bound in the active site of MesAT.
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3(3.3 Å), in agreement with its role in proton transfer (Fig. 1). The binding of (S)-β-Phe does 
not induce large-scale conformational changes or domain movements in MesAT. Only local 
conformational changes have occurred (see Discussion). 
In monomer A, a second (S)-β-Phe molecule is present in a surface pocket, with its 
aromatic ring stacked between residues L269 and L368. Its carboxylate and amino groups 
point into the solvent and do not interact with the protein. However, in the surface pockets 
of monomers B and C electron density is only present for the aromatic ring of an (S)-β-Phe 
molecule, but not for the amino- and the carboxylate groups. From this we conclude that 
(S)-β-Phe binds non-specifically in this surface pocket.
The binding of (R)-3-amino-5-methyl hexanoic acid. To investigate how an aliphatic 
β-amino acid such as (R)-3-amino-5-methylhexanoic acid (8) binds in the active site, a 1.95 Å 
resolution crystal structure was determined of MesAT in complex with this compound. 
(R)-3-amino-5-methylhexanoic acid binds covalently to the PLP cofactor via its β-amino 
group, substituting the imine bond between the ε-amine of residue K280 and the C4A atom 
of the PLP cofactor (Fig. 2B). It binds with an estimated occupancy of about 90% in the three 
subunits. The carboxylate group of (R)-3-amino-5-methylhexanoic acid has a salt bridge 
interaction with the Nε- and Nη2-atoms of residue R54, and the aliphatic side chain (atoms 
C4, C5 and C6) binds in the hydrophobic binding pocket where also the aromatic side chain 
of (S)-β-Phe was observed to bind (see above). Binding of (R)-3-amino-5-methyl hexa noic 
acid only produces limited local confor mational changes in MesAT. 
The binding of 2-oxoglutarate. To analyze how a keto-acid binds in the active site of 
MesAT we determined the crystal structure of the enzyme with bound 2-oxoglutarate 
at 1.85 Å resolution (Fig. 2C). The compound binds non-covalently in the active site. Its 
α-carboxylate has a bidentate salt-bridge interaction with the Nη1- and Nη2-atoms of R412. 
The γ-carboxylate binds with one of its oxygen atoms to the Nε- and Nη2-atoms of R54; 
the other oxygen atom is not involved in hydrogen bond formation. The keto-oxygen atom 
of 2-oxoglutarate is located at 3.0 Å from the nitrogen atom of the K280 side chain, which 
is covalently bound to the C4A atom of the PLP cofactor. The binding of 2-oxoglutarate 
thus leaves the internal aldimine intact. The orientation of 2-oxoglutarate in the active 
site of MesAT suggests that amino group transfer from PMP results in the synthesis of 
L-glutamate, in agreement with chiral HPLC analysis of the product of a reaction with 
(S)-β-Phe as amino-donor and 2-oxoglutarate as amino-acceptor (data not shown). Binding 
of 2-oxoglutarate does not result in large-scale conformational changes of MesAT. However, 
residue R412 reorients its side chain such that its Nη1- and Nη2-atoms can make a salt bridge 
interaction with the α-carboxylate of 2-oxoglutarate. This reorientation of the arginine side 
chain in response to the binding of an amino acid in the active site of an aminotransferase 
is referred to as the ‘arginine switch’ (33). 
The importance of R412 for activity was confirmed by mutagenesis. The protein yield of 
the R412A variant was similar to that of the wild-type enzyme. The kcat values of the R412A 
mutant were significantly lower than those of the wild-type enzyme (Table 1). Furthermore, 
the Km value for pyruvate had increased by a factor of 28, whereas for (S)-β-Phe it had 
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3decreased by a factor of 4. The relationship between the reaction rate of the R412A mutant 
and the substrate concentration indicated substrate inhibition, as observed in the wild-type 
enzyme (34) (Table 1). 
The binding of 2-aminooxyacetic acid (AOA). AOA (35) and 2-amino-4-pentynoic acid 
(L-PPG) (36,37) are known inhibitors of aminotransferase activity. Pre-incubation of MesAT 
with 5 mM of these inhibitors resulted in an activity decrease of 10 % upon treatment with 
L-PPG and a 96 % decrease upon treatment with AOA. Analysis of the 1.9 Å resolution 
crystal structure of MesAT with bound AOA (Fig. 2D) shows that the amino group of AOA 
binds covalently to the C4A atom of PLP, as has also been observed for the interaction of 
AOA with aspartate aminotransferase (38). The ether oxygen atom (OX1) is close to K280 
(2.9 Å) and the carboxylate group binds via a salt bridge to the Nε- and Nη2-atoms of 
R54. The binding of AOA to the PLP cofactor is irreversible; the amine-OX1 bond cannot 
be weakened by residue K280. Binding of AOA to the PLP cofactor thus prevents PMP 
formation and thereby inhibits aminotransferase activity. No significant conformational 
changes are observed upon AOA binding.
Discussion
The structure of MesAT. The structure of MesAT presented here is the first structure of a 
transaminase with specificity towards β-amino acids as well as α-amino acids. The structure 
of the enzyme is similar to that of aspartate aminotransferase (39), the archetypical fold 
type I aminotransferase. The enzyme assembles into a homo-dimer in which residues from 
both monomer A and B contribute to the binding of amino acid and their respective oxo-acid 
substrates. In contrast to aspartate aminotransferase, the binding of ligands does not induce 
large domain movements. Structural changes that do occur in MesAT upon substrate/
inhibitor binding are localized to the active site and consist of a 16° rotation of the pyridine 
ring of the PLP cofactor upon formation of the external aldimine. This rotation liberates 
Table 1. Specific activity at 37 °C of wild-type MesAT and the R412A mutant using (S)-β-Phe as 






























WT 1.6 100 1.2b 1.3 1.1 3.2b 3.9b 1.3 0.33 177b (8)b
R412A 6•10-3 0.4 0.29 5•10-3 2•10-2 47 109 4.1•10-2 3.8•10-4 2500 This 
study
a Abbreviations: Sp. act., specific activity; Rel. act., relative activity; WT, wild-type.
b Adopted from Kim and coworkers (8).
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3K280 and allows it to function as the proton transferring lysine. Another structural change 
is the rearrangement of the R412 side chain, also known as the arginine switch (33), upon 
binding of 2-oxoglutarate (mentioned above). 
Different binding modes of (S)-β-phenylalanine, (R)-3-amino-5-methylhexanoic acid 
and 2-oxoglutarate. The way in which 2-oxoglutarate binds in the active site of MesAT and 
the manner in which (S)-β-phenylalanine and (R)-3-amino-5-methylhexanoic acid bind are 
very different. The side chains of (S)-β-Phe (Fig. 2A) and (R)-3-amino-5-methylhexanoic acid 
(Fig. 2B) bind in a pocket on the 3’-O side of the PLP cofactor, which we denote the O-pocket. 
However, the side chain of the α-keto acid 2-oxoglutarate, a model for the α-amino acid 
L-glutamate, binds with its γ-carboxylate group on the phosphate side of the PLP cofactor 
(Fig. 2C), in the P-pocket. Thus, MesAT has two distinct side chain binding pockets, one for 
the side chains of β-amino acids (O-pocket, Fig. 3) and one, on the other end of the active 
site, for the side chain of α-keto acids and presumably also α-amino acids (P-pocket, Fig. 3). 
The enzyme has also two carboxylate binding pockets; one, involving R54 in the P-pocket, 
binds the α-carboxylate group of β-amino acids and of AOA, a β-alanine mimic (Fig. 2D), 
while the other, which contains R412 in the O-pocket, binds the α-carboxylate of α-keto 
acids such as 2-oxoglutarate (Fig. 2C). As a consequence, an α-amino acid and a β-amino 
acid have very different binding modes in MesAT (Fig. 3A,B).
Intriguingly, the O-pocket that binds the aliphatic and hydrophobic side chain of β-amino 
acids also binds the α-carboxylate group of α-keto acids and presumably also of α-amino 
acids. This dual functionality is made possible by a switch in position of the R412 side chain, 
the arginine switch residue (33). When a β-amino acid binds, the R412 side chain is oriented 
away from the active site, providing space in the O-pocket for the hydrophobic side chain 
of the β-amino acid (Figs. 2A,B). This orientation of R412 is stabilized by a hydrogen bond 
of its side chain Nη-atom to the carbonyl oxygen atom of A225 (monomer B, not shown). 
In contrast, upon 2-oxoglutarate binding, the side chain of R412 switches back towards the 
hydrophobic O-pocket (Fig. 2C); the hydrogen bond with A225 is broken and R412 now 
has a salt-bridge interaction with the α-carboxylate of 2-oxoglutarate. In this way the R412 
side chain allows the enzyme to accept both α-keto/amino acids and aliphatic- or aromatic 
β-amino acids in the same active site.
Because of the dual functionality of the active site pockets of MesAT we prefer to use 
O- and P-pocket, rather than L- and S-pocket nomenclature, which reflects the presumed 
size of these pockets (40).
For aminotransferase activity R412 is virtually essential, as reflected by the 870-fold 
reduction of the catalytic efficiencies for pyruvate and (S)-β-Phe, respectively, upon mutation 
of this residue to Ala (Table 1). Whereas the decreased apparent Km for (S)-β-Phe can be 
due to the reduced catalytic rate at 10 mM pyruvate, the increased Km for pyruvate strongly 
supports that R412 is important for binding pyruvate through electrostatic inter actions 
with its carboxy late. 
Comparison of MesAT and AroAT. To investigate how MesAT differs from an 
aminotransferase that only accepts α-amino acids, the MesAT structures were compared 
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3with that of the aromatic amino acid aminotransferase AroAT from P. denitrificans (11). 
In both enzymes the PLP cofactor has a similar position and orientation. In contrast to 
MesAT, AroAT has a single α-carboxylate binding pocket and charged as well as uncharged 
α-amino acids bind with their α-carboxylate groups to R386 in the O-pocket (Fig. 3C,D). 
In MesAT, the α-carboxylate group of (S)-β-Phe binds to R54 in the P-pocket, while the side 
chain of (S)-β-Phe is bound in the O-pocket (Fig. 3A). As a consequence, in MesAT, β-amino 
acids bind in a reverse orientation in comparison to the substrates of AroAT (Fig. 3A,C,D). 
Moreover, the arginine switch of MesAT (R412) is located in the O-pocket of the enzyme, 
Figure 3. Comparison of the active site architectures of the β-aminotransferase MesAT (left column) 
and the α-aminotransferase AroAT (right column). A) Surface rendition of the active site of MesAT 
bound with (S)-β-Phe (magenta) and B) with 2-oxoglutarate (magenta). C) Surface rendition of the 
active site of AroAT bound with 3-phenylpropionate (magenta) based on PDB entry 1AY8 (31) and D) 
with maleate (magenta) based upon PDB entry 1AY5 (31). The positions of the PLP cofactor as well as 
R412 and R386 in the active sites of MesAT and AroAT, respectively, are similar. R412 represents the 
arginine switch of MesAT, R292 represents the arginine switch of AroAT. LLP, the internal aldimine. 
P (P-pocket) and O (O-pocket), see text for explanation.
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3where it binds the α-carboxylate group of an α-amino acid, while in AroAT the arginine 
switch (R292), is located in the P-pocket of the enzyme and binds the side chain carboxylate 
group of α-amino/α-keto acids (Fig. 3A-D). These differences between MesAT and AroAT 
show that, while these enzymes share the same fold, the architecture of their active site is 
very different. In MesAT the active site architecture has evolved to accommodate β-amino 
acids, while retaining the ability to accommodate α-amino/α-keto acids.
The covalent adducts in the active site of MesAT represent external aldimine inter-
mediates. Structures obtained from crystals soaked with (S)-β-Phe and (R)-3-amino-5-
methyl hexanoic acid show that covalent PLP-β-amino acid adducts have formed in the active 
site of MesAT (Fig. 2A,B). These adducts represent external aldimine intermediates since the 
Nβ-, Cα-, Cβ- and Cγ-atoms are not coplanar, as would occur in the ketimine intermediate 
(Fig. 1). The non-coplanarity of the Nβ-, Cα-, Cβ- and Cγ-atoms suggests that the reaction 
has stopped before abstraction of the Cβ-proton. 
Different explanations for the trapping of the external aldimine may be considered. 
Proton abstraction is most efficient if, in the transition state, the bond to be broken is 
oriented perpendicular to the plane of the PLP ring system (41). The crystal structures 
indicate that the Cβ-proton is indeed nearly perpendicular to the PLP plane, deviating 
20-30° from the perpendicular position. Such a deviation is probably not sufficient to fully 
prevent proton abstraction. 
Another explanation may be related to the observation that in none of the external 
aldimine intermediate bound structures density is present for a hydrolytic water molecule 
near the Cβ-atom that could convert the ketimine intermediate into the pyridoxamine 
intermediate (Fig. 1). The equilibrium of the amino transferase reaction in the crystal 
structure of MesAT may thus lie towards the external aldimine intermediate rather than 
the ketimine intermediate, which could explain why the external aldimine intermediates 
of (S)-β-Phe and (R)-3-amino-5-methylhexanoic acid are trapped. 
Enantioselectivity of MesAT. MesAT is enantioselective towards the β-amino acids (S)-
β-Phe, (R)-3-amino-5-methylhexanoic acid and (R)-3-aminobutyric (8). These preferred 
enantio mers have the same stereo-configuration of functional groups on the Cβ-atom as 
(S)-β-Phe. The preference for these enantiomers can be fully explained by the architecture of 
the active site which forces these substrates to bind in an orientation in which the carboxylate 
group binds to R54 in the P-pocket and the side chain in the O-pocket followed by addition 
of an amino group at the si-face of the β-carbon of the β-keto acid. 
The insights obtained from the 3D structure of MesAT on the enzyme’s interaction with 
α- and β-amino/keto acids may facilitate structure-based protein engineering efforts to 




1. Cole, D. C. (1994) Recent stereoselective 
synthetic approaches to β-amino acids. 
Tetrahedron 50, 9517-9582
2. Weiner, B., Szymanski, W., Janssen, D. B., 
Minnaard, A. J., and Feringa, B. L. (2010) 
Recent advances in the catalytic asymmetric 
synthesis of β-amino acids. Chem. Soc. Rev. 
39, 1656-1691
3. Liljeblad, A., and Kanerva, L. T. (2006) 
Biocatalysis as a profound tool in the 
preparation of highly enantiopure β-amino 
acids. Tetrahedron 62, 5831-5854
4. Koeller, K. M., and Wong, C. H. (2001) 
Enzymes for chemical synthesis. Nature 
409, 232-240
5. Taylor, P. P., Pantaleone, D. P., Senkpeil, R. 
F., and Fotheringham, I. G. (1998) Novel 
biosynthetic approaches to the production of 
unnatural amino acids using transaminases. 
Trends Biotechnol. 16, 412-418
6. Braunstein, A. E. (1964) Binding and 
reactions of the vitamin B6 coenzyme in the 
catalytic center of aspartate transaminase. 
in Vitamins & Hormones (Harris, R. S., 
Wool, I. G., Loraine, J. A., Marrian, G. F., 
and Thimann, K. V. eds.), Academic Press. 
pp 451-484
7. Bea, H. S., Park, H. J., Lee, S. H., and Yun, 
H. (2011) Kinetic resolution of aromatic 
β-amino acids by ω-transaminase. Chem. 
Commun. (Camb.) 47, 5894-5896
8. Kim, J., Kyung, D., Yun, H., Cho, B. K., 
Seo, J. H., Cha, M., and Kim, B. G. (2007) 
Cloning and characterization of a novel 
β-transaminase from Mesorhizobium 
sp. strain LUK: a new biocatalyst for the 
synthesis of enantiomerically pure β-amino 
acids. Appl. Environ. Microbiol. 73, 1772-
1782
9. Kim, B., Park, O. K., Bae, J. Y., Jang, T. H., 
Yoon, J. H., Do, K. H., Kim, B. G., Yun, H., 
and Park, H. H. (2011) Crystallization and 
preliminary X-ray crystallographic studies 
of β-transaminase from Mesorhizobium sp. 
strain LUK. Acta Crystallogr. Sect. F Struct. 
Biol. Cryst. Commun. 67, 231-233
10. Kim, J., Kyung, D., Yun, H., Cho, B. K., and 
Kim, B. G. (2006) Screening and purification 
of a novel transaminase catalyzing the 
transamination of aryl β-amino acid from 
Mesorhizobium sp. LUK. J. Microbiol. 
Biotechn. 16, 1832-1836
11. Oue, S., Okamoto, A., Nakai, Y., Nakahira, 
M., Shibatani, T., Hayashi, H., and 
Kagamiyama, H. (1997) Paracoccus 
denitr if icans  aromatic amino acid 
aminotransferase: a model enzyme for 
the study of dual substrate recognition 
mechanism. J. Biochem. 121, 161-171
12. Barth, S., Huhn, M., Matthey, B., Klimka, 
A., Galinski, E. A., and Engert, A. (2000) 
compatible-solute-supported periplasmic 
expression of functional recombinant 
proteins under stress conditions. Appl. 
Environ. Microb. 66, 1572-1579
13. Evans, P. (2006) Scaling and assessment 
of data quality. Acta Crystallogr. D Biol. 
Crystallogr. 62, 72-82
14. Kabsch, W. (2010) Integration, scaling, 
space-group assignment and post-
refinement. Acta Crystallogr. D Biol. 
Crystallogr. 66, 133-144
15. (1994) The CCP4 suite: programs for protein 
crystallography. Acta Crystallogr. D Biol. 
Crystallogr. 50, 760-763
16. McCoy, A. J., Grosse-Kunstleve, R. W., 
Adams, P. D., Winn, M. D., Storoni, L. C., and 
Read, R. J. (2007) Phaser crystallographic 
software. J. Appl. Crystallogr. 40, 658-674
17. Jaroszewski, L., Rychlewski, L., Li, Z., Li, W., 
and Godzik, A. (2005) FFAS03: a server for 
profile-profile sequence alignments. Nucl. 
Acids Res. 33, W284-288
18. Storici, P., De Biase, D., Bossa, F., Bruno, 
S., Mozzarelli, A., Peneff, C., Silverman, 
R. B., and Schirmer, T. (2004) Structures 
of  γ-a m i nobut y r ic  ac id (GA BA) 
aminotransferase, a pyridoxal 5’-phosphate, 
and [2Fe-2S] cluster-containing enzyme, 
complexed with γ-ethynyl-GABA and with 
the antiepilepsy drug Vigabatrin. J. Biol. 
Chem. 279, 363-373
19. Langer, G., Cohen, S. X., Lamzin, V. 
S., and Perrakis, A. (2008) Automated 
macromolecular model building for X-ray 
crystallography using ARP/wARP version 
7. Nat. Protoc. 3, 1171-1179
20. Emsley, P., Lohkamp, B., Scott, W. G., and 
Cowtan, K. (2010) Features and development 
of Coot. Acta Crystallogr. D Biol. Crystallogr. 
66, 486-501
61
Structural Determinants of the β-Selectivity of a Bacterial Aminotransferase
321. Murshudov, G. N., Vagin, A. A., and Dodson, 
E. J. (1997) Refinement of macromolecular 
structures by the maximum-likelihood 
method. Acta Crystallogr. D Biol. Crystallogr. 
53, 240-255
22. Chen, V. B., Arendall, W. B., 3rd, Headd, 
J. J., Keedy, D. A., Immormino, R. M., 
Kapral, G. J., Murray, L. W., Richardson, 
J. S., and Richardson, D. C. (2010) 
MolProbity: all-atom structure validation 
for macromolecular crystallography. Acta 
Crystallogr. D Biol. Crystallogr. 66, 12-21
23. Schuttelkopf, A. W., and van Aalten, 
D. M. (2004) PRODRG: a tool for high-
throughput crystallography of protein-
ligand complexes. Acta Crystallogr. D Biol. 
Crystallogr. 60, 1355-1363
24. Claude, J.-B., Suhre, K., Notredame, C., 
Claverie, J.-M., and Abergel, C. (2004) 
CaspR: a web server for automated molecular 
replacement using homology modelling. 
Nucl. Acids Res. 32, W606-609
25. Holm, L., and Rosenström, P. (2010) Dali 
server: conservation mapping in 3D. Nucl. 
Acids Res. 38, W545-W549
26. Krissinel, E., and Henrick, K. (2007) 
Inference of macromolecular assemblies 
from crystalline state. J. Mol. Biol. 372, 774-
797
27. Adams, P. D., Afonine, P. V., Bunkoczi, G., 
Chen, V. B., Davis, I. W., Echols, N., Headd, 
J. J., Hung, L. W., Kapral, G. J., Grosse-
Kunstleve, R. W., McCoy, A. J., Moriarty, 
N. W., Oeffner, R., Read, R. J., Richardson, 
D. C., Richardson, J. S., Terwilliger, T. 
C., and Zwart, P. H. (2010) PHENIX: a 
comprehensive Python-based system for 
macromolecular structure solution. Acta 
Crystallogr. D Biol. Crystallogr. 66, 213-221
28. The PyMOL molecular graphics system, 
version 1.2r3pre. Schrodinger, LLC
29. Grishin, N. V., Phillips, M. A., and 
Goldsmith, E. J. (1995) Modeling of the 
spatial structure of eukaryotic ornithine 
decarboxylases. Prot. Sci. 4, 1291-1304
30. Schneider, G., Kack, H., and Lindqvist, 
Y. (2000) The manifold of vitamin B6 
dependent enzymes. Structure 8, R1-6
31. Okamoto, A., Nakai, Y., Hayashi, H., Hirotsu, 
K., and Kagamiyama, H. (1998) Crystal 
structures of Paracoccus denitrificans 
aromatic amino acid aminotransferase: a 
substrate recognition site constructed by 
rearrangement of hydrogen bond network. 
J. Mol. Biol. 280, 443-461
32. Soda, K., Yoshimura, T., and Esaki, N. (2001) 
Stereospecificity for the hydrogen transfer 
of pyridoxal enzyme reactions. Chem. Rec. 
1, 373-384
33. Eliot, A. C., and Kirsch, J. F. (2004) 
Pyridoxal phosphate enzymes: mechanistic, 
structural, and evolutionary considerations. 
Annu. Rev. Biochem. 73, 383-415
34. Tipton, K. F. (1996) Patterns of enzyme 
inhibition. in Enzymology LabFax (Engel, 
P. C. ed.), Academic Press, San Diego, CA 
pp 115-174
35. John, R. A., and Charteris, A. (1978) 
The reaction of amino-oxyacetate with 
pyridoxal phosphate-dependent enzymes. 
Biochem. J. 171, 771-779
36. Marcotte, P., and Walsh, C. (1975) Active 
site-directed inactivation of cystathionine 
γ-synthetase and glutamic pyruvic 
transaminase by propargylglycine. Biochem. 
Biophys. Res. Commun. 62, 677-682
37. Tanase, S., and Morino, Y. (1976) 
Irreversible inactivation of aspartate 
aminotransferases during transamination 
with L-propargylglycine. Biochem. Biophys. 
Res. Commun. 68, 1301-1308
38. Marković-Housley, Z., Schirmer, T., 
Hohenester, E., Khomutov, A. R., Khomutov, 
R. M., Karpeisky, M. Y., Sandmeier, E., 
Christen, P., and Jansonius, J. N. (1996) 
Crystal structures and solution studies of 
oxime adducts of mitochondrial aspartate 
aminotransferase. Eur. J. Biochem. 236, 
1025-1032
39. Kirsch, J. F., Eichele, G., Ford, G. C., Vincent, 
M. G., Jansonius, J. N., Gehring, H., and 
Christen, P. (1984) Mechanism of action of 
aspartate aminotransferase proposed on the 
basis of its spatial structure. J. Mol. Biol. 174, 
497-525
40. Shin, J. S., and Kim, B. G. (2002) Exploring 
the act ive site of amine:pyruvate 
aminotransferase on the basis of the 
substrate structure-reactivity relationship: 
how the enzyme controls substrate 
specificity and stereoselectivity. J. Org. 
Chem. 67, 2848-2853
41. Toney, M. D. (2011) Controlling reaction 
specificity in pyridoxal phosphate enzymes. 
Biochim. Biophys. Acta 1814, 1407-1418
62
3Acknowledgements
We acknowledge the European Synchrotron Radiation Facility (ESRF) and the EMBL 
Outstation at DESY (Deutsches Elektronen Synchrotron) for provision of synchrotron 
radiation facilities. We thank the beam line staff of ID14-1 and ID14-2 (ESRF) and X13 
(DESY) for their assistance. This project is financially supported by the Netherlands Ministry 
of Economic Affairs and the B-Basic partner organizations (www.b-basic.nl) through 
B-Basic, a public-private NWO-ACTS program (ACTS = Advanced chemical Technologies 
for Sustainability).
63
Structural Determinants of the β-Selectivity of a Bacterial Aminotransferase

supplementary data
Structural Determinants of the β-Selectivity 
of a Bacterial Aminotransferase
3Supplementary Figure S1. A) Three-dimensional structure of the MesAT dimer. The 2 monomers 
(blue and green) are related by two-fold symmetry. Each monomer contains a PLP cofactor (magenta), 
bound to the enzyme via an imine bond to residue K280. B) Three-dimensional structure of a MesAT 
monomer. The PLP cofactor (magenta) is positioned in a cleft that separates the large PLP-binding 
domain (left, green α-helices, blue 7-stranded β-sheet) from the NC-domain (right, yellow α-helices, 
deep blue β-sheets).
Table S1. Purification of recombinant wild-type MesAT from a 1.4 liter cell culture. Specific 
activity was measured at 30 °C using (S)-β-Phe as an amino donor and 2-oxoglutarate as the 
amino acceptor.






(U • mg-1) Recovery (%)
CFE 75 4350 30.5 0.007 100
IMAC 9.2 21.1 23.1 1.1 76
IEXC 6.1 12.2 18.3 1.5 60
SEC 0.7 8.4 13.5 1.6 44
CFE: cell-free extract; IMAC: immobilized metal affinity chromatography; IEXC: ion exchange chromatography; 
SEC: size exclusion chromatography.
Table S2. The primers that were used for making the R412A mutant of MesAT (mutated codon 
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Cell dimensions




184.4, 94.9, 103.0 183.8, 94.4, 103.7 183.8, 94.3,  
102.3
β (o) 113.7 113.8 113.8 113.6 114.0
Rmerge b 0.07 (0.33) 0.04 (0.24) 0.07 (0.24) 0.01 (0.44) 0.07 (0.38)
Wavelength (Å) 0.933 0.9334 0.8123 0.933 0.9334
I/σ (I) 12.6 (3.2) 19.1 (4.5) 7.6 (3.3) 8.1 (2.6) 11.9 (2.8)













Multiplicity 2.6 2.7 3.0 2.8 3.0
Refinement
Resolution (Å) 1.9 1.69 1.95 1.85 1.9
Rwork c 0.16 0.16 0.18 0.18 0.18
Rfree d 0.19 0.18 0.22 0.20 0.21
Rms deviations
Bond lengths (Å) 0.01 0.012 0.018 0.006 0.012
Bond angles (o) 1.25 1.25 1.46 0.95 1.25
Ramachandran 
(MolProbity)
Favored (%) 97.9 97.7 97.0 98.1 97.1
Outliers (%) 0.0 0.0 0.0 0.0 0.0
PDB entry 2YKU 2YKY 4AO4 2YKX 2YKV
a Values in parentheses are for the highest resolution shell.
b Rmerge = ΣhΣi |I(h)i - ‹I(h)›| / ΣhΣi ‹I(h)i›, where I is the observed intensity and ‹I› is the average intensity of 
multiple observations of symmetry-related reflections.
c Rwork = Σh|Fobs - Fcalc| / Σh|Fobs|, where Fobs and Fcalc are the observed and calculated structure factor amplitudes, 
respectively.
d Rfree is calculated as Rwork using 5 % of all reflections randomly chosen and excluded from structure factor 
calculation and refinement.
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4Abstract
By selective enrichment we isolated a bacterium that can use β-phenylalanine as sole 
nitrogen source. It was identified by 16S rRNA gene sequencing as a strain of Variovorax 
paradoxus. Enzyme assays revealed an aminotransferase activity. Partial genome 
sequencing and screening of a cosmid DNA library resulted in the identification of a 1,302 
bp aminotransferase gene, which encodes a 46,416 Da protein. The gene was cloned and 
overexpressed in Escherichia coli. The recombinant enzyme was purified and showed a 
specific activity of 17.5 U mg-1 for (S)-β-phenylalanine at 30 °C and 33 U mg-1 at the optimum 
temperature of 55 °C. The β-specific aminotransferase exhibits a broad substrate range, 
accepting ortho-, meta- and para-substituted β-phenylalanine derivatives as amino donors 
and 2-oxoglutarate and pyruvate as amino acceptors. The enzyme is highly enantioselective 
towards (S)-β-phenylalanine (E>100) and derivatives thereof with different substituents 
on the phenyl-ring, allowing the kinetic resolution of various racemic β-amino acids to 
yield (R)-β-amino acids with >95% ee. The crystal structures of the holo-enzyme and of the 
enzyme in complex with the inhibitor 2-aminooxyacetate revealed structural similarity to 
the β-phenylalanine aminotransferase from Mesorhizobium sp. LUK. The crystal structure 
was used to rationalize the stereo- and regioselectivity of V. paradoxus aminotransferase 
and to define a sequence motif with which new aromatic β-amino acid converting 
aminotransferases may be identified.
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4Introduction
Various non-proteinogenic β-amino acids occur naturally as free metabolites and as 
components of biosynthetic products (60). The simplest β-amino acid, β-alanine, occurs in 
carnosine, coenzyme A and pantothenic acid. Other β-amino acids are present in bioactive 
peptides, such as the protease inhibitor bestatin, which contains a (2S,3R)-3-amino-2-
hydroxy-4-phenylbutanoyl group, and microcystin, a cyclic non-ribosomal peptide that 
acts as a phosphatase inhibitor and contains both an aliphatic and an aromatic β-amino 
acid moiety (5, 21, 30). Further examples are cryptophycins, which are anti-tumor agents 
containing an α-methyl-β-alanine group (61) and taxol, an anti-tumor agent from Taxus 
brevifolia that contains a (2R,3S)-N-benzoyl-3-phenylisoserine group that is derived from 
(R)-β-phenylalanine (45). Other β-amino acids occur as building blocks in β-lactam 
antibiotics (30, 48) and in antifungal compounds such as jasplakinolide (11). In view of the 
growing importance of pharmaceutical compounds containing β-amino acid groups, there 
is demand for new tools for their production in enantiopure form. Chemical and biochemical 
reactions yielding enantiopure β-amino acids have recently been reviewed (74). However, the 
possibilities for biocatalytic processes are scarce and most existing options rely on kinetic 
resolution of racemates instead of the more attractive asymmetric conversions (40, 52). 
Microorganisms that can synthesize or degrade specific organic compounds are a 
rich source of enzymes for application in biocatalytic processes. However, the microbial 
metabolism of β-amino acids has been poorly investigated. Some information is available 
about the formation of aliphatic β-amino acids such as β-lysine, β-leucine or β-glutamate, 
which can be formed from a-amino acids by catabolic bacterial aminomutases and are 
subject to deamination by aminotransferases or ammonia lyases (7, 56, 76). The formation 
of β-alanine in E. coli proceeds by decarboxylation of aspartate (12). Aromatic β-amino 
acids that occur in secondary metabolite biosynthesis can be formed from proteinogenic 
a-amino acids by MIO (4-methy lidene imidazole-5-one)-dependent aminomutases that 
have a biosynthetic function. The uncommon MIO cofactor also plays a key role in catabolic 
ammonia lyases that act upon α-histidine, α-phenylalanine and α-tyrosine (10).
Attractive enzymes for asymmetric synthesis are aminotransferases (ATs). These are 
pyridoxal 5′-phosphate (PLP)-dependent enzymes that transfer amino groups between 
different metabolites and are ubiquitously present in prokaryotic and eukaryotic cells 
(8, 69). There is evidence for a role of aminotransferases (also known as transaminases) 
in the biodegradation of β-amino acids by microorganisms. For example, a study on a 
β-phenylalanine-utilizing strain of Mesorhizobium led to the discovery of a transaminase 
that converts β-phenyl alanine into 3-oxo-3-phenylpropionic acid (32, 62, 80). 
Based on the latest update of the B6 database that compiles information on PLP-
dependent enzymes, seven fold types can be distinguished (50). The ATs occur in fold type 
I and IV. Typical examples of fold type I ATs are aspartate AT, aromatic AT and ω-ATs (19). 
According to a broader classification introduced in the 1980s, based on the reaction that 
is catalyzed, ATs are divided in two subgroups: (I) a-ATs, which catalyze transamination 
of amino groups at the a-carbon, and (II) ω-ATs, which perform transamination at a β-, 
γ-, or another more distal amino group of the substrate (79). According to this older non-
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4phylogenetic classification, all ATs that convert β-amino acids are confusingly considered 
to be ω-ATs. Enzymes from subgroup II include b-alanine AT, 4-aminobutyrate AT, 
ornithine AT, acetylornithine AT and 7,8-diaminopelargonic acid AT (9, 44), as well as a 
β-transaminase from Mesorhizobium sp. strain LUK (MesAT) (33).
Application of ATs in biocatalysis has mainly been investigated for the production of 
proteinogenic amino acids, unnatural amino acids, and various other amines and amino 
alcohols (27, 35, 36, 54, 68, 72, 77). The catalytic activities can be quite high (apparent kcat values 
up to 50 s-1) (47), and apart from PLP, which is sometimes added, there is no requirement for 
an external cofactor. Aminotransferases that catalyze synthesis or conversion of β-amino 
acids could be attractive for biocatalysis if they are enantioselective (55), stable, and exhibit a 
wide substrate scope. Here, we describe the gene cloning, the biochemical properties and the 
3D structure of VpAT, an aromatic β-amino acid aminotransferase discovered in a strain of 
Variovorax paradoxus isolated from soil. Based on the crystal structure, we offer a rationale 
for the regio- and stereoselectivity of β-transaminases and identify a signature sequence 
motif that allows the discovery of new aromatic β-amino acid-converting aminotransferases.
Materials and methods
chemicals. Pyridoxal-5′-phosphate (PLP) and rac-3-amino-3-phenylpropionic acid 
(β-phenylalanine) were purchased from Acros Organics, 2-oxoglutarate (α-ketoglutarate) 
disodium salt and Brij 35 were purchased from Fluka. Ortho-phthalaldehyde (OPA), 
dimethyl sulfoxide (DMSO), trans-cinnamic acid, sodium pyruvate, rac-β-leucine, and 
2-aminooxyacetic acid (AOA) were purchased from Sigma-Aldrich. (S)-β-phenylalanine 
and (R)-β-phenylalanine were purchased from PepTech Corp. Racemic and enantiomerically 
pure ortho-, meta-, and para-substituted β-phenylalanines and α-phenylalanines were either 
purchased from PepTech Corp. or synthesized according to published procedures (71). Other 
chemicals were purchased as follows: (R)-3-amino-butyric acid (Chemcube), (R)-3-amino-
5-methyl-hexanoic acid (Fluorochem), β-asparagine (Bachem), and rac-3-amino-3-(4-
hydroxyphenyl)-propionic acid (β-tyrosine) (Innochemie GmbH).
Enrichment of a β-phenylalanine-degrading microorganism. Samples of grassland soil 
(1-2 g) were used as a source of microorganisms. Minimal medium of pH 7.0 contained per 
liter 5.3 g Na2HPO4∙12H2O, 1.4 g KH2PO4, 0.2 g MgSO4∙7H2O, 1.0 g (NH4)2SO4, 1 ml vitamin 
solution (28) and 5 ml trace element solution (20). In nitrogen-free minimal medium, 
(NH4)2SO4 was replaced by Na2SO4 and Ca(NO3)2∙4H2O was omitted from the trace element 
solution. Stock solutions of carbon source (cinnamic acid, glucose) and nitrogen source (rac-
β-phenylalanine) were prepared in 50 mM sodium phosphate buffer (pH 7.5). Inoculated 
flasks containing 50 ml minimal medium supplemented with 5 mM cinnamic acid and 
1 mM rac-β-phenylalanine were incubated in the dark at 20 °C without shaking. After 2-3 
transfers, pure cultures were isolated on minimal medium agar plates supplemented with 
β-phenylalanine as sole nitrogen source and cinnamic acid as carbon source. A fast-growing 
strain, named CBF3, was chosen for further study.
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4Bacterial strains, plasmids. E. coli strains VCS257, DH5α, MC1061 and C41(DE3) were 
used as hosts for the construction of a cosmid library, a sublibrary, for proliferation of 
cloned genes, and for overexpression of protein, respectively. Plasmids pLAFR3, pZErO-2 
(Invitrogen) and pET28b+ (Novagen) were used for DNA libraries, subcloning and 
overexpression, respectively.
Preparation of cell-free extracts. For obtaining a high yield of cells expressing 
aminotransferase, strain CBF3 was grown on glucose (10 mM) with rac-β-Phe (2 mM) as 
nitrogen source. From a 1 liter culture, about 1 g of wet cells was obtained. Cells were washed 
with 50 mM Tris-SO4 buffer (pH 8.0) and then suspended in 3 ml of this buffer containing 
0.01% (vol/vol) b-mercaptoethanol. Sonication was performed with a Sonic Wibra cell, 
followed by centrifugation at 15,000 rpm and 4 °C for 1 h. The supernatants were used as 
cell-free extracts (CFEs).
Enzyme assays and amino acid analysis. To test the enzyme activity, an aminotransferase 
(AT) assay cocktail was prepared, consisting of 10 mM rac-β-phenylalanine, 5 mM 
2-oxoglutarate (or pyruvate) and 50 µM PLP in 50 mM MOPS, pH 7.6. Reactions were 
started by addition of purified enzyme or CFE and incubated at 30 °C. The conversion 
was monitored by taking samples at different times. To 50 µl sample, 50 µl 2 M HCl was 
added to quench the reaction, and the mixture was kept on ice for 5 min. Then, 45 µl 2 M 
NaOH was added to neutralize the pH and 50 µl of water for dilution. Immediately prior 
to injection, 1 µl of sample was mixed with 2 µl ortho-phthalaldehyde (OPA) solution 
and 5 µl of 0.4 M NaBO3, pH 10.4, in an HPLC autosampler (24). The OPA solution was 
prepared by first dissolving 15 mg OPA in 50 μl absolute ethanol, which then was added 
to a mixture of 4.42 ml of 0.4 M NaBO3, pH 10.4, 15 μl of 30% (wt/vol) Brij 35 and 11 μl of 
β-mercaptoethanol.
Quantification of glutamate, alanine and β-phenylalanine was performed with a C18 
OPA Adsorbosphere column connected to a Jasco HPLC system after pre-derivatization 
with OPA. Elution was done with 20 mM sodium acetate, pH 5.5, containing 5% (vol/
vol) tetrahydrofuran (THF) as eluent A and acetonitrile as eluent B, with a flow rate of 
1 ml/min. Eluent A and eluent B were used with a gradient program as follows: 0-5 min, 
100:0; 5-12 min, from 100:0 to 80:20; 12-16 min 80:20; 16-24 min from 80:20 to 40:60; 
24-28 min 40:60; from 28-30 min 40:60 to 100:0; from 30-35 min re-equilibration at 
100:0. Detection was done with a fluorescence detector, using excitation at 350 nm and 
measuring emission at 450 nm. Retention times for derivatized L-a-glutamate, L-a-alanine 
and β-phenylalanine were 2.3 min, 7.7 min and 23.2 min, respectively. One unit is defined 
as the amount of enzyme that catalyzes the formation of one μmol of L-a-glutamate 
min-1 at concentrations of 10 mM rac-β-phenylalanine and 5 mM 2-oxoglutarate. Protein 
concentrations were determined with Coomassie brilliant blue.
To determine the pH optimum of VpAT, Britton-Robinson buffer was used with a pH 
range from pH 2 to pH 12. The buffer consists of a mixture of 0.04 M H3BO3, 0.04 M H3PO4 
and 0.04 M CH3COOH that is titrated to the desired pH with 0.2 M NaOH. A sufficient 
amount of enzyme was added and its activity was assayed using rac-β-phenylalanine 
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4(10 mM) as the amino donor and 2-oxoglutarate (5 mM) as the amino acceptor. The initial 
reaction rates were plotted against pH.
The optimum temperature was determined by measuring the specific activity of VpAT 
in MOPS buffer (50 mM, pH 7.6) at temperatures between 20 °C and 65 °C. Enzyme was 
added and activity was assayed with rac-β-phenylalanine (10 mM) as the amino donor and 
2-oxo glutarate (5 mM) as the amino acceptor. 
For following the kinetic resolution of rac-β-phenylalanines with VpAT, separation 
of enantiomers was performed using a Crownpak CR(+)HPLC column connected to a 
UV detector (210 nm), as described elsewhere (71). Because of the low solubility of the 
racemates, they were tested in 50 mM MOPS (pH 7.6) at a concentration of 3 mM, using 
5 mM 2-oxoglutarate and 50 µM PLP, at 30 °C.
Cloning and sequence analysis. All chemicals used in DNA manipulation procedures were 
purchased from Roche Diagnostics (Mannheim, Germany) and Qiagen NV (Venlo, The 
Netherlands) and used as recommended by the manufacturer.
The 16S rRNA gene of strain CBF3 was sequenced after PCR amplification. For 
amplification, two universal primers of the 16S rRNA gene were used, namely 27F as the 
forward primer (5′–AGAGTTTGATCMTGGCTCAG–3′) and 1492R as the reverse primer 
(5′–GGYTACCTTGTTACGACTT–3′) and genomic DNA as the template (75). The PCR 
product was sequenced by GATC Biotech, Konstanz, Germany. 
Genomic DNA was isolated from bacterial cells as described elsewhere (51), and subjected 
to paired-end sequencing by Baseclear BV (Leiden, The Netherlands), using an Illumina 
GAIIx platform to obtain about 50 bp reads as raw data. The DNA reads were assembled 
into contigs using CLC Genomics Workbench software (CLC Bio).
For library construction, chromosomal DNA was partially digested with Sau3A, 
resulting in DNA fragments of 15 kb to 40 kb, which were cloned in BamHI-digested and 
dephosphorylated cosmid vector pLAFR3 (57, 66). Ligated DNA was packaged in vitro and 
transfected to E. coli VCS257 according to the recommendations supplied with the kit 
(Stratagene). Recombinant clones were stored as glycerol stocks at -20 °C. Transformants 
were grown in 96-well microtiter plates (MTPs) containing 1 ml of LB medium and 
tetracycline (25 µg/ml) at 30 °C and 900 rpm. After 24 h, rac-β-phenylalanine was added to 
a final concentration of 7.5-10 mM to each well of the MTP. Screening for AT activity was 
performed by testing for the formation of acetophenone, which is formed by spontaneous 
decarboxylation of the expected transaminase product 3-oxo-3-phenylpropionic acid. The 
assay is based on the reaction of acetophenone with 2,4-dinitrophenylhydrazine (DNPH), 
forming a hydrazone that appears as an orange-red precipitate (4). For screening, MTPs were 
covered with a paper filter impregnated with a DNPH solution and incubated for 2 days at 
30 °C and 900 rpm.
For subcloning, the vector pZErO-2 and the pLAFR3 positive clone were digested with 
EcoRI, and fragments were ligated. DNA was transformed to E. coli DH5a ElectroMAX 
cells (Invitrogen) and screening was performed as described for the pLAFR3 cosmid library. 
A 5 kb insert containing the CBF3 VpAT-encoding gene was isolated and sequenced by 
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4primer walking (GATC Biotech). Sequence comparisons were performed with Clustal Ω 
(65) and Geneious Pro software version 5.5 (15).
For amplification of the entire VpAT gene, two primers were designed, a forward primer 
(5′-GCGCGCATATGA CCCATGCCGCCATAG–3′) (NdeI site underlined, start codon in 
bold) and a reverse primer (5′–CGCGCGCTCGAGTT AGTTCG CGCGGGGCAGC–3′) 
(XhoI site underlined, stop codon in bold). The 1.3 kb PCR product was cloned using the 
NdeI and XhoI sites of the pET28b+ plasmid. The MesAT triple mutant I56V/A312S/M414F 
was expressed and purified as previously reported for MesAT WT (78).
The VpAT R41A mutant was prepared by site-directed mutagenesis (QuikChange, 
Stratagene). The R41A forward primer (5′–GGAGCCAACAGCGCCTCCGTGCTGTT
C –3′) and R41A reverse primer (5′–GAACAGCACGGAGGCGCTGTTGGCTCC–3′) 
(mutated codons in bold) were used according to the manufacturer’s recommendations. 
All constructs were confirmed by sequencing (GATC Biotech AG, Konstantz, Germany). 
The MesAT I56V/A312S/M414F triple mutant was prepared by site-directed mutagenesis 
(QuikChange, Stratagene) in three rounds.
Overexpression and purification of VpAT in E. coli. The pET28b+ construct containing 
the gene for VpAT was used to produce the enzyme with an N-terminal His6-tag 
(MGSSHHHHHH) followed by a 10 amino acid linker (SSGLVPRGSH) in E. coli C41(DE3). 
Cells were grown at 37 °C in LB medium with 50 mg/ml of kanamycin. Expression of 
VpAT was induced by adding 0.8 mM isopropyl-β-D-thiogalactopyranoside (IPTG) to 
the growing cells when the OD600 reached 0.6. Cultivation was continued for 16 h at 28 °C 
and 170 rpm. Cells were obtained by centrifugation and disrupted by sonication at 4 °C 
followed by centrifugation for 45 min at 15,000 rpm to obtain cell-free extract (CFE). 
The enzyme was purified in two steps using immobilized metal affinity chromatography 
(IMAC, HisTrap HP column 5 ml, GE Healthcare) and ion-exchange chromatography 
(IEXC, Q-Sepharose HP column 5 ml, GE Healthcare). In case of IMAC, VpAT was 
eluted at a flow rate of 1 ml/min with 15 column volumes of a linear gradient of 0-0.5 M 
imidazole in a buffer containing 20 mM Tris-HCl, pH 8.0, 0.5 M NaCl, and 0.01% (vol/vol) 
β-mercaptoethanol, whereas for IEXC elution was performed with 15 column volumes of a 
gradient of 0-1 M NaCl in a buffer containing 20 mM Tris-HCl, pH 8.0, and 0.01% (vol/vol) 
β-mercaptoethanol. For use in crystallization experiments, the fractions containing 
active enzyme were pooled, concentrated (Ultracel 30K MWCO, Amicon) and applied 
to a Superdex 200 10/300 GL size exclusion chromatography column (GE Healthcare), 
equilibrated in 20 mM Tris-HCl, pH 7.5, containing 200 mM NaCl. After elution the 
fractions corresponding to the protein peak were pooled, concentrated (Amicon) and 
dialyzed overnight against a buffer containing 20 mM Tris-HCl, pH 7.5 and 10 μM of PLP, 
and concentrated to 20 mg/ml.
Protein crystallization. Crystallization experiments were set up at 20 °C, and a single 
crystal was obtained under the condition of 0.02 M sodium/potassium phosphate, 0.1 M 
1,3-bis(tris(hydroxyl-methyl)-methylamino)-propane, pH 6.5, and 20% (wt/vol) PEG 
3350K. Crystals of VpAT grew within a week after which they were transferred to a cryo-
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4protection solution consisting of the mother liquor with 20% (vol/vol) glycerol. This was 
achieved in 4 steps of 5 min each, starting with a solution containing 2% (vol/vol) glycerol 
followed by solutions with 5, 10 and finally 20% glycerol. Crystals from this last solution 
were cooled in liquid nitrogen. For the 2-aminooxyacetate (AOA) binding study, the same 
steps were followed, but with the cryo-protection solutions supplemented with 2, 5, 10 and 
20 mM AOA. 
Diffraction data collection and processing. Diffraction data were collected at beamline 
ID14-4 of the European Synchrotron Radiation Facility (ESRF, Grenoble, France). Indexing 
and integration of reflections was done using XDS (18) and scaling and merging of the data 
was achieved using SCALA (31) from the CCP4 software suite (2). For molecular replacement 
the Phaser program (43) was used with MesAT (PDB code 2YKU (78)) as the input model. 
The resulting model structure was subjected to successive rounds of automatic model 
building using ARP/wARP (39) at 1.7 Å resolution followed by manual model building and 
manipulation in Coot (17). Refmac5 was used for refinement of the atomic coordinates and 
atomic B-factors (46). After refinement the model quality was validated with MolProbity 
(6). Hetero-compound coordinate files were obtained from the HIC-Up server (34) while 
the PRODRG2 server (59) was used to generate the stereochemical restraints. Structural 
homologues of VpAT were obtained with the Dali server (26). PISA from the CCP4 software 
suite was used for protein interface analysis (38) while PyMOL (http://www.pymol.org/) was 
used for making images of the protein structure. Data collection and refinement statistics 
are given in the supplemental material (Table S2).
Substrate docking. Docking of the PLP-(S)-β-phenylalanine intermediate was carried 
out with Rosetta software which allows both side-chain and backbone flexibility during 
docking (13, 14). Rosetta’s redesign specificity application (53) was used (without permitting 
mutations); this application allowed for optimizing the surrounding protein structure to 
bind the (S)-β-phenylalanine intermediate while preserving the known binding orientation 
of the PLP (MesAT, PDB code 2YKY). To model the flexibility of the protein, Monte 
Carlo optimizations of side chain rotamers (collections of thermodynamically accessible 
conformations) were carried out three times. Each of these optimization rounds was followed 
by an energy minimization, which also allowed backbone atoms to move. Residues up to 8 Å 
from the intermediate were allowed to change conformation. Rotamers for the PLP-(S)-β-
phenylalanine intermediate were prepared with Yasara (www.yasara.org) (37). AM1-BM3 
charges of the PLP-intermediate were assigned by OEchem (1). A total of 1,040 docking runs 
were carried out of which the lowest energy solution was selected.
Accession numbers. The 16S rRNA gene sequence of V. paradoxus CBF3 has been 
deposited at GenBank under accession number JN990697. The sequences of the DNA contig 
containing the VpAT encoding gene and of the VpAT enzyme are deposited at EMBL 
under accession numbers HE608883 and CCE46017, respectively. Atomic coordinates and 
structure factors have been deposited in the Protein Data Bank (http://www.pdb.org) under 




Isolation of a β-phenylalanine-degrading bacterium. The isolation of a bacterial strain 
possessing β-phenylalanine transaminase activity was carried out by an enrichment 
procedure using rac-β-phenylalanine as the sole nitrogen source. After growth was 
observed, a pure culture was obtained by repeated transfer to fresh medium and streaking 
onto minimal medium plates supplemented with β-phenylalanine and trans-cinnamic 
acid. The most rapidly growing strain (named CBF3) was selected for further investigation. 
The 16S rRNA gene (1,517 bp) of strain CBF3, identified by PCR and paired-end genome 
sequencing, has 99% sequence identity to the 16S rRNA genes of Variovorax paradoxus 
S110 (CP001635.1) and V. paradoxus EPS (CP002417.1) (81). This affiliates strain CBF3 to 
the genus of V. paradoxus.
Activity assays with HPLC analysis showed that strain CBF3 possesses a β-phenylalanine 
AT activity that converts β-phenylalanine and 2-oxoglutarate (or pyruvate) to 3-oxo-3-
phenylpropionic acid and L-a-glutamate (or L-a-alanine). Attempts to purify the VpAT 
using wild-type CBF3 as the source of enzyme failed due to low protein recovery after 
partial purification.
Isolation of the vpAT gene. A DNA library, consisting of about 4,000 clones, was constructed 
in cosmid pLAFR3. The insert size of the DNA fragments was between 15-25 kb. The genome 
size of V. paradoxus is about 6.7 Mb (23), thus the number of obtained clones was sufficient for 
9-fold coverage of the whole genome. Screening individual clones for AT activity yielded two 
positive clones of which one was investigated further. The insert was subcloned into vector 
pZErO-2 and rescreening for acetophenone formation yielded six positive hits. Restriction 
analysis identified a shared 5 kb EcoRI fragment that likely contains the AT-encoding gene.
DNA sequence analysis showed the presence of a 1,302 bp gene encoding an 
aminotransferase, which was subsequently transferred to the pET28b+ expression vector. 
The encoded 434 amino acid protein has a theoretical pI of 6.06 and a calculated molecular 
mass of 46.42 kDa (http://web.expasy.org/compute_pi/). The sequence of a 20.6 kb contig 
found by paired-end genome sequencing indicated that around the vpAT gene there 
were no regulatory regions or open reading frames related to other enzymes of amino 
acid metabolism.
Protein sequence analysis. Sequence analysis showed that VpAT has 55% sequence identity 
to glutamate-1-semialdehyde-2,1-aminomutase from Polaromonas sp. JS666 (PoGSAM), 
which has been reported to have activity with aromatic β-amino acids (ABE43415.1) 
(Fig. 1), 51% sequence identity to the aromatic β-phenylalanine aminotransferase (MesAT) 
(ABL74379.1) from Mesorhizobium sp. LUK, and 35% sequence identity to a glutamate-1-
semialdehyde-2,1-aminomutase from Synechococcus elongatus (SeGSAM) (ABB56677.1). 
These data suggest that VpAT, just as MesAT and PoGSAM, is a fold type I aminotransferase 
and furthermore that VpAT belongs to subgroup II transaminases which is based on an 
enzyme’s substrate specificity (3, 33, 78). VpAT has 19% sequence identity to a transaminase 
from Alcaligenes denitrificans that has been reported to have activity towards aliphatic 
β-amino acids (AdbpAT) (AAP92672.1) (80). A sequence comparison between VpAT, MesAT, 
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4PoGSAM and AdbpAT shows that the amino acid residues that are involved in cofactor 
binding are conserved in addition to several residues that, based on the structures of VpAT 
and MesAT, are involved in substrate and cofactor binding (Fig. 1).
Purification of VpAT expressed in E. coli. The recombinant protein was overproduced 
with an N-terminal His6-tag in E. coli strain C41(DE3). VpAT was mainly present as a 
soluble protein. The enzyme was purified by three chromatography steps. Size exclusion 
chromatography indicated a molecular mass of approximately 100 kDa, suggesting that 
VpAT exists as a dimer in solution. The purified protein showed a single band of about 
Figure 1. Partial sequence alignment of VpAT with other aminotransferases made with Clustal 
Ω (65). The structure of MesAT and SeGSAM are known and α-helices have been assigned based 
on these structures. For PoGSAM, this has been assigned on the basis of sequence conservation. 
Since the structure of AdbpAT has not been elucidated and since the sequence identity to VpAT 
is low, secondary structural elements are not indicated. The proposed aromatic β-transaminase 
signature sequence is shown in the enclosed box and its residues are highlighted in dark grey boxes. 
Square black boxes indicate relevant residues for substrate and cofactor binding. Proteins: VpAT, 
β-transaminase of Variovorax paradoxus (this study; CCE46017.1, PDB code 4AO9); PoGSAM, 
glutamate-1-semialdehyde 2,1-aminomutase of Polaromonas sp. strain JS666 (ABE43415.1); MesAT, 
β-transaminase of Mesorhizobium sp. strain LUK (ABL74379.1, PDB code 2YKY); SeGSAM, glutamate-
1-semialdehyde 2,1-aminomutase from Synechoccus elongatus (ABB56677.1, PDB code 2HOZ); 
AdbpAT, β-alanine:pyruvate transaminase of Alcaligenes denitrificans (AAP92672.1). The numbers 
6, 11, 17, 23, 29, 35, 40 and 46 refer to the proteins that are listed in Supplemental Material, Table S3.
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448 kDa in an SDS-PAGE gel (Supplemental Material, Fig. S1). The overall yield from 1 L of 
culture was 40-50 mg (Supplemental Material, Table S1). The specific activity of the purified 
enzyme was 17.5 U mg-1 at 30 °C, corresponding to a kcat of 11.8 s-1 per monomer. The VpAT 
R41A mutant was overexpressed and purified under the same conditions as the wild-type 
enzyme, resulting in similar amounts of purified protein.
Catalytic properties. The pH-activity profile of VpAT showed that the enzyme has a high 
activity over a broad pH range (4 to 11.2) at 30 °C. The optimum temperature of the enzyme 
was tested by measuring the specific activity at temperatures between 20 °C and 65 °C. 
VpAT exhibits a maximum specific activity of 33 U mg-1 at 55 °C, which is about 2-fold 
higher than the specific activity at 30 °C (Supplemental Material, Fig. S2). These data show 
that VpAT is more active toward (S)-β-phenylalanine than other β-trans aminases reported 
earlier (3, 33, 80). The activity of VpAT with pyruvate is 85% of that with α-ketoglutarate as 
the amino acceptor.
The relationship between reaction rate and the substrate concentration displayed 
Michaelis-Menten kinetics with substrate inhibition (73). The apparent Km and kcat values (per 
monomer) for (S)-β-phenylalanine in the presence of 10 mM a-ketoglutarate were 1.5 mM 
and 11.8 s-1, respectively, with an apparent substrate inhibition constant (Ki) of 40.3 mM. 
When using 10 mM (S)-β-phenylalanine, the apparent Km and kcat for a-ketoglutarate were 
0.3 mM and 10.6 s-1, respectively, with an apparent Ki of 82.4 mM.
Substrate scope and enantioselectivity of VpAT. To investigate the substrate scope of the 
enzyme, a number of β-amino acids and a-amino acids, were tested (Table 1). The results 
show that VpAT acts exclusively on β-amino acids and that the enzyme prefers aromatic 
β-amino acids (Table 1, entries 1-3, 8-20) over aliphatic β-amino acids (Table 1, entries 
21-27). The most favorable substituent positions on the phenyl ring of β-phenylalanine for 
activity were para- and meta-, while ortho-substituted analogues were poorly converted. The 
β-phenylalanine derivatives bearing linear alkyl substituents at the para position, i.e. ethyl 
or propyl (Table 1, entries 13-14), were converted more efficiently than other substituted 
substrates (Table 1, entries 12, 16-20). However, introduction of a branched alkyl substituent, 
i.e. iso-propyl, at the para position results in a decrease of activity (Table 1, entry 15). The 
enzyme showed no activity for a-phenylalanine or its meta-chloro, meta-bromo and para-
hydroxy substituted (a-tyrosine) derivatives, which contrasts with MesAT for which activity 
was reported with a-phenylalanine and other a-amino acids (33). The activity of MesAT 
towards a-phenylalanine however could not be confirmed by us. 
VpAT further preferentially converts the (S)-enantiomers of aromatic β-amino acids, 
(Table 1, entries 1-3, 9, 10, 12 and 16) and the (R)-enantiomers of aliphatic β-amino acids 
(which have a similar configuration of functional groups around the chiral carbon atom but 
a change in Cahn–Ingold–Prelog priority). However, the activity of VpAT towards several 
aliphatic β-amino acids was quite low (Table 1, entries 22-23). We also investigated the 
regio- and enantioselectivity of VpAT with several racemic substrates (Table 1, entries 1, 9, 
10, 12 and 16). The enzyme appeared highly enantioselective towards the (S)-enantiomers 
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4Table 1. Substrate range of VpATa.
Entry Amino donor Relative activity (%) Conversion (%) ee (%), E
I.    β-phenylalanine derivatives
1 rac-β-phenylalanine 100 49 >99 (R), >200
2 (S)-β-phenylalanine 100 99c –
3 (R)-β-phenylalanine NAb –d –
4 rac-2-methyl-β-phenylalanine 5 19 NDe
5 rac-2-fluoro-β-phenylalanine 15 26 NDe
6 rac-2-chloro-β-phenylalanine 4 32 NDe
7 rac-2-bromo-β-phenylalanine 4 25 NDe
8 rac-3-methyl-β-phenylalanine 54 64 NDe
9 rac-3-fluoro-β-phenylalanine 48 48 >98 (R), >200
10 rac-3-chloro-β-phenylalanine 56 47 >95 (R), >100
11 rac-3-bromo-β-phenylalanine 53 99 NDe
12 rac-4-methyl-β-phenylalanine 100 53 >95 (R), >200
13 rac-4-ethyl-β-phenylalanine 134 47 NDe
14 rac-4-propyl-β-phenylalanine 126 48 NDe
15 rac-4-iso-propyl-β-phenylalanine 61 25 NDe
16 rac-4-trifluoromethyl-β-phenylalanine 73 49 >95 (R), >100
17 rac-4-fluoro-β-phenylalanine 87 59 NDe
18 rac-4-bromo-β-phenylalanine 62 61 NDe
19 rac-4-nitro-β-phenylalanine 32 6 NDe
20 rac-4-hydroxy-β-phenylalanine 61 39 NDe
II.    Other β-amino acids
21 rac-3-amino-butyric acid 1 6 NDe
22 (R)-3-amino-butyric acid 3.1 11 –
23 (R)-3-amino-5-methyl-hexanoic acid 48 75 –
24 rac-β-asparagine 1 4 NDe
25 rac-β-leucine 38 51 NDe
26 β-alanine NAb –d –
27 β-glutamic acid NAb –d –
III.    α-amino acids
29 (S)-α-phenylalanine NAb –d –
30 rac-3-chloro-α-phenylalanine NAb –d –
31 rac-3-bromo-α-phenylalanine NAb –d –
32 (S)-α-tyrosine NAb –d –
a Reaction mixtures (0.4 ml volume) contained amino donor (3 mM) and α-ketoglutarate (5 mM) as acceptor. 
Initial rates were measured and conversion was determined after 16 h at 30 °C. The activity for β-phenylalanine, 
corresponding to 17.5 U mg-1, was taken as 100%. 
b No activity (less than 0.001 U mg-1)
c Conversion after 0.5 h.
d No conversion observed after 16 h.
e ND, not determined.
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4of β-phenylalanine and its meta- and para ring-substituted derivatives thereby producing 
highly pure (R)-enantiomer preparations (ee >95%).
3D structure of VpAT. The crystal structure of the VpAT holo-enzyme was solved by 
molecular replacement, using the structure of MesAT (PDB code 2YKU) (78) as a search 
model, and subsequently refined at 1.5 Å resolution. VpAT crystallizes in space group 
P212121 with two molecules (chains A and B) per asymmetric unit, which are related by 
non-crystallographic two-fold symmetry. Chains A and B are very similar to each other with 
RMSD values of Cα atom positions of approximately 0.2 Å. For both monomers, electron 
density is absent for the first 21 N-terminal residues. This includes the N-terminal His6-tag, 
10 amino acids included as a linker in the expression construct, and the first amino acid 
(methionine) of the VpAT polypeptide. The interface between the monomers buries an area 
of about 4,400 Å2, which equals a quarter of the total surface area of the monomer pair 
(Fig. 2). Since the active sites of chains A and B are located at this interface and shaped by 
residues from both monomers, this suggests that the two monomers in the asymmetric unit 
form the functional VpAT dimer observed in solution (see above).
The structure of the VpAT monomer. The VpAT monomer has a curved shape and consists 
of a PLP-binding domain and a domain formed by the N- and C-termini of the polypeptide 
chain (NC-domain; residues 1-86 and 320-434) (Fig. 2). The two domains line a cleft into 
which the PLP cofactor protrudes. The monomer consists of 11 α-helices of at least 2 turns 
and 13 β-strands that form a central 7-stranded mixed β-sheet in the PLP-binding domain 
Figure 2. Structures of monomer and dimer of VpAT. (A) The monomer of VpAT with the PLP cofactor 
(magenta) positioned in the cleft in between the PLP-binding domain (left half of the monomer, 
containing the 7-stranded mixed β-sheet) and the NC-domain (right half of the monomer, containing 
the two 3-stranded anti-paralell β-sheets and the N- as well as the C-termini of the polypeptide chain 
indicated by N and C, respectively). (B) Two monomers of VpAT assemble into a dimer, here viewed 
along the two-fold non-crystallographic axis relating the two monomers. The two PLP cofactors are 
shown in magenta and are linked to the polypeptide backbone via a Schiff base with K267. The α-helices 
are colored blue, the β-strands are colored yellow and the loops are colored red. N and C indicate the 
N- and C-termini, respectively.
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4and two 3-stranded anti-parallel β-sheets in the NC-domain. The overall structure of 
the enzyme is similar to that of aspartate aminotransferase, the archetype of a fold type 
I aminotransferase (Z score 22, RMSD of 4.3 Å for 308 Cα atoms, 17 % sequence identity, 
PDB code 1BKG) (22, 58), but is most similar to that of MesAT (Z-score 60, RMSD of 1.1 Å 
for 429 Cα atoms, 50 % sequence identity, PDB code 2YKU) (78).
The PLP cofactor. Each VpAT dimer contains one PLP cofactor per monomer, which is 
positioned close to the surface (Fig. 3). The PLP cofactor is anchored to the protein via 
a covalent imine bond with the ε-amino group of residue K267, which is conserved in 
the sequence alignment of homologous PLP-dependent enzymes. In addition, the three 
phosphate oxygen atoms are at hydrogen bonding distance to the amide protons of residues 
G132, T133 and T300* (monomer B). Two of the phosphate oxygen atoms also make a 
hydrogen bond to a water molecule, which in turn is hydrogen-bonded to peptide backbone 
atoms. The phosphate ester oxygen atom is not involved in hydrogen bond formation. The 
PLP cofactor is positioned in between V242 (at the Si-face of the C4’ of the aldimine) and 
Y159 (at the Re-face of the C4’ of the aldimine) while the pyridine nitrogen makes a hydrogen 
bond with the side chain of D240. The interactions of the PLP cofactor with residues K267, 
V242, Y159 and D240 keep the PLP cofactor fixed in the active site (Fig. 3A).
The binding of 2-aminooxyacetic acid. Aminooxyacetic acid (AOA), a mimic of β-alanine, 
is a known inhibitor of aminotransferases (29) and also inhibits VpAT. To investigate how 
AOA binds in VpAT, enzyme crystals were soaked with AOA. The structure of VpAT with 
AOA (Fig. 3A, B) shows that the amino group of the inhibitor covalently binds to the C4A 
atom of the PLP cofactor, as also described for aspartate aminotransferase (42), and recently 
for MesAT (78). The ether-oxygen atom (Oχ1) of AOA is positioned close (3.0 Å) to the 
ε-amino group of residue K267. The carboxylate group binds via a salt bridge to the Nε- and 
Nη2-atoms of R41. The binding of AOA in the active site of VpAT is similar to how AOA 
binds in the active site of MesAT (PDB code 2YKV). AOA inhibits aminotransferase activity 
because the amine-ether oxygen bond of AOA cannot be weakened by K267, and hence 
hydrolysis and formation of the PMP intermediate does not occur (Fig. 3B).
Docking of PLP-(S)-β-phenylalanine in the active site of VpAT. To investigate how an 
aromatic β-amino acid such as (S)-β-phenylalanine binds in the active site of VpAT, initially 
a structure was determined after a VpAT crystal had been soaked with (S)-β-phenylalanine. 
However, this structure only revealed the presence of a pyridoxamine 5′-phosphate (PMP) 
intermediate in the active site of the enzyme. Since trapping of (S)-β-phenylalanine in the 
active site of VpAT apparently had not occurred, the external (S)-β-phenylalanine aldimine 
intermediate was modeled into the active site of VpAT using Rosetta, which allows docking 
with flexible backbone and side chains. In the docked structure, the aromatic ring of the 
substrate is bound between V43, Y76, Y159, and A212 (Fig. 3C), similar to the way (S)-
β-phenylalanine is bound to MesAT (78). This region was previously termed by us as the 
O-pocket, because it is positioned on the 3-hydroxyl side of the PLP cofactor ((78), see below). 
Similar to the conformational changes observed in MesAT upon formation of the external 
aldimine intermediate with (S)-β-phenylalanine (78), also in VpAT the arginine switch 
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4Figure 3. Wall-eyed stereo presentation of VpAT bound with an inhibitor and a docked intermediate. 
(A) The PLP cofactor (yellow) is shown bound to 2-aminooxyacetate (AOA) (yellow). The monomer 
A of VpAT is shown in light blue, whereas monomer B is shown in orange. (B) The inhibitor 
2-aminooxyacetate (AOA) bound in VpAT. The holo-enzyme without inhibitor is shown in green. The 
X-ray structure with AOA bound is shown with different colors for monomer A (light blue), monomer B 
(orange), and the inhibitor (yellow). (C) X-ray structure of holo-VpAT with docked (S)-β-phenylalanine. 
The X-ray structure of the holo-enzyme is shown in green, while the modeled structure with docked (S)-
β-phenylalanine is in light blue for monomer A, and orange for monomer B. The docked intermediate 
is shown in yellow. The side chains of residues interacting with the docked intermediate and the 
backbone atoms of A212 are also shown. R41 (P-pocket) is the residue that binds the α-carboxylate 
of β-phenylalanine. In the O-pocket, R398 is the arginine switch residue (compare panel B with C).
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4residue R398 in the O-pocket is displaced during the docking, freeing space for the phenyl 
ring of the substrate. Instead, the R398 side chain Nη2 atom forms a hydrogen bond to the 
carbonyl oxygen of A212. Also V43 and Y159 have reoriented to better accommodate the 
docked external aldimine intermediate. In the absence of (S)-β-phenylalanine the docking 
procedure resulted in minor shifts of less than 0.5 Å of the backbone atoms around the 
active site. While the ortho hydrogen atoms of the phenyl ring of the bound intermediate 
are buried, the para and meta hydrogen atoms of the phenyl ring are solvent exposed in the 
docked structure. The carboxylate of the docked (S)-β-phenylalanine is buried in a region 
we term the P-pocket, which is at the phosphate group side of the PLP cofactor. Here, residue 
R41 is directly involved in binding of (S)-β-phenylalanine by making a salt-bridge to the 
carboxylate group (Fig. 3C). The importance of R41 for the binding of (S)-β-phenylalanine 
is underscored by the observation that the R41A mutant was inactive when tested with (S)-
β-phenylalanine as amino donor and a-ketoglutarate as amino acceptor.
Identification of aromatic β-amino acid aminotransferases. The VpAT structure with 
bound AOA, a β-alanine mimic, and the docking results with β-phenylalanine show that 
R41 is important for binding the α-carboxylate of β-amino acids, as is the corresponding 
residue R54 in MesAT (78). The side chain of R41 interacts with E75, which may assist the 
function of R41 by orienting its side chain and shaping the carboxylate-binding P-pocket. 
We therefore hypothesized that the presence of an R41-E75 pair in an aminotransferase 
protein sequence indicates enzymatic activity with β-amino acids. A comparison of the 
crystal structures of VpAT and MesAT showed that the R41-E75 salt bridge is conserved 
in MesAT (R54-E88). In addition, a sequence alignment between VpAT and a glutamate-
1-semialdehyde-2,1-aminomutase from Polaromonas sp. JS666 (PoGSAM), for which no 
structure is available but which has activity towards aromatic β-amino acids (3), also 
showed conservation of R41 and E75 (as R51 and E85, respectively) (Fig. 1). In contrast, the 
crystal structure of Synechococcus elongatus glutamate-1-semialdehyde-2,1-aminomutase 
(SeGSAM, PDB code 2HOZ) (67), which is structurally very similar to that of VpAT 
(Z-score 47; RMSD of 1.8 Å for 404 Cα atoms, 35 % sequence identity), shows that no Arg 
and Glu residues equivalent to R41 and E75 of VpAT are present, in agreement with the 
enzyme’s lack of activity on β-amino acids. 
We subsequently tested whether R41 and E75 could be used to define a sequence 
motif with which aromatic β-amino acid aminotransferases can be distinguished from 
aminotransferases with a similar fold but with a different substrate specificity. For this, 
BLAST searches were performed using the VpAT, MesAT, and PoGSAM (ABE43415.1) 
protein sequences. For each query sequence, 2,000 homologous sequences were retrieved 
with ≥ 18% sequence identity. After omitting duplicates, the resulting 2,222 sequences were 
included in a multiple sequence alignment, and inspected for residues that are important 
for substrate binding.
We used the P-pocket R41-E75 pair as the starting point to identify a motif with which 
aminotransferases with activity towards aromatic β-amino acids may be distinguished 
from aminotransferases with a similar fold but a different activity. The R41-E75 starting 
pair was subsequently broadened by including the O-pocket residues V43 and Y76 since 
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4the equivalent residues in MesAT (I56 and Y89) were shown to be involved in substrate 
binding. At position 43 Val, Ile, and Ala were allowed, but hydrophobic residues with more 
bulky side chains such a Leu, Phe, Tyr and Trp were excluded since they were expected to 
prevent aromatic substrate binding for steric reasons. At position 75, apart from Glu, we 
also allowed Asp, Gln and Asn since these may still be able to interact with the side chain 
of R41. At position 76, Phe and Trp were also allowed since they are frequently found in 
the same position as Tyr in other fold type I aminotransferases. We next extended the 
motif with conserved residues at positions that appear structurally important by adding a 
conserved Pro at position 50, which is in the center of a hydrophobic cluster in the VpAT 
and MesAT structures, and an Asp at position 65 and a Gly at position 66, which form a 
β-turn, of which the Asp is hydrogen bonded to A23 and S24, residues that are located in 
the α-helix that precedes loop 1.
The motif that was finally defined, R-X-[AVI]-X(6)-P-X(14)-D-G-X(8)-[EDNQ]-[YFW] 
(Fig. 1), retrieved 46 unique sequences (Supplemental Material, Table S3) that we hypothesize 
may represent fold type I aminotransferases with activity towards aromatic β-amino acids.
Discussion
Catalytic properties and enantioselectivity of Variovorax AT. Isolation of microorganisms 
that use β-phenylalanine as sole nitrogen source yielded a gram-negative bacterium of the 
genus Variovorax paradoxus that produces a β-amino acid selective aminotransferase. The 
gene encoding this enzyme was cloned, sequenced and overexpressed to a high level in 
E. coli. Sequence analysis showed that the enzyme is a fold type I AT, just as several other 
subgroup II ω-ATs. VpAT shares highest sequence identity with biochemically characterized 
β-phenylalanine ATs (3, 33), including the Mesorhizobium aminotransferase (MesAT) 
described by Kim et al. (33), of which the structure was recently solved (78). MesAT and 
VpAT have similar activities with a-ketoglutarate and pyruvate as amino acceptors (33), but 
differ from a-transaminases, which generally show a clear preference for either pyruvate, 
a-ketoglutarate, or oxaloacetate (41, 64, 70). Striking differences between MesAT and VpAT 
are that VpAT has a higher catalytic activity, is active over a very broad range of pH values, 
and only accepts β-amino acids. On the other hand, VpAT shows the same enantiopreference 
for (S)-β-phenylalanine and a very high enantioselectivity (E>100), just as MesAT (32) 
and PoGSAM (3). This allows a biotechnologically relevant kinetic resolution of racemic 
mixtures, from which the remaining (R)-β-phenylalanines can be obtained with very high 
ee (Table 1, entries 1, 9, 10, 12 and 16). 
Although the differences in activity are difficult to explain, a comparison of the residues 
surrounding the active site of VpAT with those of MesAT shows that V43, S298* (monomer 
B) and F400, which line the hydrophobic O-pocket of the active site of VpAT, differ from 
the residues found at these positions in MesAT (I56, A312* and M414). A triple mutant of 
MesAT (I56V/A312S/M414F) was generated and showed a two-fold increase (3.3 U mg-1) in 
activity with (S)-β-phenylalanine compared to MesAT WT (1.6 U mg-1 (33)), indicating an 
important role of these residues in activity with (S)-β-phenylalanine.
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4Structure of VpAT and architecture of the active site. The structure of VpAT revealed the 
overall topology of the enzyme, the position of the cofactor, and provided insight into the 
architecture of the active site of VpAT. A comparison with the structure of MesAT shows that 
the two enzymes are structurally similar (RMSD of 1.0 Å for 423 Cα atoms, 51 % sequence 
identity) and confirms that they both belong to the fold type I aminotransferase family 
(22). As in MesAT, both monomers in VpAT contribute to the binding of the PLP cofactor, 
suggesting that dimerization is essential for catalytic activity (Fig. 3).
Previously, we proposed to use the notation P-pocket (pointing in the same direction as 
the PLP phosphate) and O-pocket (at the side of the hydroxyl substituent of the PLP) to define 
substrate binding sites of amino acid converting fold type I ATs (78). This notation is more 
generally applicable than using L(arge) and S(mall) pocket (63), since the size of a pocket 
at a topologically conserved position may vary, whereas the O-pocket and the P-pocket are 
topologically fixed (Fig. 4).
Computer-aided docking of (S)-β-phenylalanine suggested binding of β-phenylalanine 
with the carboxylate group in the P-pocket, which is opposite to the binding mode of the 
a-phenylalanine analogue 3-phenylpropionate in the active site of aromatic amino acid 
aminotransferase from Paracoccus denitrificans (PDB code 1AY8) (49), but similar to the 
Figure 4. Schematic representation of (S)-β-phenylalanine (in bold) bound to PLP (external aldimine) 
docked in the active site of VpAT. A number of relevant amino acid residues for binding and catalysis 
are shown.
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4binding mode of β-phenylalanine in MesAT (78). The docking results further indicated that 
several residues in the O-pocket, including R398, must rearrange to enable binding of the 
phenyl ring of β-phenylalanine (Fig. 3C). This switch was also observed for MesAT complexed 
with (S)-β-phenylalanine (PDB code 2YKY) and 2-oxoglutarate (PDB code 2YKX), and 
appears necessary to allow binding of both the phenyl group of (S)-β-phenylalanine AT 
and the a-carboxylate of 2-oxoglutarate (78). In class I ATs accepting aromatic α-amino 
acids, a so-called arginine switch has also been identified (e.g. R292 in AroAT), but here 
the arginine switch and co-substrate non-α-carboxylate binding site are located in the 
P-pocket, in agreement with reverse mode of substrate binding of β-Phe in VpAT and MesAT 
as compared to a-phenylalanine in AroAT (16). The docking further indicated that the 
para- and meta-positions of the phenyl ring are solvent exposed while the ortho position 
is buried in the O-pocket of the protein (Fig. 3C). This is in agreement with the observed 
higher catalytic activities for substrates substituted at the para- and meta-positions relative 
to ortho-substituted substrates (Table 1, entries 4-7), for which steric hindrance by S298* 
(monomer B) and Y76 may prevent productive binding (Fig. 3C). The importance of steric 
crowding at the ortho position is confirmed by the relatively high activity with the ortho-
fluorine substituted substrate as compared to the compounds with larger substituents, i.e. 
chlorine and bromine (Table 1, entries 5-7). Thus, it appears that the substrate specificity of 
VpAT with regard to substituted β-phenylalanine derivatives is mainly determined by the 
residues that line the hydrophobic O-pocket.
A sequence motif for aromatic β-amino acid aminotransferases. A combination of 
sequence analysis, structural data and information on substrate range may be used to define 
aminotransferase sequence motifs that can be applied to identify enzymes with certain 
substrate specificity (25). As observed in the VpAT structure bound with AOA (Fig. 3A, B), 
as well as in the modeled VpAT-(S)-β-phenylalanine structure (Fig. 3C), residues R41 in 
loop1 and E75 in loop2 of the NC-domain contribute to shaping the carboxylate binding 
site for β-amino acids in the P-pocket. For this reason, and also taking into account that E75 
is conserved in MesAT and PoGSAM but not in SeGSAM (Fig. 1), we used the conserved 
functional P-pocket R41/E75 pair as the starting point to identify a motif that may distinguish 
aminotransferases with activity towards aromatic β-amino acids from aminotransferases 
with a similar fold but a different activity. Extension of the R41/E75 motif with residues 
selected on the basis of sequence conservation or position in the structure yielded a motif 
R-X-[AVI]-X(6)-P-X(14)-D-G-X(8)-[EDNQ]-[YFW] that comprises 36 residues in the 
N-terminal segment of the NC domain. When used to screen a set of over 2,200 (putative) 
class I aminotransferases, it allowed the selection of 46 sequences (Supplemental Material, 
Table S3), among which the sequences of the conserved β-selective enzymes VpAT, MesAT 
and PoGSAM. Although several retrieved sequences have been annotated as glutamate-
1-semialdehyde 2,1-aminomutase (Table S3), we propose that the sequences selected by 
the motif are ATs with activity towards aromatic β-amino acids. Although our motif may 
be applied to identify aminotransferases in a set of fold type I aminotransferases it can 
probably not predict β-aminotransferase activity in less related sequences or enzymes 
lacking activity with aromatic substrates. For example, AdbpAT (80), which is inactive with 
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4aromatic β-amino acids and has an opposite enantiopreference for aliphatic β-amino acids as 
compared to VpAT (Table 1) and MesAT (33), is not covered by the motif. This may suggest 
that AdbpAT belongs to a different phylogenetic cluster and may have a different mode of 
substrate binding. 
Outlook 
Although more experiments or structure and modeling studies are needed, we are confident 
that the newly discovered β-phenylalanine aminotransferase from V. paradoxus strain CBF3, 
along with its promising biocatalytic properties and its 3D structure, is an attractive template 
for future β-aminotransferase engineering efforts towards the synthesis of enantiomerically 
pure β-amino acids.
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4Table S1. Purification of the recombinant VpAT from E. coli strain C41(DE3).
Purification step







(fold) Reco very (%)
Cell-free extract 2.9 1134 3288 1 100
HisTrap chromatography 7.4 248 1835 2.5 56
Q-Sepharose 
chromatography
17.5 90.4 1582 6 48
Table S2. Data collection and refinement statistics of VpAT crystal structures.
Parameters VpAT holo VpAT + AOA
Beamline ID14-4 ID14-4
Data collection
Resolution (Å) a 46.42-1.5 (1.58-1.5) 66.31-2.28 (2.4-2.28)
Space group P212121 P212121
Cell dimensions
a, b, c (Å) 88.74, 100.1, 104.8 88.67, 99.88, 104.7
 Rmerge b 0.043 (0.136) 0.095 (0.158)
Wavelength (Å) 0.9395 0.9395
 I/σ (I) 21.9 (9.3) 10.9 (7.5)
Completeness (%) 99.7 (100.0) 99.8 (99.8)
No. unique reflections 148964 (21628) 43283 (6220)
Multiplicity 4.8 4.0
Refinement
Resolution (Å) 1.5 2.3
Rwork c 0.17 0.18
Rfree d 0.18 0.23
Rmsd
Bond lengths (Å) 0.08 0.08
Bond angles (o) 1.22 1.11
Ramachandran (Molprobity)
Favored (%) 98 97.0
Outliers (%) 0.0 0.0
PDB code 4AO9 4AOA
a Values in the parentheses are for the highest resolution shell.
b Rmerge = ΣhΣi |I(h)i - ‹I(h)›| / ΣhΣi ‹I(h)i›, where I is the observed intensity and ‹I› is the average intensity of 
multiple observations of symmetry-related reflections.
c Rwork = Σh||Fobs| - |Fcalc|| / Σh|Fobs|, where |Fobs| and |Fcalc| are the observed and calculated structure factor 
amplitudes, respectively.
d Rfree is calculated as Rwork using 5 % of all reflections randomly chosen and excluded from structure calculation 
and refinement.
96
4Table S3. List of putative aromatic β-amino acid aminotransferases. (Continued.)
NCBI reference 
sequence annotation strain seq. id.
1 CCF34891 aminotransferase class-III Colletotrichum higginsianum 41
2 EFQ30679 aminotransferase class-III Glomerella graminicola M1.001 41
3 EFW16762 conserved hypothetical protein Coccidioides posadasii str. Silveira 39
4 EFW99062 aminotransferase class 3 Grosmannia clavigera kw1407 38
5 EFZ00111 glutamate-1-semialdehyde 
2,1-aminomutase, putative
Metarhizium anisopliae ARSEF 23 42
6 EGU77831 hypothetical protein FOXB_11695 Fusarium oxysporum Fo5176 44
7 EGX43269 hypothetical protein AOL_s00215g5 Arthrobotrys oligospora ATCC 24927 38
8 EGX48176 hypothetical protein AOL_s00081g39 Arthrobotrys oligospora ATCC 24927 42
9 EGY14282 glutamate-1-semialdehyde 
2,1-aminomutase
Verticillium dahliae VdLs.17 41
10 EHA25332 hypothetical protein 
ASPNIDRAFT_186860
Aspergillus niger ATCC 1015 37
11 EHK26440 hypothetical protein 
TRIVIDRAFT_36134
Trichoderma virens Gv29-8 43
12 EHK45279 hypothetical protein 
TRIATDRAFT_138933
Trichoderma atroviride IMI 206040 40
13 EIM84416 aminotransferase class-III Stereum hirsutum FP-91666 SS1 49
14 GAA86562 aminotransferase class-III Aspergillus kawachii IFO 4308 37
15 GAA93170 aminotransferase class-III Aspergillus kawachii IFO 4308 37
16 XP_001218204 predicted protein Aspergillus terreus NIH2624 37
17 XP_001248198 hypothetical protein CIMG_01969 Coccidioides immitis RS 40
18 XP_001824703 acetylornithine aminotransferase Aspergillus oryzae RIB40 41





20 XP_002145750 glutamate-1-semialdehyde 
2,1-aminomutase, putative
Penicillium marneffei ATCC 18224 33
21 XP_002150372 glutamate-1-semialdehyde 
2,1-aminomutase, putative
Penicillium marneffei ATCC 18224 43
22 XP_002383909 acetylornithine aminotransferase, 
putative
Aspergillus flavus NRRL3357 41
23 XP_002483365 acetylornithine aminotransferase, 
putative
Talaromyces stipitatus ATCC 10500 38
24 XP_003040355 hypothetical protein 
NECHADRAFT_34859
Nectria haematococca mpVI 77-13-4 39
25 XP_003065334 aminotransferase class III family 
protein
Coccidioides posadasii C735 delta 
SOWgp
39
26 XP_003295515 hypothetical protein PTT_01400 Pyrenophora teres f. teres 0-1 39
27 XP_003711910 glutamate-1-semialdehyde 
2,1-aminomutase
Magnaporthe oryzae 70-15 39
28 XP_381362 hypothetical protein FG01186.1 Gibberella zeae PH-1 42
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4Table S3. List of putative aromatic β-amino acid aminotransferases. (Continued.)
NCBI reference 
sequence annotation strain seq. id.
29 YP_001862264 class III aminotransferase Burkholderia phymatum STM815 55
30 YP_001890102 class III aminotransferase Burkholderia phytofirmans PsJN 58
31 YP_002944294 class III aminotransferase Variovorax paradoxus S110 87
32 YP_003481853 aminotransferase class-III Natrialba magadii ATCC 43099 35
33 YP_004154921 class III aminotransferase Variovorax paradoxus EPS 87
34 YP_004978979 class III aminotransferase Burkholderia sp. YI23 56
35 YP_006397172 glutamate-1-semialdehyde 
2,1-aminomutase
Sinorhizobium fredii USDA 257 43
36 ZP_02187576 aminotransferase class-III alpha proteobacterium BAL199 50
37 ZP_02885261 aminotransferase class-III Burkholderia graminis C4D1M 56
38 ZP_06895587 possible glutamate-1-semialdehyde 
2,1-aminomutase
Roseomonas cervicalis ATCC 4995 42
39 ZP_07281103 glutamate-1-semialdehyde 
2,1-aminomutase
Streptomyces sp. AA4 41
40 ZP_07777755 aminotransferase class-III Pseudomonas fluorescens WH6 52
41 ZP_08528159 threonine dehydratase Agrobacterium sp. ATCC 31749 27
42 ZP_09395248 glutamate-1-semialdehyde 
2,1-aminomutase
Acetobacteraceae bacterium AT-5844 50
43 ZP_10156387 class III aminotransferase Hydrogenophaga sp. PBC 50
44 ZP_10393152 glutamate-1-semialdehyde 
aminotransferase
Acidovorax sp. CF316 56
45 ZP_10477025 class III aminotransferase Pseudomonas sp. Ag1 54
46 ZP_10571586 glutamate-1-semialdehyde 
aminotransferase
Variovorax sp. CF313 90
Seq. id. = percentage sequence identity to the protein sequence of VpAT.
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4Figure S1. SDS-PAGE of VpAT at different steps of purification. The gel contained 10% polyacrylamide. 
Lanes: M, molecular weight marker (kDa); 1, cell-free extract of E. coli strain C41(DE3) expressing 
the recombinant enzyme; 2, HisTrap fraction; 3, Q-Sepharose HP fraction.
Figure S2. Effect of temperature on the specific activity of VpAT.
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Structural Investigations into the Stereochemistry 
and Activity of a Phenylalanine-2,3-Aminomutase 
from Taxus chinensis
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Dick B. Janssen2 and Bauke W. Dijkstra1,*
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Phenylalanine-2,3-aminomutase (PAM) from Taxus chinensis, a 4-methylidene-imidazole-
5-one (MIO)-dependent enzyme, catalyzes the reversible conversion of (S)-α-phenylalanine 
into (R)-β-phenylalanine via trans-cinnamic acid. The enzyme also catalyzes the direct 
addition of ammonia to trans-cinnamic acid, a reaction that can be used for the preparation of 
β-amino acids, which occur as frequent constituents of bioactive compounds. To explain the 
stereochemistry of the PAM-catalyzed reaction different hypotheses have been formulated, 
but structural evidence for these hypotheses is lacking. Furthermore, it remains unclear 
how the PAM MIO group is formed from its three-amino-acid (A-S-G) sequence motif. For 
these reasons, we elucidated PAM 3D structures with a bound (R)-β-phenylalanine analogue 
and with bound trans-cinnamic acid. In addition, 3D structures of the Y322A and N231A 
mutants of PAM were elucidated, which were found to be MIO-less. The data suggest i) that 
the stereochemistry of the PAM-catalyzed reaction originates from the enzyme’s ability to 
bind trans-cinnamic acid in two different orientations, and ii) that N231 initiates MIO group 
formation in the A-S-G-containing loop.
Abbreviations and textual footnotes
Abbreviations: (R)-β-Phe, (R)-β-phenylalanine; (S)-α-Phe, (S)-α-phenylalanine; (S)-β-Phe, 
(S)-β-phenylalanine; t-CA, trans-cinnamic acid; MIO, 4-methylidene-imidazole-5-one; PAM, 
Taxus chinensis phenylalanine-2,3-aminomutase; TcPAM, Taxus cuspidata phenylalanine-
2,3-aminomutase; PaPAM, Pantoea agglomerans phenylalanine-2,3-aminomutase; TAM, 
Streptomyces globisporus tyrosine-2,3-aminomutase; PAL, Rhodosporidium toruloides 
phenylalanine ammonia lyase; PpHAL, Pseudomonas putida histidine ammonia lyase; TAL, 
Rhodobacter sphaeroides tyrosine ammonia lyase. 1 T. cuspidata PAM and T. chinensis PAM 
have the same GenBank accession nr. AY582743
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5Introduction
The development of methods for the synthesis of β-amino acids has attracted considerable 
attention because of the interesting biological activities of various compounds in which they 
are present (1, 2). Many β-amino acid-containing bioactive compounds isolated from plants 
and microorganisms have been described, of which taxol (paclitaxel, 1) (Fig. 1A), obtained 
from Taxus brevifolia by Wani et al. (3), is a noticeable example. Taxol is an effective anti-
tumor drug (4) for which there is a strong demand. However, the natural supply of taxol is 
limited since Taxus sp. are slow-growing and produce only small quantities of the compound 
(5). Total synthesis of taxol has been demonstrated, but is not efficient (6-8). Semi-synthesis 
using more readily available Taxus metabolites is feasible, but starting materials still need 
to be harvested from the trees (9). Synthesis of taxol via a biosynthetic pathway is therefore 
considered of paramount importance for the wider application of this compound (10).
An important step in the production of taxol is the synthesis of the N-benzoyl-phenyl-
isoserinoyl side chain, which is essential for biological activity (11). This side chain is 
Figure 1. A) (R)-β-Phe (2) is the precursor of the N-benzoyl-phenylisoserinoyl side chain (bracket) 
of taxol synthesized by Taxus sp. B) The PAM-catalyzed reaction. The formation of (R)-β-Phe (2) and 
(S)-α-Phe (4) proceeds via t-CA (3) and requires the interchange of the amino group and the pro-S 
proton. C) The chemical structure of the MIO group (right), which is formed from residues A175, S176 
and G177 (left). D) (S)-3-amino-2,2-difluoro-phenylpropionic acid (5), an analogue of (R)-β-Phe, used 
for PAM analogue binding studies. 
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5synthesized from (R)-β-phenylalanine ((R)-β-Phe, 2, Fig. 1B) (12), which, in Taxus sp., is 
made from (S)-α-phenylalanine ((S)-α-Phe, 4, Fig. 1B) by the action of phenylalanine-2,3-
aminomutase (PAM) (13, 14). PAM also catalyzes the reverse reaction and can be utilized for 
the synthesis of enantiopure aromatic β-amino acids by either the isomerization of α-amino 
acids (15) or amination of trans-cinnamic acid (t-CA, 3, Fig. 1B) and its ring-substituted 
derivatives (16, 17).
PAMs from three different sources have been characterized. PAM from T. chinensis 
(PAM) is a tetrameric protein with a molecular mass of 75.3 kDa (687 residues) per 
monomer (14). Its 3D-structure has been elucidated with bound β-mercaptoethanol (PDB 
entry 2YII) (Fig. 2) (18). The enzyme is virtually identical to a PAM from T. cuspidata 
(TcPAM, 698 residues per monomer, molecular mass 76.5 kDa, 98 % sequence identity) 
(19, 20). Of this latter enzyme1 a 3D-structure has been elucidated with bound t-CA (PDB 
entry 3NZ4) (21). The 3D-structure of a prokaryotic PAM from Pantoea agglomerans 
(PaPAM, 541 residues per monomer, molecular mass 59.3 kDa, 21 % sequence identity) 
(22) has been determined showing a mixture of covalently bound (S)-α-Phe and (S)-β-Phe 
(PDB entry 3UNV, (23)). These PAMs show significant sequence identity (24 %) to tyrosine 
aminomutase from Streptomyces globisporus (TAM), a protein with a molecular mass of 
Figure 2. A) Structure of PAM (PDB entry 2YII (18)). The 4 monomers are related by 222 symmetry. 
Monomer A is colored green and the brackets denote, from top to bottom, the head domain, body 
domain and tail domain. The oval shows the approximate location of the active site of PAM, which is 
located in the head domain. B) The active site of PAM is covered by the lid-loop, which contains Y80 (the 
tyrosine base). For clarity, the β-mercaptoethanol molecule bound to the MIO group has been removed.
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558.1 kDa (539 residues) per monomer (24). The 3D-structure of TAM (PDB entry 2OHY 
(25)) has been determined with covalently bound fluorinated β-tyrosine analogues (PDB 
entries 2QVE and 2RJS (26)). The PAM structures are also highly similar to the structures of 
Rhodosporidium toruloides phenylalanine ammonia lyase (PAL, 716 residues per monomer, 
molecular mass 76.9 kDa, 32.8 % sequence identity) with bound t-CA (PDB entry 1T6J) 
(27)), Pseudomonas putida histidine ammonia lyase (PpHAL, 510 residues per monomer, 
molecular mass 53.8 kDa, 21.6 % sequence identity, PDB entry 1B8F (28)), and Rhodobacter 
sphaeroides tyrosine ammonia lyase (TAL, 523 residues per monomer, molecular mass 
54.9 kDa, 21.7 % sequence identity) with bound p-coumaric acid (PDB entry 2O7B) and 
caffeic acid (PDB entry 2O7D) (29).
All these proteins share a three-amino-acid sequence motif (generally A-S-G but T-S-G 
in PaPAM (23)) from which the 4-methylidene-imidazole-5-one (MIO) prosthetic group 
is formed by autocatalytic post-translational modifications (Fig. 1C) (28). The MIO group 
is an electrophile, which reacts with the amino group of the substrate (α-phenylalanine 
(PAM/PAL), α-tyrosine (TAM/TAL) or α-histidine (PpHAL)) and thereby acidifies the 
Cβ-protons of these amino acids (30, 31). The acidification facilitates the stereo-selective 
abstraction of one of the Cβ-protons by a nearby tyrosine base (25, 32-34) located in the 
lid-loop (residues 78-97 (35)) that covers the active site of the enzyme (29). The abstraction 
of the proton is accompanied, sequentially or simultaneously, by the cleavage of the 
N-Cα bond and leads to the formation of a product with an unsaturated Cα-Cβ bond. 
Subsequently, in lyases, the unsaturated product and the amino group (as ammonia) are 
released into the environment (36). In contrast, in aminomutases, the amine group (as a 
MIO-amine adduct) and the unsaturated product are retained in the active site and the 
unsaturated product is re-aminated and reprotonated at the other carbon atom (19, 22, 
26). In both Taxus PAMs this reaction results in the synthesis of (R)-β-Phe from (S)-α-Phe 
(16, 37). Thus, the PAM-catalyzed conversion can be considered to proceed via two half 
reactions. In the first half reaction, the enzyme abstracts the Cβ pro-S proton and the 
Cα-amino group from (S)-α-Phe. In the second half reaction, the enzyme re-adds the 
proton to the si-face of the Cα-atom of t-CA at the position formerly occupied by the 
amino group, and re-adds the amino group to the re-face of the Cβ-atom of t-CA at the 
position formerly occupied by the pro-S proton (Fig. 1B). In the reverse reaction, creating 
(S)-α-Phe from (R)-β-Phe, the enzyme interchanges the Cβ-amino group with the Cα 
pro-S proton (19, 37).
To explain how the Taxus PAMs, in the second half reaction, manage to re-add the pro-S 
proton to the si-face of the Cα-atom of t-CA, and to re-add the amino group to the re-face of 
the Cβ-atom of t-CA, and in particular to explain the stereochemistry of the PAM-catalyzed 
reaction, two hypotheses have been formulated. Feng et al. (21) have suggested that the t-CA 
molecule that is generated after the first half reaction rotates simultaneously around its 
Cγ-Cβ and Cα-Ccarboxyl bonds to expose the opposite face of the molecule to the MIO-amine 
adduct, with the carboxylate remaining bound to an arginine residue (R325) in the same 
mode throughout the catalytic cycle. We (18) proposed that a rotation event occurs solely 
around the Cγ-Cβ bond of the t-CA molecule and that repositioning of the carboxylate group 
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5triggers amine addition at the Cβ-atom. However, no structural evidence has been obtained 
for either hypothesis. Furthermore, although it is evident that for the formation of the MIO 
group a nucleophilic attack from the amide N-atom of G177 onto the carbonyl C-atom of 
A175 has to occur, it remains unclear, despite investigations into MIO group formation in 
PpHAL (38), how this attack is initiated in PAM. The glutamate residue that is supposed to 
activate the amide N-atom of G144 in PpHAL (G177 in PAM) is a glutamine in PAM, which 
cannot have the same catalytic role.
Therefore, in an attempt to clarify these issues, we elucidated the crystal structures 
of wild-type PAM and an Y80A PAM mutant in complex with a non-reactive (R)-β-Phe 
analogue (Fig. 1D) and with bound t-CA. In addition, we also elucidated 3D-structures of 
Y322A and N231A PAM, mutants of which the effect on MIO group formation has not yet 
been established. The investigations suggest i) that the stereochemistry of the PAM-catalyzed 
reaction originates from the enzyme’s ability to bind t-CA in two different orientations, and 
ii) that N231 initiates MIO-group formation through charge repulsion between the Oδ-atom 
of N231 and the carbonyl O-atom of S176 in the MIO-forming loop. 
Experimental procedures
Protein expression and purification. Expression and purification of wild-type PAM, Y80A 
PAM, Y322A PAM and N231A PAM were carried out as described by Wu et al. (18) with 
the following modifications. The purification of wild-type PAM and Y80A PAM was done 
without reducing agent. Reducing agent (0.20 mM tris-(2-carboxyethyl)-phosphine (TCEP), 
pH adjusted to 7.0) was added to the protein sample prior to setting up crystallizations. 
1,4-Dithiothreitol (DTT, 2.0 mM) was used as the reducing agent in the purification of 
Y322A and N231A PAM.
Protein crystallization. The crystallization conditions and cryo-protection procedures 
followed the procedures described by Wu et al. (18). For binding studies, cryoprotection 
solutions were supplemented with 0.20 mM TCEP (pH 7.0) and 2.0, 5.0, 10 and 20 mM 
ligand, and crystals were soaked for 5 min in a cryosolution before transferring them to 
Table 1. Specific activity of wild-type PAM and its mutants.







*taken from Wu et al. (16) # Crystals of Y80F PAM diffracted poorly. Y322F PAM is the equivalent of PpHAL 
Y280F. The effect of this mutation on MIO group formation was established by Baedeker and Schulz (38).
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5the cryosolution with the next higher ligand concentration. (S)-3-amino-2,2-difluoro-
phenylpropanoic acid was synthesized according to Christianson et al. (39). For (R)-β-Phe 
binding studies, Y80A PAM was crystallized in the presence of 0.5 mM TCEP (pH 7.0) 
and 4.0 mM (R)-β-Phe (PepTech Corp.). After a week, crystals were soaked for 5 s in 
cryoprotection solutions supplemented with 0.25 mM TCEP (pH 7.0) and 2.0 mM (R)-
β-Phe. Y322A and N231A PAM crystals were grown in the presence of 2.0 mM DTT, and 
4.0 mM t-CA (Acros Organics) or 2.0 mM (S)-α-Phe, respectively, which were also added 
to the respective cryoprotection solutions.
Diffraction data collection and processing. Diffraction data were collected at beam lines 
ID14-1, ID23-1, ID23-2 and ID29 of the European Synchrotron Radiation Facility (ESRF, 
Grenoble, France). Indexing and integration of the reflections were done using XDS (40). 
SCALA (41) from the CCP4 software suite (42) was utilized for scaling and merging of the 
data. For molecular replacement, the Phaser program (43) was used with PAM (PDB entry 
2YII (18)) as the input model. Refinement of the atomic coordinates and B factors was 
done with Refmac5 (44) and the model was manipulated in Coot (45). Data collection and 
refinement statistics are given in Table 2. The model quality of wild-type PAM, Y80A, Y322A 
and N231A PAM was validated with MolProbity (46). The PRODRG2 server (47) was used 
to generate the stereochemical restraints for the analogue molecule. PISA (48) was used for 
protein interface analysis. To generate simulated annealing composite omit maps we utilized 
PHENIX (49). Chemical structure drawings were made with ChemDraw (CambridgeSoft) 
and images of protein structures were made with PyMOL (50). Atomic coordinates and 
structure factors have been deposited with the Protein Data Bank with PDB entries 4C5R, 
4C5S, 4C5T, 4C5U, and 4C6G (Table 2).
Table 2. Data collection and refinement statistics of PAM crystal structures. (Continued.)




WT PAM + 
(R)-β-Phe Y322A PAM* N231A PAM
Beam line ID 14-1 ID23-2 ID 23-2 ID 23-1 ID29
Data collection










Space group P21 P21 P21 P21 P21
Cell dimensions
a, b, c (Å) 99.4 145.5 99.6 99.8 146.2 100.4 99.9 146.4 100.5 99.5 147.3 99.8 99.0 146.6 99.3
β (o) 99.5 99.3 99.6 99.8 100
Rmerge b 0.08 (0.38) 0.07 (0.45) 0.11 (0.49) 0.05 (0.40) 0.07 (0.4)
Wavelength (Å) 0.9334 0.8726 0.8726 1.710 0.9793
I/σ (I) 9.9 (3.0) 11.3 (2.3) 6.0 (2.0) 11.3 (2.6) 11.2 (2.9)
Completeness (%) 99.4 (97.5) 100 (100) 99.6 (99.1) 95.4 (92.3) 99.8 (99.5)
No. unique reflections 151434 (21709) 241051 (35117) 222303 (32224) 136388 (19209) 161887 (23559)
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5Table 2. Data collection and refinement statistics of PAM crystal structures. (Continued.)




WT PAM + 
(R)-β-Phe Y322A PAM* N231A PAM
Multiplicity 2.8 (2.7) 2.9 (2.9) 2.6 (2.6) 2.5 (2.5) 3.8 (3.7)
Refinement
Resolution (Å) 2.20 1.90 1.90 2.2 2.10
Rwork c 0.17 0.18 0.18 0.19 0.20
Rfree d 0.21 0.21 0.22 0.22 0.24
Rms deviations
Bond lengths (Å) 0.008 0.01 0.01 0.01 0.009
Bond angles (o) 1.25 1.30 1.37 1.37 1.28
Ramachandran 
(MolProbity)
Favored (%) 98.2 98.1 98.0 97.3 97.2
Outliers (%) 0.00 0.00 0.00 0.04 0.00
Average Atomic 
B-factors
Protein 25.0 19.4 24.4 41.5 46.2
Ligand 30.5 20.7 30.5 n/a n/a
Solvent 24.7 21.3 26.8 30.6 36.3
Nr. of atoms/ASU 20505 20797 20776 19779 19587
Mean B-factor 25.0 19.5 24.5 41.5 46.0
Wilson B-factor 21.3 17.8 20.4 35.3 29.6
PDB entry 4C5R 4C5S 4C5T 4C5U 4C6G
a Values in parentheses are for the highest resolution shell.
b Rmerge = ΣhΣi |I(h)i - ‹I(h)›| / ΣhΣi ‹I(h)i›, where I is the observed intensity and ‹I› is the average intensity of 
multiple observations of symmetry-related reflections.
c Rwork = Σh|Fobs - Fcalc| / Σh|Fobs|, where Fobs and Fcalc are the observed and calculated structure factor amplitudes, 
respectively.
d Rfree is calculated as Rwork using 5 % of all reflections randomly chosen and excluded from structure factor 
calculation and refinement.
# The analogue is (S)-3-amino-2,2-difluoro-phenylpropanoic acid (Fig. 1D, 5).
* The crystal is pseudo-hemihedrally twinned with a twin fraction α that equals 0.14. The twin operator, a 
two-fold axis, is from h,k,l to l,-k, h and lies in the a-c plane of the unit cell along the diagonal between a and c.
Construction of PAM mutants. Mutants of PAM were generated using the mega-primer method 
and the coding sequence for PAM in plasmid pBAD-His-PAM as the template (16). Mutagenesis 
primers used were: for Y80A 5′-GTGGTCACGCCCGCGATATCAGCACCATCTTC-3′, 
for Y322A 5′-GCCTAAACAGGACCGGGCAGCCCTGCGTAG-3′, and for N231A 
5′-CAACTGCAGTAGCGAAGCTTGTACCGGCTACCAGAGCCAG-3′, with the mutated 




Structure determination of PAM. To provide structural insight into the ability of PAM to 
form (S)-α-phenylalanine ((S)-α-Phe) from (R)-β-phenylalanine ((R)-β-Phe), we elucidated 
crystal structures of wild-type PAM and Y80A PAM (Table 1), both with bound (S)-3-amino-
2,2-difluoro-phenylpropanoic acid (Fig. 3A,B), an inhibitor and analogue of the (R)-β-Phe 
substrate (Fig. 1D). We also elucidated a crystal structure of Y80A PAM with bound trans-
cinnamic acid (t-CA) (Fig. 3C) as well as structures of Y322A and N231A PAM (Fig. 4A,B and 
Table 1). In all cases PAM crystallized in space group P21 with 4 monomers per asymmetric 
unit obeying 222 symmetry, similar to the wild-type protein (18).
The PAM monomer structure. Similar to previously published crystal structures of MIO-
dependent enzymes (21, 27), the T. chinensis PAM monomer has an elongated shape and 
contains three domains, the tail domain, the body domain, and the head domain (Fig. 2A). 
These three domains mainly consist of α-helices, but the head domain also contains 7 short 
β-strands, which form three anti-parallel β-sheets. The head domain contains the MIO 
group and the lid-loop (residues 78-97), which covers the active site (Fig. 2B).
The PAM tetramer structure. As previously found, four PAM monomers (A-D) assemble 
into a dimer of dimers (Fig. 2A) (18). The most extensive contacts are between monomers A 
and B, and between C and D, with buried surface areas of ~7,600 Å2 per pair. The A-C pair 
and the B-D pair have also extensive contacts (~7,400 Å2 buried surface area per pair). The 
head domain of monomer A interacts with the body domains of B and C, while its body 
domain contacts the head domains of B and C. The contacts between the A-D pair, and 
the B-C pair are much less extensive (~2,300 Å2 buried surface per pair), and only the tail 
domains take part in this interaction. The four monomers bury a total area of ~34,500 Å2, 
while the total surface area of the PAM tetramer is ~73,000 Å2. A large fraction of the PAM 
monomer surface is thus involved in tetramerisation.
The MIO prosthetic group. The MIO group is located in the head domain; it is post-
translationally formed from the three-amino-acid A175-S176-G177 sequence motif (Fig. 1C). 
Besides the covalent main chain peptide bonds to S174 and N178, the MIO group is held 
in position by hydrogen bonds between the MIO O2-atom and the Nδ-atom of N231, and 
between the MIO N2-atom and the hydroxyl group of Y322 (monomer B when the MIO 
group is from monomer A). The MIO further has aromatic interactions with F371 and 
L179, residues that are located at the re- and si-face of the Cβ2-atom of the MIO group, 
respectively (Fig. 7). 
Structures of wild-type and Y80A PAM with a bound (R)-β-Phe analogue. To analyze how 
(R)-β-Phe binds in the active site of wild-type PAM, we determined a crystal structure of PAM 
with bound (S)-3-amino-2,2-difluoro-phenylpropanoic acid, an analogue of (R)-β-Phe, at 
2.2 Å resolution (Fig. 3A, 5A). The following description is for monomer A, but in the other 
PAM monomers the situation is equivalent. The analogue is covalently bound via its β-amino 
group to the Cβ2-atom of the MIO group and the aromatic ring is bound in a hydrophobic 
pocket (not shown) lined with residues from monomers A (F86, L104, V230, C107, L108, 
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5L179, L227, E455, N458, Q459) and C (the apolar part of the side chain of K427). One of the 
analogue’s carboxylate oxygen atoms is at hydrogen bonding distance to the Nδ-atom of N355 
(monomer A) and the Nη2-atom of R325 (monomer B). The other carboxylate O-atom (O1) 
is at hydrogen bonding distance to the Nδ-atom of N231. The Cα pro-S fluorine atom of the 
analogue, which represents the pro-S proton of (R)-β-Phe, is positioned between the side chains 
of Y322 and R325 (monomer B), near the Y322 hydroxyl O-atom and the Nη1- and Nη2-atoms 
of R325. The Cα pro-R fluorine atom of the analogue is close (2.5 Å) to the hydroxyl O-atom 
of Y80 and near (3.1 Å) the amide N-atom of G87, a residue that is part of the lid-loop. In this 
conformation, the analogue has an Nβ-Cβ-Cα-Fpro-R dihedral angle of -165°, which is near the 
180° angle expected for the trans-elimination of the β-amino group and the Cα pro-R proton. 
However, the conversion of (R)-β-Phe into (S)-α-Phe requires the abstraction of the Cα pro-S 
proton (19, 37). Moreover, in the analogue-bound structure the Cα pro-S proton does not have 
a good orientation for a trans (or cis) elimination reaction, and it is not near Y80 or another 
residue that could function as a base. Thus, in this structure the conformation of the analogue 
does not represent the stereochemistry of the PAM-catalyzed reaction. In addition, a 1.9 Å 
resolution crystal structure of the inactive Y80A PAM mutant was elucidated bound with the 
same (R)-β-Phe analogue. Similar to the wild-type complex, the structure revealed a covalent 
bond between the β-amino group of the analogue and the Cβ2-atom of the MIO group, with the 
aromatic ring of the analogue binding in the same position as in wild-type PAM. However, the 
carboxylate group of the analogue is bound differently, resulting in different positions of the Cα 
pro-R and pro-S fluorine atoms (Fig. 3B, 5A). The carboxylate’s O1-atom has hydrogen-bonding 
interactions with the Nδ-atoms of N231 and N355, while the other O-atom has hydrogen bonds 
with the Nη2-atom of R325 (monomer B) and a solvent molecule. Two solvent molecules are 
present at the location of the aromatic ring of Y80 in wild-type PAM. They are at hydrogen 
bonding distance to the fluorine atoms of the analogue. The Nβ-Cβ-Cα-Fpro-R dihedral angle 
is -82° instead of -165° as observed in the complex with wild-type PAM, showing that the side 
chain of residue 80 has a dramatic influence on the binding mode of the analogue. The Nβ-
Cβ-Cα-Fpro-S dihedral angle of the analogue is 163°, which is compatible with a geometry that 
allows the trans-elimination of the Cα pro-S proton and the β-amino group.
The Y80A PAM trans-cinnamic acid bound structure. To analyze how a natural substrate 
would bind, we co-crystallized (inactive) Y80A PAM with (R)-β-Phe. However, the crystal 
structure, elucidated at 1.9 Å resolution, revealed a non-covalently bound t-CA molecule 
rather than (R)-β-Phe bound in the active site (Fig. 3C). This suggests that (R)-β-Phe was de-
Figure 3. Stereo figures (wall-eyed) of simulated annealing composite 2mFo-DFc omit maps, contoured 
at 1σ. A) wild-type PAM with bound (S)-3-amino-2,2-difluoro-phenylpropionic acid (magenta). 
Green residues from monomer A, blue residues from monomer B. # denotes residue N231. The blue 
sphere represents the amide N-atom of G87. B) Y80A PAM with bound (S)-3-amino-2,2-difluoro-
phenylpropionic acid (magenta). C) Y80A PAM with bound t-CA (magenta). The si,si-face of the t-CA 
molecule is oriented towards A80, the re,re-face of the t-CA molecule is oriented towards the MIO 
group. # denotes residue N231, * denotes residues N458 and F371. 
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5aminated, in spite of Y80A PAM being inactive. The aromatic ring of t-CA binds at a similar 
position as the aromatic ring of the (R)-β-Phe analogue in wild-type and Y80A PAM. The 
carboxylate group of t-CA interacts with R325 via a bidentate salt bridge. One O-atom of the 
carboxylate makes an additional hydrogen bond to the Nδ-atom of N458. The other O-atom 
makes an additional hydrogen bond to a solvent molecule, which in turn makes hydrogen 
bonds to the Nδ-atoms of N231 and N355. The interactions of the t-CA carboxylate group 
(Fig. 3C) differ from those observed for the (R)-β-Phe analogue in Y80A PAM or wild-type 
PAM, where the carboxylate group has a monodentate interaction with R325 (Fig. 3A,B). As 
a consequence, the t-CA carboxylate group has a different orientation, showing that PAM 
allows considerable plasticity in the carboxylate-binding mode. In this orientation, the 
re,re-face of the t-CA molecule is exposed to the Cβ2-atom of the MIO group (at 3.1 Å) and 
the si,si-face is directed towards the amide N-atom of G87 (at 3.6 Å). However, the density is 
not sufficiently clear to exclude the opposite binding mode in which the si,si-face is exposed 
to the MIO Cβ2-atom, or the presence of a mixture of both t-CA binding modes. 
The structure of Y322A PAM. To obtain details on the roles of other essential residues in the 
active site of PAM, we determined the crystal structures of Y322A and N231A PAM (Table 1), 
both of which are inactive. The 2.2 Å resolution structure of Y322A PAM revealed that all 
Figure 4. Stereo figures (wall-eyed) of simulated annealing composite 2mFo-DFc omit maps, contoured 
at 1σ. A) The Y322A mutant of PAM showing the MIO-forming loop (magenta). No density is present 
for F371. B) The N231A mutant of PAM showing the MIO-forming loop (magenta).
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5Figure 5. A) The (R)-β-Phe analogue bound in the 
active site of wild-type PAM (green, ball and stick) 
superposed onto the (R)-β-Phe analogue bound in 
the active site of Y80A PAM (cyan sticks). The ‘r’ 
denotes the Cα pro-R fluorine atom. The blue sphere 
represents a water molecule. B) The (R)-β-Phe 
analogue bound in the active site of wild-type PAM 
(green, ball and stick) superposed onto the (S)-β-
tyrosine analogue bound in the active site of TAM 
(cyan sticks). C) The (R)-β-Phe analogue bound 
in the active site of Y80A PAM (green, ball and 
stick) superposed onto the (S)-β-tyrosine analogue 
bound in the active site of TAM (cyan sticks).
Figure 6. The t-CA bound structure of PAM 
(green, ball and stick, this study) superposed onto 
the t-CA bound structure of TcPAM (cyan sticks, 
PBD entry 3NZ4 (21)).
monomers are MIO-less (Fig. 4A). In monomers A, C and D residues A175-S176-G177 are 
present as a peptide loop that has not reacted to form the MIO group. Whereas in monomer B 
residues 175-177 have no defined electron density, in the other monomers the carbonyl C-atom 
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5of A175 is at 3.3 Å from the amide N-atom of G177. S176, in the center of the MIO-forming 
loop, is located in a position, which in wild-type PAM is occupied by the aromatic ring of F371 
(Fig. 7A); in Y322A PAM this residue and flanking residues 368 to 372 are not defined in the 
electron density maps. Thus, our results show that Y322 is essential for MIO group formation 
and that Y322A PAM is inactive because of the absence of a functional MIO group.
The structure of N231A PAM. The 2.1 Å resolution crystal structure of N231A PAM (Fig. 4B) 
revealed that all its four monomers are MIO-less and contain an unreacted MIO-forming loop 
(residues A175-S176-G177), which takes up the same space as the MIO group in wild-type 
PAM (Fig. 7B). The absence of a functional MIO group explains the lack of catalytic activity of 
N231A PAM. Interestingly, in the four monomers the distance between the amide N-atom of 
G177 and the carbonyl C-atom of A175 is 2.8 Å, which would be compatible with a nucleophilic 
attack of the N-atom on the carbonyl C-atom. Nevertheless, this reaction has not occurred, 
demonstrating that the N231 side chain is essential for MIO group formation. 
Figure 7. A) The structure of wild-type PAM (green, ball and stick) superposed onto the structure of 
Y322A PAM (cyan sticks). F371 in Y322A PAM is absent. In wild-type PAM, the side chain of N231 may 
also orient itself such that the Nδ-atom of the N231 side chain is at hydrogen bonding distance to the 
O2-atom of the MIO group. B) The structure of wild-type PAM (green, ball and stick, PDB entry 2YII 
(18)) superposed onto the structure of N231A PAM (cyan sticks). C) The structure of wild-type PAM 
(green, ball and stick) superposed onto the structures of Y322A PAM (yellow sticks) and N231A PAM 
(magenta sticks). The right panel has been rotated 90° counter clockwise with respect to the left panel. 
The labels Y322, N231, F371 and L179 have been inserted for reference, and denote the approximate 
locations of these residues with respect to the MIO group and MIO-forming loops.
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5The structure of N231A PAM also shows that the mutation has resulted in significant 
conformational flexibility/disorder of residues 78 to 98. In monomer B residues 78-86 have a 
conformation similar to that in wild-type PAM, but in the other monomers they have moved 
away from the active site (Fig. 8). The residues in the second part of the loop (residues 87-98) 
are disordered and have no interpretable electron density. This conformational flexibility/
disorder suggests that the N231 side chain is important for stabilizing the conformation of 
the lid loop.
Discussion
The structure of PAM. To explain how the Taxus PAMs catalyze the interchange of an 
amino group and a proton at neighboring C-atoms we have elucidated crystal structures of 
wild-type PAM with a bound (R)-β-phenylalanine analogue, of Y80A PAM with the same 
analogue, and of Y80A PAM with a bound trans-cinnamic acid (t-CA) (Fig. 3A,B,C). In 
addition, we have elucidated structures of Y322A and N231A PAM, which are both inactive 
and MIO-less (Fig. 4A,B). In all cases, the structures are highly similar to the structure of 
wild-type PAM, except for residues 78-97 in the N231A mutant, which show conformational 
flexibility/disorder (see Results). 
Figure 8. Monomer A of wild-type PAM (the green Cα-trace) superposed onto monomer A of N231A 
PAM (the blue Cα-trace).
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5The (R)-β-Phe analogue bound structures of PAM. To investigate the PAM-catalyzed 
reaction (19, 37) we elucidated structures of PAM with bound (S)-3-amino-2,2-difluoro-
phenylpropanoic acid, an analogue of (R)-β-Phe (Fig. 5A). A similar compound, (R)-3-
amino-2,2-difluoro-(4-methoxyphenyl)-propanoic acid, a mimic of (S)-β-tyrosine, has 
been used to investigate substrate recognition and the reaction mechanism of Streptomyces 
globisporus tyrosine aminomutase (TAM) (Fig. 5B,C) (26). In wild-type PAM, the analogue 
is covalently bound to the MIO group via its β-amino group. The Nβ-Cβ-Cα-Fpro-R dihedral 
angle is -165°, which is close to the optimal angle for a trans-elimination reaction. The pro-R 
fluorine atom, which represents the pro-S proton of (R)-β-Phe, is at 2.5 Å from the hydroxyl 
group of Y80, suggesting that the Y80 side chain functions as the base that abstracts the 
pro-R proton from the Cα-atom of an (R)-β-Phe substrate. However, in this conformation, 
the geometry of the Cα-Hpro-R…O (Y80) interaction with (R)-β-Phe is not compatible with a 
hydrogen bond. Moreover, PAM abstracts the Cα pro-S proton from (R)-β-Phe, not the Cα 
pro-R proton (19, 37). For these reasons we consider it unlikely that the observed binding 
mode of the (R)-β-Phe analogue in the wild-type enzyme represents a productive (R)-β-Phe 
binding mode. 
To investigate whether the unproductive binding mode of the (R)-β-Phe analogue 
could be caused by the interaction of Y80 with the analogue’s pro-R fluorine atoms, which 
are often involved in multipolar C-F…H-X (X = N, O, S) interactions (51), we elucidated a 
crystal structure of Y80A PAM bound with the same (R)-β-Phe analogue (Fig. 3B). The 
aromatic ring of the analogue binds in the same position as in wild-type PAM. However, its 
carboxylate group has a different binding mode (Fig. 5A). Instead of interacting with N231 
via its O1-atom and via the other carboxylate O-atom with N355 and R325, the carboxylate 
group now interacts via its O1-atom with the N231 and N355 side chains and via its other 
carboxylate O-atom with the R325 side chain and a water molecule. As a consequence, 
the pro-S fluorine atom of the analogue is near the position of the Y80 hydroxyl group in 
wild-type PAM. The Nβ-Cβ-Cα-Fpro-S dihedral angle has become 163°, while the Nβ-Cβ-
Cα-Fpro-R dihedral angle has changed from -165° to -82°. Thus, the conformation of the 
(R)-β-Phe analogue in Y80A PAM is fully compatible with the trans-elimination of the pro-S 
proton and the β-amino group, and is in agreement with the stereochemistry of the PAM-
catalyzed reaction (19, 37). The experiment thus gives credence to our supposition that the 
conformation of the (R)-β-Phe analogue in wild-type PAM is non-productive.
The trans-cinnamic acid bound structure of PAM. The conformation of the (R)-β-Phe 
analogue in Y80A PAM is consistent with the stereochemistry of the PAM-catalyzed 
reaction. However, a structural comparison of the Y80A and wild-type PAM (R)-β-Phe 
analogue bound structures showed that the Cα pro-S fluorine atom of the analogue in Y80A 
PAM would be positioned very close (1.2 Å) to the Y80 hydroxyl group of wild-type PAM 
(Fig. 5A). Therefore, we co-crystallized (inactive) Y80A PAM with (R)-β-Phe. However, the 
resulting crystal structure revealed that t-CA was bound in the PAM active site instead of 
(R)-β-Phe (Fig. 3C). This suggests that the substrate had reacted, even though the tyrosine 
base was absent. Conceivably, water molecules that fill the space vacated by the phenyl-ring 
upon mutation were, in conjunction with the MIO group, instrumental in proton transfer 
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5and cleavage of the MIO-adduct. Alternatively, the t-CA molecule bound in the active site 
of Y80A PAM might originate from a t-CA contamination in the (R)-β-Phe solution used 
to prepare our co-crystallization experiment.
The binding mode we observe for t-CA in Y80A PAM is very similar to that of t-CA 
bound to wild-type TcPAM (Fig. 6) (21). However, the electron density (Fig. 3C) is not 
sufficiently clear to unambiguously determine whether the re,re- or the si,si-face of the 
t-CA molecule is oriented towards the MIO group. Possibly, the molecule can bind in both 
orientations in the PAM active site.
Nevertheless, the binding mode of t-CA provides a rationale for the enzyme’s substrate 
specificity, which has been extensively investigated (15-17). PAM de-aminates phenylalanine 
and aminates t-CA and various apolar ortho-, meta- and para-substituted t-CA derivatives. 
From the structure it is clear that the hydrophobic binding pocket of PAM is narrower 
near the meta- and ortho-positions of the t-CA aromatic ring, which correlates well with 
the observation that PAM only accepts rather small ortho- and meta-fluoro-, chloro-, 
bromo- and methyl-substituted cinnamic acid derivatives. The presence of several aromatic 
residues that line the hydrophobic binding pocket of PAM explains the enzyme’s affinity for 
derivatives of t-CA with apolar substituents.
Function of Y322 and N231. Previous screening experiments showed that Y322 and N231 
are essential for PAM activity (18). Y322A and N231A PAM, just as Y80A PAM, are inactive 
(Table 1). We elucidated their 3D-structures, which revealed that they do not have an intact 
MIO group (Fig. 4, 7). This shows that Y322 and N231 are involved in the formation of the 
MIO group, either directly or indirectly. A comparison of the structures of Y322A and 
wild-type PAM revealed that in Y322A PAM the atoms of residue 176, in the center of the 
MIO-forming loop, occupy the position of the aromatic side chain of F371 in wild-type 
PAM, a residue that is invisible in Y322A PAM (Fig. 7A,C). Comparison of the N231A 
and wild-type PAM structures shows that in general the atoms of the N231A PAM MIO-
forming loop superpose onto the atoms of the MIO-group in wild-type PAM (Fig. 7B,C). 
The G177 N-atom is at 2.8 Å from the carbonyl C-atom of A175, in agreement with its 
proposed role as nucleophile initiating the condensation reaction to form the MIO group. 
Since this condensation reaction has not occurred, this suggests that the G177 N-atom in 
N231A PAM is not sufficiently activated to perform a nucleophilic attack. Investigations 
into MIO group formation in P. putida HAL by Baedeker and Schulz (38) suggested that 
the equivalent N-atom (G144) in the MIO-forming loop is activated by E414 via a water 
molecule. Although in N231A PAM a water molecule is present near the G177 N-atom, the 
residue equivalent to E414 is Q459, which is not in an environment that could facilitate 
water molecule deprotonation (Fig. 7). Other residues near the MIO-forming loop, such as 
F371, L179, and Y322 (Fig. 7) are also unlikely to participate in an activation mechanism, 
since they are either chemically inert or too far away from the G177 N-atom. The only 
polar residue that is near the G177 N-atom is residue N231 (Fig. 7B). In wild-type PAM the 
Nδ-atom of the N231 side chain is at hydrogen bonding distance to the carbonyl O-atom of 
N355, while the side chain Oδ-atom is near the carbonyl O-atom of the peptide bond that 
connects residues 176 and 177 in the MIO-forming loop (Fig. 7B). We therefore envisage 
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5that a charge interaction between the N231 side chain Oδ-atom and the carbonyl O-atom 
of S176 increases the nucleophilicity of the G177 N-atom, which may initiate MIO-group 
formation. Quantum-chemical calculations may further validate this proposal. In Y322A 
PAM the carbonyl O-atom of residue 176 in the MIO-forming loop is at 4 Å distance from 
the Oδ-atom of the N231 side chain, which likely reduces the charge interaction with the 
carbonyl O-atom (Fig. 7A). In addition, the MIO-forming loop has a conformation that is 
not very favorable for the nucleophilic attack of the G177 N-atom onto the carbonyl C-atom 
of A175 (Fig. 7A,C).
Figure 9. The proposed reaction mechanism of PAM. The scheme shows the formation of (S)-α-Phe 
from (R)-β-Phe via t-CA. A) The formation of (S)-α-Phe starts with (R)-β-Phe entering the active 
site. The amino group is activated by residue Y322. B) Nucleophilic attack of the amine group onto 
the methylidene of the MIO group. C) The Cα pro-S proton is acidified and abstracted by Y80. The 
amine group is abstracted by the MIO group. D) Formation of the MIO-amine adduct and formation 
of t-CA (re,re-face binding mode), which subsequently rotates 180° around its longitudinal axis. 
E) The Cα pro-S proton is re-added to the Cβ-atom of t-CA (si,si-face binding mode), while the amine 
group is re-added to the Cα-atom. F,G) Formation of (S)-α-Phe. The formation of (R)-β-Phe from 
(S)-α-Phe proceeds in the reverse order. The release of t-CA occurs at D). Proton shuttling and MIO 
aromatization adapted from Pilbak et al. (54).
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5The PAM-catalyzed isomerization reaction. Apart from the presence of an un-reacted 
MIO-forming loop, the structure of N231A PAM also revealed that the lid-loop (residues 
78-98) has increased conformational flexibility/disorder in the mutant. However, in 
wild-type PAM N231 does not interact with any lid-loop residue and it therefore cannot 
directly influence lid-loop rigidity. Lid-loop flexibility may be an intrinsic property of the 
enzyme, which is supported by observations that i) related MIO-dependent phenylalanine 
ammonia lyases have flexible lid-loops (27, 52, 53), ii) PAM has lyase activity (16, 19), and 
iii) the t-CA molecule generated during the PAM-catalyzed reaction must be able to rotate 
within the PAM active site to allow the enzyme to convert (S)-α-Phe into (R)-β-Phe via 
t-CA (Fig. 9), which from the Y80A PAM t-CA bound structure appears impossible if the 
PAM lid-loop is assumed to be inflexible. The t-CA molecule must rotate because upon de-
amination of (S)-α-Phe, the si,si-face of the molecule is exposed to the MIO-amine adduct. 
To convert the t-CA molecule into (R)-β-Phe, the re,re-face of the t-CA molecule must be 
exposed to the MIO-amine adduct (Fig. 9). The rotation has been proposed to occur via either 
a rotation around the t-CA molecule’s Cγ-Cβ and Cα-Ccarboxyl bond (21) or via a rotation 
around the t-CA molecule’s Cγ-Cβ bond (18). In addition, it seems possible that the whole 
t-CA molecule rotates within the PAM active site (Fig. 9), due to the flexibility of the lid-loop 
Figure 10. Proposed (R)-β-Phe, (S)-α-Phe and t-CA carboxylate-binding modes. A) The carboxylate-
binding mode of (R)-β-Phe (this research, and PDB entry 3UNV (23)). B) The carboxylate-binding 
mode of t-CA after β-elimination (based upon PDB entry 3NZ4 (21)). The re,re-face of the t-CA 
molecule is directed towards the MIO group, the si,si-face is directed towards Y80. C) The t-CA 
carboxylate-binding mode after β-elimination and rotation (Fig. 3C, and ‘see Discussion’), and prior 
to α-addition and conversion to (S)-α-Phe (9E) (according to Wu et al. (18)). D) The t-CA carboxylate-
binding mode prior to α-addition and conversion to (S)-α-Phe (based upon PDB entry 3UNV (23)). 
E) The carboxylate-binding mode of (S)-α-Phe (PDB entry 3UNV (23)).
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5that covers the active site. A rotation of the whole molecule is energetically favorable, since 
it does not break the conjugation within the t-CA molecule, which is especially problematic 
in the case of rotation around both the Cγ-Cβ and Cα-Ccarboxyl bonds. In any case, rotation of 
the t-CA molecule within the PAM active site necessitates a change in the t-CA molecule’s 
carboxylate interactions. This is evident from a comparison of the Y80A PAM t-CA bound 
structure (Fig. 3C) with the Y80A PAM (R)-β-Phe analogue bound structure (Fig. 3B). It 
shows that the PAM active site has one aromatic-ring binding site in its hydrophobic binding 
pocket, but two distinct carboxylate-binding sites within its carboxylate-binding pocket. The 
re,re-face binding mode of t-CA, immediately after rotation, must therefore have a different 
carboxylate-binding mode than the si,si-face binding mode of t-CA generated immediately 
after (S)-α-Phe de-amination and deprotonation (Fig. 10). Because the carboxylate-binding 
mode of this si,si-face binding mode is likely the same as the carboxylate-binding mode of 
(S)-α-Phe from which it is generated, the carboxylate-binding mode of the re,re-face binding 
mode of t-CA, immediately after rotation, must be the same as the carboxylate-binding mode 
of t-CA in Y80A PAM (Fig. 3C, 6). The data thus suggest that the two carboxylate-binding 
sites within the PAM carboxylate-binding pocket have evolved to allow the t-CA molecule 
to rotate within the PAM active site, and to enable the enzyme to reversibly interconvert 
(S)-α-Phe and (R)-β-Phe (Fig. 10).
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Summary, Discussion, and Future perspectives

&The research presented in this thesis has focused on three enzymes that catalyze amino group 
transfer, and have the ability to synthesize β-amino acids, building blocks of compounds 
with potentially useful activities. To gain insight into the enzymatic properties of these 
enzymes we have elucidated their 3D structures at atomic resolution, by means of protein 
X-ray crystallography. In addition, we used several biochemical techniques to characterize 
the properties of these enzymes.
 
In Chapter 1, we provide the context for our research into amino group transfer by MesAT, 
a pyridoxal-5’-phosphate (PLP) dependent β-aminotransferase from Mesorhizobium sp. 
LUK and VpAT, a PLP-dependent β-aminotransferase from Variovorax paradoxus, as well 
as a 4-methylidene-imidazole-5-one (MIO) dependent phenylalanine-2,3-aminomutase 
(PAM) from Taxus chinensis. In the first section of the introduction (pages 1-43) the 
progress in investigations into the properties of aminotransferases are presented, which 
started already in 1930 with the discovery of the phenomenon of amino group transfer 
between two molecules. In the second section of the introduction, the reactions catalyzed by 
various aminomutases are presented, which are enzymes that contrary to aminotransferases, 
catalyze the intra- rather than the inter-molecular migration of an amino group.
In Chapter 3 the 3D structures of a β-aminotransferase from Mesorhizobium sp. LUK 
(MesAT) with bound (S)-β-phenylalanine, (R)-3-amino-5-methylhexanoic acid, 2-oxo-
glutarate (a model for L-α-glutamate) and an inhibitor, are presented. MesAT is able to 
accept both β-amino acids and α-amino acids, due to the dual functionality of the enzyme’s 
active site carboxylate and side-chain binding pockets. The aromatic or aliphatic side chain 
of a β-amino acid is bound in a pocket located at the 3’-O side of the PLP cofactor. The same 
pocket is utilized by MesAT to bind the α-carboxylate group of an α-amino acid. A β-amino 
acid thus binds in a reverse orientation within the MesAT active site as compared to an 
α-amino acid. The β-amino acid was bound within the MesAT active site as a covalent 
adduct, more specifically as an external aldimine intermediate. Nonetheless, the reason why 
an external aldimine intermediate was trapped remained unanswered. The amino group of 
the enzyme’s lysine base was close to the Cβ-proton of the external aldimine intermediate, 
which suggested that the enzyme, in principle, was able to convert the external aldimine 
intermediate into the ketimine intermediate, and subsequently upon hydrolysis, into PMP. 
Since the efficiency of proton abstraction in the transition state is correlated to the angle 
between the bond to be broken and the plane of the pyridine ring (Dunathan, 1966), we 
proposed that this angle (20°-30°), prevented proton abstraction and thus prevented the 
external aldimine from being deprotonated and converted into a ketimine intermediate. 
However, since we could not exclude that MesAT was able to abstract the Cβ-proton, we 
therefore, as an alternative, proposed that the absence of a water molecule within the 
MesAT active site prevented the ketimine intermediate from being converted into PMP. 
This proposal assumed that MesAT had actually bound a mixture of the external aldimine 
intermediate (major fraction) and the ketimine intermediate (minor fraction). The absence 
of a water molecule would shift the equilibrium of the MesAT reaction towards the external 
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&aldimine intermediate, hence its presence in the MesAT active site. To test these proposals, an 
experiment was performed (not published) in which the structure of MesAT was elucidated 
after the crystal was soaked 24 hours in mother liquor containing (S)-β-phenylalanine, then 
for an equal amount of time in mother liquor without (S)-β-phenylalanine. The structure 
revealed bound PMP. In crystallo the equilibrium of the MesAT reaction thus indeed has 
shifted towards external aldimine, but not because MesAT is unable to deprotonate the 
external aldimine intermediate, nor because MesAT is unable to hydrolyze the ketimine 
intermediate to PMP. The equilibrium shift however may be related to the formation of the 
transition state, after deprotonation of the external aldimine intermediate. The transition 
state, in which the π-orbitals of the aromatic ring may be conjugated with the π-orbitals of 
the Schiff-base and the π-orbitals of the pyridine ring of the PLP cofactor, may not be easily 
formed due to a lack of space within the MesAT active site in crystallo. Experiments utilizing 
spectroscopy may confirm this hypothesis.
In Chapter 4 the biochemical properties and 3D structure of VpAT are presented. The 
organism was isolated from a grassland soil sample, and the aminotransferase enzyme 
biochemically characterized, and its 3D structure determined. The biochemical properties 
of VpAT and the 3D structure of VpAT are similar to the 3D structure and biochemical 
properties of MesAT (50 % sequence identity). VpAT accepts both β-amino acids and 
α-amino acids and has a fold-type I 3D structure with an active site architecture that is 
the same as that of MesAT. However, the specific activity of VpAT for (S)-β-phenylalanine 
is 17.5 U · mg-1, which is significantly higher than the specific activity of MesAT for the 
same compound (1.6 U · mg-1). In addition, VpAT is active over a rather broad pH range. 
Last, because aromatic β-amino acid aminotransferases may be utilized as biocatalysts in 
the synthesis of aromatic β-amino acids, the 3D structure of VpAT (and MesAT) was used 
to formulate an amino acid sequence motif that may be used to identify new aromatic 
β-aminotransferases from aminotransferase amino acid sequences. This may allow the 
identification of aromatic β-aminotransferases with new properties, especially since several 
of the putative aromatic β-aminotransferases have relatively low sequence identities to VpAT.
In Chapter 5 our structural investigations into a MIO-dependent phenylalanine-2,3-
aminomutase (PAM) from Taxus chinensis are presented. The enzyme catalyzes a reversible 
isomerization reaction that leads to the conversion of (S)-α-phenylalanine into (R)-β-
phenylalanine via trans-cinnamic acid. Although structures of PAM and homologues 
of PAM had been elucidated, it remained difficult to explain the stereochemistry of the 
PAM-catalyzed reaction. In addition it remained unclear how the MIO prosthetic group, 
which is required for enzymatic activity, was formed from its three-amino-acid sequence 
motif (A-S-G). Therefore 3D structures of PAM and PAM mutants were elucidated with a 
bound (R)-β-phenylalanine analogue and with bound trans-cinnamic acid. In addition, 
3D structures of MIO-less PAM mutants were elucidated. The structures revealed that the 
stereochemistry of the PAM-catalyzed reaction originated from the enzyme’s ability to bind 
trans-cinnamic acid in two binding orientations and furthermore that N231, one of four 
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&residues that flank the MIO group, initiates MIO group formation from the A-S-G sequence 
motif. Although our research had provided significant insight into the stereochemistry of the 
PAM-catalyzed reaction, it remains unclear, why PAM does not accept both enantiomers of 
α- or β-phenylalanine, nor how PAM mutants alter the 51:49 α:β-regioselectivity of wild-type 
PAM (Wu et al., 2009) to 12:88 for Q319M PAM and 5:95 for Q319MQ459E PAM (Wu et al., 
2012). The t-CA bound structure of PAM however does provide some clues. The side chain 
of Q459 is near the unsaturated bond of t-CA. Therefore electrostatic effects, upon mutating 
Q459 to E459, may alter the electron distribution along the t-CA unsaturated bond, which 
may explain the increased β-regioselectivity of Q459E PAM (Wu et al., 2009). The Q319M 
mutation may have a similar effect since residue 319 is located near the carboxylate group of 
t-CA. However, the Q319M mutation may also alter the binding mode of t-CA, although it 
remains to be elucidated if, and then how, this affects the β-regioselectivity of this mutant.
The MesAT, VpAT and PAM are potential biocatalyst for β-amino acid synthesis. MesAT 
has been used as a biocatalyst for the asymmetric synthesis of (S)-β-phenylalanine (Kim et 
al., 2007), while PAM has been used as a biocatalyst for the asymmetric synthesis of (R)-
β-phenylalanine (Wu et al., 2009). However, it remains to be determined whether MesAT, 
VpAT and PAM can be developed to become suitable biocatalysts for the industrial scale 
synthesis of aromatic β-amino acids. For example, while a method was developed for the 
asymmetric synthesis of (S)-β-phenylalanine using MesAT as a biocatalyst, the method 
utilizes (R)-3-aminobutyric acid as an amino donor (a β-amino acid), and the ethyl-ester 
derivative of the keto-acid of (S)-β-phenylalanine (3-oxo-3-phenylpropionic acid) as amino 
acceptor (Kim et al., 2007). The method requires the addition of a lipase to the reaction 
mixture, since the ethyl-ester derivative of 3-oxo-3-phenylpropionic acid is not a MesAT 
substrate. In addition, the specific activity of MesAT in comparison to VpAT is relatively 
low. VpAT is therefore a more attractive biocatalyst for the asymmetric synthesis of (S)-β-
phenylalanine than MesAT also because VpAT is active over a broad pH range. Nonetheless, 
it remains to be seen whether VpAT, via protein engineering efforts, can be engineered to 
directly accept the ethyl-ester of 3-oxo-3-phenylpropionic acid, or can be engineered to 
allow the asymmetric synthesis of dicarboxylic β-amino acids.
For PAM it would be beneficial to develop an even more efficient biocatalyst. Previous 
investigations have already shown that PAM can be used to synthesize enantiopure 
preparations of (R)-β-phenylalanine via the asymmetric amination of trans-cinnamic 
acid (Wu et al., 2009; Wu et al., 2012). Although recent investigations have succeeded in 
increasing the trans-cinnamic acid amination efficiency two-fold upon by mutagenesis of 
the PAM lid-loop (Bartsch et al., 2013), this increase may still be too low to satisfy industrial 
requirements for (R)-β-phenylalanine synthesis. Further research into the factors that govern 
the efficiency of the PAM trans-cinnamic acid amination reaction is therefore required.
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